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This thesis includes work dealing with topics related to the modeling, understanding, and
controlling the acute inammatory response. After the introductory chapter, the second
chapter discusses a small (four equation) ordinary di¤erential equation (ODE) model of the
acute inammatory response to endotoxin stimuli. Many scenarios of endotoxin tolerance
are reproduced and explained in the context of inammation. The third chapter explores the
numerical aspects of coding an algorithm produced by Bernd Krauskopf and Hinke Osinga
[63] for generating 2D (un)stable manifolds for 3D ordinary di¤erential equation systems.
The fourth chapter returns to the topic of endotoxin tolerance, but now in an abstract
mathematical setting. The fth chapter presents an exposition regarding the application
of nonlinear model predictive control to the four equation ODE model (now with pathogen
instead of endotoxin) to explore strategies to modulate the inammatory response during
severe infection.
iii
TABLE OF CONTENTS
PREFACE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xii
1.0 INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1 Using Mathematical and Engineering Tools to Study the Acute Inammatory
Response . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1.1 Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1.2 Prior Research and Current Directions . . . . . . . . . . . . . . . . . . 3
1.2 Interesting Biology-Inspired Mathematical Problems . . . . . . . . . . . . . 7
1.2.1 Manifolds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
1.2.2 Endotoxin Tolerance from a Purely Mathematical Perspective . . . . . 8
1.3 Organization of Thesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
2.0 MODELING ACUTE INFLAMMATION AND ENDOTOXIN TOL-
ERANCE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
2.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
2.2 A mathematical model of the acute inammatory response to endotoxin . . 13
2.3 Model simulations of experimental scenarios Endotoxin tolerance scenario . 17
2.3.1 Endotoxin tolerance scenarios . . . . . . . . . . . . . . . . . . . . . . 17
2.3.2 Potentiation scenarios sub-lethal and lethal doses . . . . . . . . . . . . 27
2.4 The importance of the dynamics of the late proinammatory and anti- in-
ammatory mediators to tolerance . . . . . . . . . . . . . . . . . . . . . . . 31
2.5 Insight from the models responses to endotoxin administration . . . . . . . 34
2.6 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
2.7 Supplementary materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
iv
3.0 AN IMPLEMENTATION OF AN ALGORITHM FOR GENERAT-
ING 2-D (UN)STABLE MANIFOLDS FOR 3-D ODE SYSTEMS . . . 51
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
3.2 The Algorithm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
3.3 Implementation Using MatLab . . . . . . . . . . . . . . . . . . . . . . . . . 60
3.4 Limitations and challenges . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
4.0 MATHEMATICAL EXPLORATION OF TOLERANCE . . . . . . . . . 110
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
4.2 Preliminary Denitions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112
4.3 Theorems extending the window of tolerance . . . . . . . . . . . . . . . . . 114
4.4 First Observations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 120
4.5 Tolerance in General 2D Linear ODE systems . . . . . . . . . . . . . . . . . 128
4.5.1 Setup . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 128
4.5.2 Case 1: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 128
4.5.3 Case 2: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 130
4.5.3.1 Case 2a: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131
4.5.3.2 Case 2b: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132
4.5.4 Case 3: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 135
4.5.4.1 Case 3a: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136
4.5.4.2 Case 3b: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136
4.5.4.3 Case 3c: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 137
4.5.5 Eigenvector Congurations and Regions of Tolerance . . . . . . . . . . 139
4.5.5.1 Eigenvector Conguration (a): . . . . . . . . . . . . . . . . . . 140
4.5.5.2 Eigenvector Conguration (b): . . . . . . . . . . . . . . . . . . 145
4.5.5.3 Eigenvector Conguration (c) . . . . . . . . . . . . . . . . . . 150
4.5.5.4 Eigenvector Conguration (d) . . . . . . . . . . . . . . . . . . 155
4.5.6 Examples . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 160
4.6 Tolerance in 2D General Nonlinear ODE Systems . . . . . . . . . . . . . . . 167
4.6.1 Isoclines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 169
4.6.2 Numerical Approaches for Finding Tolerance . . . . . . . . . . . . . . 190
v
4.6.2.1 Tolerance Algorithm . . . . . . . . . . . . . . . . . . . . . . . 190
4.6.2.2 Isoclines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 193
5.0 USING NONLINEAR MODEL PREDICTIVE CONTROL TO FIND
OPTIMALTHERAPY STRATEGIES TOMODULATE INFLAMMA-
TION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 197
5.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 197
5.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 199
5.3 Research and Development Phase . . . . . . . . . . . . . . . . . . . . . . . . 204
5.3.1 Conguration 1: No Mismatch; 1 Therapy . . . . . . . . . . . . . . . 204
5.3.2 Conguration 2: No Mismatch; 2 Therapies . . . . . . . . . . . . . . 208
5.3.3 Conguration 3: Patient-Model Mismatch; 2 Therapies . . . . . . . . 209
5.3.4 Extraction Therapy Considered . . . . . . . . . . . . . . . . . . . . . 215
5.3.5 Conguration 4: Patient-Model Mismatch; 2 Therapies; Pathogen Up-
date; CA therapy cap . . . . . . . . . . . . . . . . . . . . . . . . . . . 217
5.4 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 222
5.4.1 Alternative Therapies for Multi-Patient Simulations . . . . . . . . . . 222
5.4.2 Results: Conguration 1 . . . . . . . . . . . . . . . . . . . . . . . . . 224
5.4.3 Results: Conguration 2 . . . . . . . . . . . . . . . . . . . . . . . . . 232
5.4.4 Results: Conguration 3 . . . . . . . . . . . . . . . . . . . . . . . . . 234
5.4.5 Results: Conguration 4 . . . . . . . . . . . . . . . . . . . . . . . . . 239
5.4.6 Preliminary Results: Current/Future Congurations . . . . . . . . . . 243
5.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 245
6.0 CONCLUSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 247
APPENDIX. GLOSSARY OF ABBREVIATIONS . . . . . . . . . . . . . . . 250
BIBLIOGRAPHY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 252
vi
LIST OF TABLES
1 Model parameter names and values used in simulations . . . . . . . . . . . . 15
2 Scenario 1 (adapted from the experiments of Sly et al., 2004) . . . . . . . . . 19
3 Scenarios 2a - 2c (adapted from the experiment of Wysocka et al., 2001) . . . 19
4 Scenarios 3a - 3c (adapted from the experiments of Rayhane et al., 1999) . . 20
5 Scenario 4 (adapted from the experiments of Balkhy et al., 1999) . . . . . . . 20
6 Scenario 5 (adapted from the experiments of Berg et al., 1995) . . . . . . . . 20
7 Endotoxin administration parameter values and gure references for in silico
simulations of Scenarios 1-8 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
8 Explanation of model parameters used in simulations . . . . . . . . . . . . . . 50
9 Model parameter ranges for Conguration 3 . . . . . . . . . . . . . . . . . . . 211
10 Model parameter ranges for Conguration 4 . . . . . . . . . . . . . . . . . . . 219
11 Results for Conguration 3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 237
12 Uber Standard Therapy Results for Conguration 3 . . . . . . . . . . . . . . 239
13 Results for Conguration 3 with Direct Pathogen Update . . . . . . . . . . . 240
14 Results for Conguration 4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 241
15 Results for Work in Progress . . . . . . . . . . . . . . . . . . . . . . . . . . . 244
vii
LIST OF FIGURES
1 Basic endotoxin administration scenarios. . . . . . . . . . . . . . . . . . . . . 18
2 Numerical results of simulations following scenario 1 in Table 2. . . . . . . . . 23
3 Numerical results of simulations following scenarios 2a2c in Table 3. . . . . . 24
4 Numerical results of simulations following scenarios 3a3c in Table 4. . . . . . 25
5 Numerical results of simulations following scenario 4 in Table 5. . . . . . . . . 26
6 Numerical results of simulations based on scenario 5 in Table 6. . . . . . . . . 28
7 Numerical results of simulations for sub-lethal potentiation scenario. . . . . . 29
8 Numerical results of simulations for lethal potentiation scenario. . . . . . . . 30
9 Instantaneous versus continuous endotoxin administration. . . . . . . . . . . . 32
10 Endotoxin tolerance (based on scenario 1) illustrated with the N*-CA phase
plane. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
11 Potentiation (based on scenario 6) illustrated with the N*-CA phase plane. . 38
12 Rescue scenario in the N*-D-CA phase space. . . . . . . . . . . . . . . . . . . 39
13 Dependence of tolerance on preconditioning dose timing and magnitude. . . . 42
14 Initial discrete circle around the Saddle Point . . . . . . . . . . . . . . . . . . 55
15 The half plane perpendicular to the previous circle at point, r . . . . . . . . . 56
16 Example trajectories illustrating the shooting method for nding the next point
on the plane in the mesh of the stable manifold . . . . . . . . . . . . . . . . 56
17 The rst two bands of the stable manifold, connected via a triangular mesh . 57
18 A view of the stable manifold of the origin in the Lorenz system . . . . . . . 58
19 A view of the stable manifold of the origin in the Lorenz system . . . . . . . 59
20 A closeup of the mesh of the Lorenz manifold . . . . . . . . . . . . . . . . . . 60
viii
21 The original trajectory and the curve of all possible shifted points. . . . . . . 112
22 Illustration for Proposition 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . 114
23 Illustration for Theorem 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
24 Illustration of the case when the original and competing trajectories converge
monotonically in the rst component and lie on the same solution curve. . . 122
25 Illustration for Proposition 10 . . . . . . . . . . . . . . . . . . . . . . . . . . 124
26 Regions in the rst quadrant for all relevant eigenvector congurations . . . . 140
27 Eigenvector congurations . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
28 Eigenvector conguration (a) with the rst quadrant divided into three regions. 143
29 Eigenvector conguration (a) with an arbitrary initial condition labeled in
Region 1a. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
30 Eigenvector conguration (b) with the rst quadrant divided into three regions.146
31 Eigenvector conguration (b) with an arbitrary initial condition labeled in
Region 1b. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 147
32 Eigenvector conguration (b) with an arbitrary initial condition labeled in
Region 2b. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 148
33 Eigenvector conguration (b) with an arbitrary initial condition labeled in
Region 3b. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149
34 Eigenvector conguration (c). . . . . . . . . . . . . . . . . . . . . . . . . . . . 152
35 Eigenvector conguration (c) with an arbitrary initial condition labeled in
Region 1c. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152
36 Eigenvector conguration (c) with an arbitrary initial condition labeled in
Region 2c. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 153
37 Eigenvector conguration (c) with an arbitrary initial condition labeled in
Region 3c. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 154
38 Eigenvector conguration (d). . . . . . . . . . . . . . . . . . . . . . . . . . . . 157
39 Eigenvector conguration (d) with an arbitrary initial condition labeled in
Region 1d. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 157
40 Eigenvector conguration (d) with an arbitrary initial condition labeled in
Region 2d. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 158
ix
41 Linear Example 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 160
42 Linear Example 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161
43 Linear Example 3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 162
44 Linear Example 4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 163
45 Linear Example 5 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
46 Linear Example 6 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 165
47 Linear Example 7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 166
48 The isoclines for the linear system given in Example 8. . . . . . . . . . . . . . 173
49 Isoclines and shifted points in Example 8. . . . . . . . . . . . . . . . . . . . . 175
50 Regions I-IV dening the relationship between the coe¢ cients of the analytic
solutions of original trajectory and the competing trajectory in Example 8. . 177
51 The lines that form the regions I-IV, overlayed on the content shown in Figure
49. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 178
52 Isoclines for Example 9. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 180
53 Isoclines and shifted points in Example 9. . . . . . . . . . . . . . . . . . . . . 181
54 Numerical evidence of tolerance in Example 9. . . . . . . . . . . . . . . . . . 183
55 Important features of Example 10. . . . . . . . . . . . . . . . . . . . . . . . . 184
56 Isoclines for Example 11. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 185
57 Isoclines and shifted points for Example 11. . . . . . . . . . . . . . . . . . . 187
58 Isoclines and trajectories for Example 11. . . . . . . . . . . . . . . . . . . . . 189
59 Numerical results from the application of the tolerance algorithm to Example
11. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 189
60 Comparison of numerical results and the results acquired from the isocline
method and the linear method for Example 8. . . . . . . . . . . . . . . . . . . 194
61 A sample simulation from a simulation incorporating four therapies. . . . . 216
62 The scatterplot showing the distribution of patient outcomes with respect to
pathogen growth rate and the inital value of pathogen. . . . . . . . . . . . . . 218
63 An example of a standard therapy dose prole. . . . . . . . . . . . . . . . . . 223
64 An example of a simulation under Conguration 1 with an aseptic outcome for
the placebo case. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 226
x
65 Example of Conguration 1, where the septic response in Figure 67 is modu-
lated with therapy from the NMPC algorithm. . . . . . . . . . . . . . . . . . 227
66 The simulation shown in Figure 65 is rerun with a heavy weight on Damage. 228
67 An example of a simulation under Congurations 1 and 2 with a septic outcome
for the placebo case. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 229
68 The NMPC algorithm is run on he septic scenario under Conguration 1 shown
in Figure 67. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 230
69 Th simulation run in Figure 68 for the septic scenario under Conguration 1
is rerun with a signicant weight increase on Damage. . . . . . . . . . . . . 231
70 An example of a simulation under Conguration 2, where the septic response
presented in Figure 67 has been modulated with therapy fromt the NMPC
algorithm. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 233
71 40 hour intervention time for NMPC simulation run on septic scneario of Figure
67. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 235
xi
PREFACE
I would like to extend my thanks to the following people who have played a
direct role in the completion of my thesis:
 Jonathan Rubin - my primary advisor, who stepped in to that role after a job transition
that took my initial advisor away from Pittsburgh. Thank you for working together to
make the switch over a smooth process, keeping me connected to the projects in which
I was already involved. Thank you as well for helping to continue my support as a GSR
through the years and for your advice and opinions on matters with which a graduate
student has limited experience. Lastly, I often smile thinking of some of our meetings,
where afterward I knew that I had probably talked too fast and too much, possibly
leaving your head spinning from the rush of many trains of thoughts that just ew
by. Your patience to endure my loquaciousness is, Im sure, a quality betting a saint!
(Although, perhaps you knew what you were getting yourself into after overhearing me
teach a calculus recitation that rst year.)
 Carson C. Chow - my initial advisor and co-advisor, who rst opened the door for
me into the world of bio math and encouraged me to step through, supporting my early
research generously with equipment and supplies whenever needed. Thank you for
extending the option of and entrusting me with the wonderful opportunity of a GSR
appointment in the very early stages of my graduate career. I have always been grateful
for that privilege and I attribute it to one of the things that enabled me to continue
along this path without crashing and burning.
 Gilles Clermont - a member of my thesis committee, colleague, and friend, whose
undying optimism always chose to speak about things that were not as though they were
(e.g.Dr. Day). I have enjoyed collaborating with you and look forward to future
xii
opportunities. You have also been responsible for my continued support as a GSR and
I have been thankful for this continued support. In addition, you and Anne-Marie have
been a great encouragement to me. I will always cherish the excursions after conferences
that I was able to make with you and A-M in Germany. You both have been so generous
and provided me with such great opportunities. Thank you!
 Yoram Vodovotz - a member of my thesis committee, one of my most enthusiastic
colleagues, and a great conversationalist, who has continued to keep me connected to the
big picture concerning our research and whose optimism has kept me hopeful about the
possibilities. Thank you for your encouragement and willingness to o¤er opportunities
to me to develop my professional path and for your advice along the way. I look forward
to working toward those possibilities about which you have remained fervent.
 Beatrice Riviere - a member of my thesis committee, whose encouraging words during
the stressful nishing stages lifted some of the weight o¤ of my shoulders. I appreciate
your willingness to serve on my committee and thank you for bringing a constructive,
positive presence to the table.
I would also like to thank my family and friends for their support, encour-
agement, and love throughout the years:
 My parents, who have patiently waited a long time to see me nally nish school for
good.
 My in-laws, who have abundantly poured their love into my life for the 6 wonderful years
that I have known them so far.
 My sister, Jennifer, who is one of my closest friends since we stopped borrowing each
others clothes and grew up enough to realize what a gift it is to have a sister
 Gabrielle and Ray Kardohely - faithful friends from day one!
 My brother, Eric, who let me play with his Legos and matchbox cars when we were kids,
which probably helped develop some of the skills that enabled me to get this far
 My sister-in-law, Jenni, who is a good friend and who leaves the most amusing messages
on our answering machine
xiii
 My brother-in-law, Jacob, whose G-mail chats were always a most welcome interruption
 Angela Reynolds, who has worn many hats for me: good friend, colleague, o¢ ce mate,
collaborator, GSO copresident, walking partner along with a dozen others
 Jyotsna Didwadkar, who has been a joy to get to know and whose vocabulary I highly
envy
 Stephanie Hoogendoorn, who has showed me a smile and given time to entertain my
ramblings from the very rst day we met
 Chris and Bojana Jones, who are great, fun friends and who have greatly empathized
with me during all the nal stages of the creation and submission of this thesis
 Jerry Day, who Im taking with me when I leave
xiv
1.0 INTRODUCTION
1.1 USING MATHEMATICAL AND ENGINEERING TOOLS TO STUDY
THE ACUTE INFLAMMATORY RESPONSE
The use of tools from mathematics and engineering is becoming more widespread for gaining
insight into biological phenomena and making advances in the medical industry by assisting
with practical solutions to clinical challenges in the treatment of patients. The "math-
ematical biology" community is no longer simply made up of mathematicians looking for
interesting mathematical problems arising from biological phenomena. Crossdisciplinary
research groups, consisting of mathematicians and engineers as well as clinicians and exper-
imentalists are no longer the exception, with many realizing that research is most e¤ective
when there are di¤erent yet complementary areas of expertise involved. This is certainly
the case with respect to the research that has focussed on understanding the dynamics and
complexities of the acute inammatory response.
1.1.1 Background
The initial response of the body to acute biological stress such as bacterial infection or
tissue trauma is an acute inammatory response. This response involves a cascade of events
mediated by a large array of cells and molecules that locate invading pathogens or damaged
tissue, alert and recruit other cells and e¤ector molecules, eliminate the o¤ending agents, and
restore the body to equilibrium. [55] Ideally, the inammatory response works e¤ectively
in this manner; however, there are times when inammation can rise out of control, leaving
the body susceptible to massive tissue damage, eventually leading to multi-organ failure and
1
death. [70, 56, 103, 107]
Inammation, while necessary for successful eradication of harmful agents, can cause
more inammation via a positive feedback loop. The cells and molecules that initially re-
spond can cause damage, by either crowding an area or as a result of the release of molecules
such as nitric oxide and superoxide intended to destroy foreign entities. [83, 57, 7] Conse-
quently, damaged cells send signals upon death that alert the body of danger, since o¤ending
agents are typically the cause of damaged tissue. This, in turn, brings about the recruit-
ment of more inammatory mediators that attempt to help remedy the situation, causing a
necessary yet, potentially, dangerous positive feedback loop. [53, 74]
There are anti-inammatory mediators present to help control inammation; however
in cases of severe inammation, these may be rendered ine¤ective. In addition, anti-
inammatory mediators might be initially suppressing inammation and working against the
purpose of eliminating the o¤ender, allowing it, instead, to grow uncontrolled and destroy
more tissue. [14] Ideally, an optimal strategy exists between pro- and anti- inammatory
mediators for eliminating the o¤ending agent, while not accruing excessive tissue damage.
This ideal, however, is a delicate balancing act. [93, 94]
Laboratory experiments have shed enormous light on various signaling pathways and
mediators responsible for inammation. [85, 90] However, the highly nonlinear, systemic
nature of the problem has made it extremely di¢ cult to gain understanding of the process as
a whole from experimentation alone, much less generate e¤ective strategies to correct immune
dysfunction. As noted in the paper by Vodovotz et al, the limitations of animal models have
reduced results to highly specic information available at only a few time points, making it
di¢ cult to interpret the results with respect to the global problem. [112] Therapies that
have been found to be successful in such experiments have mostly been unable to improve
survival in large clinical trials. [15, 71]
One reason for a lack of e¤ective therapies in combatting uncontrolled inammation is
due to the fact that most were designed to target one specic mediator of inammation.
However, mediators that may be the cause of inammation during one phase of the response
might be completely irrelevant at a later point in time. In addition, the inammatory
response to an insult is dependent on a number of patient factors, including age, genetic
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predisposition, and gender. Clinical manifestations of an insult might be very similar in
di¤erent individuals, yet treatment might help one and not the other. During the course
of an inammatory response to an insult, a single patient at di¤erent times can experience
being hyper-inamed or immunosuppressed. Hence, the timing of events in the inammatory
cascade is crucial to understanding when and how a therapy will be e¤ective. In addition,
the need for therapies tailored for individual patients, as well as therapies that target multiple
mediators, is apparent. [13, 26]
In 2004, the U.S. Food and Drug Administration (FDA) reported that "A new product
development tool kitcontaining powerful new scientic and technical methods such as ani-
mal or computer-based predictive models, biomarkers for safety and e¤ectiveness, and new
clinical evaluation techniquesis needed to improve predictability and e¢ ciency along the
critical path from laboratory concept to commercial product." [39] The use of mathematical
models, which can be subject to a countless number of numerical experiments, has allowed
for unhindered exploration of the acute inammatory response in general, as well as specic
problems that can arise in a response. In addition, the cost of using these tools are minis-
cule compared to the cost of wet lab experiments. This is not to assert that traditional
laboratory experimentation is obsolete and of little value, but, rather, to emphasize again
the importance of using as many available resources as possible. Mathematical models are
not perfect and need verication and validation from classical experimental studies.
It has been a¢ rmed and rea¢ rmed that a systems approach to understanding inam-
mation is imperative. [16, 39, 109] Highlights from some of the prior and current research
using mathematical models for exploring the intricacies of the acute inammatory response
are now discussed.
1.1.2 Prior Research and Current Directions
In general, mathematical modeling of biological systems, especially with ordinary di¤eren-
tial equations, is not novel. Mathematical models of the immune system have appeared in
literature in some form for more than a decade from the date of this writing (see, for exam-
ple, [75]) and there are a plethora of models describing the pathogenesis of any number of
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diseases, such as HIV, tuberculosis, and cancer. [61, 92, 88] There are also plenty of books,
some dating from the 1970s about mathematical modeling in biology and the subsequent
analysis of them. [80, 81, 34, 99] Even so, with each new biological discovery and with
the wealth of data that has been acquired from experiments, there is still plenty of room
for new and improved models. In particular, only recently have clinical researchers begun
to understand the complex ubiquitous role that inammation plays in the pathogenesis of
many di¤erent diseases. The push to understand this systemic process has emerged as a
major focus of research groups worldwide. In fact, the Society for Complexity in Acute Ill-
ness (http://www.scai-med.org/ ) was formed specically to bring together "clinicians, bench
scientists, and modelers" from "hospitals, research institutions, and companies" to bridge
the gap between the discoveries made under the microscope and the patient in the intensive
care unit.
The primary approaches to modeling inammation have consisted of modeling with or-
dinary di¤erential equations (ODE), partial di¤erential equations (PDE), and agent based
modeling (ABM). This dissertation joins a substantial body of work that has sought insight
and answers to inammation related problems. In 2004, a review of some ODE and ABM
models of inammation was made by Vodovotz et al. [113]. In this review, the strengths
and weaknesses of both types of models are given, along with some examples. [4, 5, 21, 22]
ODE models, while conducive to rigorous mathematical modeling, can become very complex
as the number of equations increases, making them di¢ cult to calibrate and validate with
experimental data. ABM models, which lend themselves to being easily constructed and in-
terpreted, especially for nonmathematicians, can be computationally expensive to simulate
with the number of agents needed to represent the system. It is also di¢ cult to analyze the
mechanisms of such a system. As a result, validation can be di¢ cult to carry out on such
models. However, in both cases progress has been made toward nding ways to improve
the accuracy and prediction power of these models.
A more recent and comprehensive review by Vodovotz [110] is an update discussing
modications and improvements to the models previously discussed as well as new ODE
and ABM models that deal with various aspects of inammation. The models described in
[20, 112, 114] are large scale ODEmodels consisting of 15-31 di¤erential equations, describing
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the interactions of many of the cells, cytokines, and other molecules that play a role in the
inammatory cascade. These models may have several di¤erent instigators of inammation,
such as pathogen (bacteria), bacterial Lipopolysaccharide (LPS or endotoxin), trauma, or
hemorrhagic shock. Because of the high detail of these models, they can be used for
qualitative as well as quantitative insights. The many parameters that exist due to the
large number of equations are mostly determined via methods that t the model dynamics
to existing animal data. Typically, the model is t to a set or two of data for particular
scenarios (for instance, an initial load of 3mg/kg or 6mg/kg of endotoxin) and then used to
predict a separate set of data for a di¤erent scenario (an initial load of 12 mg/kg endotoxin)
as validation of the models accuracy and prediction capability.
The models presented in [77, 69] are ABM models of inammation and wound heal-
ing used in the setting of diabetic foot ulcer pathology and biomechanical stresses related to
phonotrauma. These models qualitatively reproduce behaviors and make predictions consis-
tent with the literature and recent experimental ndings. Another model under construction
by Reynolds et al. explores the e¤ect of inammation on gas exchange in the lung, using
a combination of partial di¤erential equations and ordinary di¤erential equations. In this
model, tissue is treated as a separate spatial compartment. This allows for the exploration
of the e¤ects of inammation on the di¤usion of gas molecules in the context of an infection
that rst started either in the blood or in tissue. To simplify the computational aspects of
the model, the equations representing the gas molecules were reduced to ordinary di¤erential
equations. [97]
The models presented in [65, 98, 28] are small scale ODE models containing 3, 4 and 4
di¤erential equations, respectively. These models qualitatively, rather than quantitatively,
reproduce biologically observable behavior of the inammatory response to either pathogen
[65, 98] or endotoxin [28]. The variables or mediators that are modeled in these examples
represent general characteristics of several actual mediators rather than specic cells or mole-
cules. For instance, one variable might be labeled the "early pro-inammatory" mediator,
which could be representative of a host of cells and molecules that have pro-inammatory
e¤ects early in the course of an inammatory response to an insult. Even though general-
izations like this are made, these models have not only qualitatively reproduced the di¤ering
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clinical and experimental outcomes that are seen with mild to serious infections, but have
added insight into the nature and behavior of inammation for various insults.
In [65], a three equation model was presented which included an equation for the inam-
matory instigator, pathogen, and two equations for inammatory mediators, one directly
incited by pathogen and the other indirectly incited by the rst pro-inammatory mediator
in a positive feedback loop. Based simply on varying the initial magnitude of the pathogen
insult, three di¤erent outcomes were possible in the model:
 healthy: all mediators resolve to baseline levels
 aseptic: pathogen is eliminated, but the other mediators remain elevated
 septic: All mediators as well as pathogen remain elevated
Analysis of the model led to suggestions of possible therapeutic interventions to correct an
aseptic or septic outcome and the insight that "the clinical condition of sepsis can arise from
several distinct physiological states, each of which requires a di¤erent treatment approach."
In [98], a four equation model was constructed based on the idea founded in [65] of
using general variables to represent characteristics of the inammatory response. However,
not only was a fourth equation representing an anti-inammatory mediator added, but a
model was constructed anew using an approach involving the creation of simple subsystems
between the mediators. For instance, the subsystem consisting of pathogen and the early
pro-inammatory mediator was constructed to ensure the desired bistability of an excitable
system (i.e. health and death states would be both possible based on initial magnitude
of the insult). This model also qualitatively reproduced the di¤erent clinically observable
outcomes mentioned above based on the magnitude and strength of the pathogen insult.
Moreover, with the addition of an anti-inammatory mediator, the authors were able to
highlight "the importance of dynamic antiinammation in promoting resolution of infection
and homeostasis." In addition, a simple therapeutic intervention involving the increase or
decrease of the anti-inammatory levels in the model during the course of the infection was
explored. The authors showed that in some cases an addition of anti-inammation would
be benecial, while in other cases it could be problematic and even detrimental to recovery.
Also shown, was that the ability to remove anti-inammation could be benecial in cases
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where a pathogen was particularly virulent and the patient would need maximum host defense
to overcome the infection. Consequently, it is obvious that there is a need for a systematic
approach to nding the proper type, timing, and dosage amount of therapy. This is the
subject of Chapter 5 of this dissertation where nonlinear model predictive control, a tool
typically used in engineering applications, is utilized to nd appropriate ways to administer
di¤erent types of therapy, both pro- and anti-inammatory.
In [28], the model from [98] is slightly modied to have endotoxin as the inammatory
response instigator instead of pathogen. As will be discussed in Chapter 2, endotoxin is a
highly conserved, highly immunogenic, constituent molecule of the outer cell wall of Gram-
negative bacteria. When bacteria are lysed by immune e¤ector cells and molecules, surges
of endotoxin may be released into the host, intensifying the inammatory response and
causing further activation of immune e¤ector cells [2, 54]. It has been observed that in some
instances repeated doses of endotoxin result in a considerably less vigorous immune response,
a phenomenon referred to as endotoxin tolerance [10]. In fact, the induction of tolerance can
greatly blunt the e¤ect of a dose of endotoxin that would be lethal to a naïve animal. There is
also the more intuitive observation that repeated doses of endotoxin result in a more vigorous
immune response (potentiation). In this work, we suggest via the mathematical model that
endotoxin tolerance is a direct result of the dynamic interactions between components of
innate immunity, rather than a specic, distinct phenomenon.
1.2 INTERESTING BIOLOGY-INSPIRED MATHEMATICAL PROBLEMS
Although mathematical biology has become much more application focussed, there are still
interesting mathematical problems that arise in the study of biological systems, which may
not necessarily have direct application to the biological problem from which they originated.
In other words, although the subsequent research may add some insight into the biology
or assist in visualization and understanding, the results might be much more interesting
and signicant from a mathematical perspective. Two such problems originated from the
research discussed in Chapter 2 with respect to endotoxin tolerance, both of which t nicely
into dynamical systems theory.
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1.2.1 Manifolds
In Chapter 2, an illustration is presented showing a type of threshold or "dividing line"
between two di¤erent steady states of the system, representing two very di¤erent outcome:
life and death, or healthy and unhealthy. This divider is formally known as the separatrix
and it consists of the stable manifold of the saddle point in a particular phase space. Initial
conditions that begin on one side of this structure will evolve to the healthy state, while those
beginning on the other side approach the unhealthy xed point. The fascinating aspect of
this structure is that the future trajectory of any initial condition is completely determined
by which side of the manifold the initial condition lies.
If one considers this as a representation of what happens to a patient in the absence of
any therapy, the fate of the patient can be determined solely from the initial starting point.
Unfortunately, in practice, it is virtually impossible to know a patients "starting conditions"
since the manifestations of an infection do not always appear immediately, not to mention
that measurements of crucial entities such as pathogen concentration and growth rate are
impossible to acquire. Hence, this tool, while instructive for illustration purposes, holds
little direct application to helping predict patient outcome.
However, the ability to numerically generate this structure is an extremely interesting
dynamical systems problem and one that many have successfully solved. [30, 31, 32, 33,
44, 46, 58, 63] Unfortunately, there is no software or code currently available. Hence, the
focus of Chapter 3 is with respect to the implementation of one of these algorithms, due
to Krauskopf and Osinga. [63] Although the actual algorithm is not a part of the original
content of this thesis, the code implementing the various steps is, since there exist several
key computational challenges that arise for some of the steps in the algorithm that are not
explicitly discussed in the original authorspaper.
1.2.2 Endotoxin Tolerance from a Purely Mathematical Perspective
Endotoxin tolerance as well as its counterpart, potentiation, are well established and thor-
oughly explored issues in the biological and experimental literature. (See [10, 27, 102, 119])
As mentioned previously, Chapter 2 discusses a model that reproduces many scenarios that
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exhibit endotoxin tolerance. One of the model mediators represents the tolerance variable,
or the component that experiences a blunting (or potentiating) a¤ect to repeated doses
of endotoxin. Tolerance can be seen when time courses of this mediator for single dose
simulations (original) versus repeated dose simulations (competing) are compared. When
overlapped on a graph, the competing time course which initially starts at a higher value in
this component, will at some time point manage to descend to a lower value in this compo-
nent, compared to the original single dose time course. In essence, it can be thought of as
a type of race.
This idea, brought up during the course of researching endotoxin tolerance with this
ODE model, made it evident that the tolerance behavior may not be unique to this one
system of equations. In fact, the problem deals with transient behavior of a dynamical
system, something not very well developed in the theory. In order to pursue this idea in a
purely dynamical systems context, the concepts of tolerance and potentiation are formalized
mathematically.
From this, statements and theorems are made regarding the existence of tolerance in
two-dimensional linear and non-linear systems. The 2D linear case has been characterized
completely. The 2D nonlinear case is much more complicated than the linear case and
requires substantial creativity because analytical solutions are not generally available for
nonlinear systems and tools for studying transients are not well developed. Nevertheless,
signicant progress has been made toward pinpointing when tolerance can be exhibited in a
system. These ideas and results are presented in Chapter 4.
1.3 ORGANIZATION OF THESIS
The chapters of this thesis are organized as follows:
 Chapter 1 is dedicated as this introduction.
 Chapter 2 presents the ODE model of the acute inammatory response to endotoxin and
the results and insights from reproducing various experimental scenarios of endotoxin
tolerance.
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 Chapter 3 discusses the MatLab computer program used to generate the two-dimensional
stable manifold shown in the second to last gure of Chapter 2.
 Chapter 4 introduces the theoretical work done with respect to mathematically formaliz-
ing the idea of the tolerance phenomenon that was discussed in an experimental setting
in Chapter 2.
 Chapter 5 explores the application of nonlinear model predictive control to nding ther-
apeutic strategies to assist with immunomodulation of the acute inammatory response
during the course of an infection.
 Chapter 6 gives a brief summary of the results acquired, the challenges faced, and the
ideas for future extensions and improvements.
 Glossary of Abbreviations
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2.0 MODELING ACUTE INFLAMMATION AND ENDOTOXIN
TOLERANCE
2.1 INTRODUCTION
The initial response of the body to acute biological stress such as bacterial infection or
tissue trauma is an acute inammatory response. This response involves a cascade of events
mediated by a large array of cells and molecules that locate invading pathogens or damaged
tissue, alert and recruit other cells and e¤ector molecules, eliminate the o¤ending agents,
and restore the body to equilibrium. Bacterial lipopolysaccharide (LPS; endotoxin) is a
highly conserved, highly immunogenic, constituent molecule of the outer cell wall of Gram-
negative bacteria. When bacteria are lysed by immune e¤ector cells and molecules, surges of
endotoxin may be released into the host, intensifying the inammatory response and causing
further activation of immune e¤ector cells [2, 54]. In fact, the administration of antibiotics
can lead to pulses of endotoxin release from Gram-negative bacteria as the antibiotics kill the
invading bacteria, conrming the clinical importance of this subject matter[35]. Since direct
endotoxin administration in animals and humans can induce an acute inammatory response
that reproduces many of the features of an actual bacterial infection, such as fever, it stands
as a valid experimental model for investigating the inammatory response [23, 79, 91].
High doses of endotoxin can be lethal, even though this bacterial byproduct does not
proliferate as a Gram-negative bacteria would [104]. It has been observed, however, that in
some instances repeated doses of endotoxin result in a considerably less vigorous immune
response, a phenomenon referred to as endotoxin tolerance [10]. In fact, the induction
of tolerance can greatly blunt the e¤ect of a dose of endotoxin that would be lethal to a
naive animal. A variety of studies have followed up on Beesons initial reports of endotoxin
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tolerance (for a historical perspective see Cross [27]; Schade [102]; West and Heagy [119]).
Experimentally, it is now possible to assess the activation status of inammatory cells or the
levels of signaling proteins, such as cytokines, in organs or the blood as direct measures of
inammation [82, 84]. The cytokine Tumor Necrosis Factor- (TNF ) in blood serum, for
instance, has become a prominent marker of inammation [55, 101]. Thus, observing that
the concentration of this cytokine is lower than levels normally observed after endotoxin
administration suggests that inammation is being suppressed.
Interestingly, the inverse phenomenon, called potentiation, has also been observed. In the
extreme, an otherwise non-lethal dose of endotoxin rapidly following another non-lethal dose
can result in death [18]. We hypothesized that a simple mathematical model of the acute
inammatory response could reconcile tolerance and potentiation, on the premise that the
observed outcomes result from dynamic interactions between components of innate immunity.
Accordingly, we adapted a recently developed computational model of the inammatory
response [98] and simulated various scenarios involving repeated endotoxin administration.
We use actual experimental mouse scenarios to guide in silico experiments that recreate these
scenarios qualitatively, including the phenomena of endotoxin tolerance and potentiation.
In our simulations, we nd that both the timing and magnitude of endotoxin doses,
relative to each other and to the dynamical interplay between pro- and anti-inammatory
mediators, are central in discriminating between the seemingly disparate phenomena of en-
dotoxin tolerance and potentiation. Our results, derived from a mathematical model not
constructed specically to address the issue of preconditioning, support the perspective that
endotoxin tolerance and related phenomena could be better explained and understood as
inammatory-stimuli-inducede¤ects rather than specic, distinct phenomena [18]. This
perspective is also supported by studies showing that various inammatory stimuli (e.g.
trauma, hemorrhage, cytokines) can act either to tolerize or to prime the host for subse-
quent homologous or heterologous stimuli [17, 19, 59, 60, 67, 76, 115, 125]. The intent here
is not to carry out a detailed mathematical analysis of our model. Rather, we hope to
argue convincingly that endotoxin tolerance, potentiation, and other phenomena related to
repeated endotoxin administration are best viewed and understood via the acute inamma-
tory response [23, 122] and to demonstrate this with a mathematical model of that response.
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2.2 A MATHEMATICAL MODEL OF THE ACUTE INFLAMMATORY
RESPONSE TO ENDOTOXIN
To examine repeated endotoxin administration in the context of the acute inammatory
response, we use a mathematical model that incorporates the e¤ects of key aspects of the
immune systems response to an insult (Eqs. 2.1-2.4). The detailed derivation of this model,
based on previous experimental ndings, and a term-by-term explanation of its components
are outlined by Reynolds et al. [98]. The model we use replaces the pathogen equation
of Reynolds et al. with an endotoxin equation. These changes introduce several di¤erent
parameters that replace or add to those used in Reynolds et al. These include pe (1/h),
knpe (mg/kg/h), i (mg/kg), ti (h), and  (h) which are described in Table 1. However, all
other equations and parameter values have been maintained to agree with those presented in
Reynolds et al. A substantial number of these parameters were obtained from existing exper-
imental literature (Table 1). For more information on parameter acquisition and estimation,
please see Section 2.7: Supplementary Materials.
This model consists of a system of ordinary di¤erential equations containing two pro-
inammatory mediators, N and D, as well as an anti-inammatory mediator, CA. N
is biologically comparable to phagocytic immune cells or early, typically pro-inammatory
cytokines, such as TNF and Interleukin-1 (IL-1). The other pro-inammatory variable, D,
not only serves as a marker for tissue damage/dysfunction, but also as a positive feedback
into the earlier pro- and anti-inammatory arms of the system, as damaged (e.g. injured or
necrotic) tissue would [74]. The anti-inammatory mediator, CA, acts on a slower time scale
than N. For instance, CA behaves more like the cytokine Transforming Growth Factor-1
(TGF-1) rather than Interleukin-10 (IL-10). However, it could also represent other typi-
cally anti-inammatory mediators such as cortisol. In Section 2.4, we discuss the importance
of dynamically modeling D and the necessity for the anti-inammatory mediator to posses
certain qualitative properties for tolerance to occur in the model.
Units forN, CA andD are not given explicitly because there is no single biological entity
or marker that these variables represent and thus there are no specic units that can quantify
these variables empirically. Hence, we use N-units,CA-units,and D-unitsbecause
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we cannot be any more precise about them. Although CA (Anti-inammatory Mediator) has
characteristics of IL-10 and TGF-, it would be inappropriate to assign real units to this
variable and quantitatively compare it to actual data from these or other anti-inammatory
mediators.
The immune response instigator, pathogen endotoxin or PE (mg/kg), serves as the initial
stimulus that recruits N with a rate of knpe which has units mg/kg/h. This begins the
inammatory cascade. PE decays exponentially with rate pe, having units per hour, with
no other mediators a¤ecting its decay. In addition, multiple intravenous injections (i.v.) of
endotoxin can be emulated with Heaviside step functions in the PE equation. The parameters
i and ti in the Heaviside functions represent the endotoxin dosage load for the ith dose given
at time ti hours, respectively, for i = 1; 2; :::n, the number of doses. If we want a total of
 mg/kg to be given over a duration of time, , then =(mg/kg/h)given for  hours will
accomplish this. The parameter  is set to 0.01 h, which matches the time step of our
numerical integration, when we wish to emulate a pulse, or a quick ono¤, instantaneous
injection. For instance, if  = 0:01, the administration of a load amount of 3 mg/kg given
at time t hours would stop at t +  = t + 0:01 h, thereby essentially giving the whole
load all at once. Larger values of  will result in longer infusion times. For example, in
scenario 8 we set  equal to 24, thereby giving 3/24 = 0.125 (mg/kg/h) continuously over
the span of 24 h. This also gives a total of 3 mg/kg but over a longer span of time than the
instantaneous injection. Although we model i.v. type injections, studies have shown that
endotoxin administration given either intravenously or intraperitoneally invokes a similar
inammatory response [23]. Table 1 gives the parameter values that were established for
this model, which is represented by Eqs. 2.1-2.4.
dPE
dt
=  pePE +
nX
i=1
i

S(ti; ti + ); (2.1)
dN
dt
=
snrR
knr +R
  nN; (2.2)
dD
dt
= kdn
f(N)6
x6dn + f(N
)6
  dD; (2.3)
dCA
dt
= sc + kcn
f(N + kcndD)
1 + f(N + kcndD)
  cCA (2.4)
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Table 1: Model parameter names and values used in simulations
Name Range Value Used Description Sources
pe 0.620714.85 3/h Decay rate of pathogen endotoxin (PE) [51,
117,
123]
i n/a Various (mg/kg) Amount of the ith PE dose administration
 n/a 0.01 or 24 hr Duration of PE injection: 0.01 corre-
sponds to instantaneous delivery (1/100
of an hour) and 24 corresponds to con-
stant delivery of a dose over 24 hours.
ti n/a Various (h) Time at which the ith PE dose is given
knpe Estimated 9/(mg/kg)/h Activation of phagocytes by pathogen en-
dotoxin (PE)
knn Estimated 0.01/N-units/h Activation of phagocytes by already acti-
vated phagocytes (or the cytokines that
they produce )
snr Estimated 0.08/NR-units/h Source of resting phagocytes
nr 0.069-0.12 0.12/h Decay rate of resting phagocytes
(macrophages and neutrophils)
[25]
n Less than nr 0.05/h Decay rate of activated phagocytes
(macrophages and neutrophils)
[25]
knd Less than knpe 0.02/D-units/h Activation of phagocytes by tissue dam-
age (D)
[6]
kdn Estimated 0.35/D-units/h Max rate of damage production by acti-
vated phagocytes (and/or associated cy-
tokines/free radicals)
xdn Estimated 0.06 N-units Determines level of activated phagocytes
(N*) needed to bring damage production
up to half its maximum level
d 0.0174 (min) 0.02/h Decay rate of damage; combination of re-
pair, resolution, and regeneration of tissue
HMGB-1 release by damage
[29,
116]
c1 Estimated 0.28/CA-units/h Threshold for e¤ectiveness of the anti-
inammatory response
[50]
sc Estimated 0.0125CA-units/h Source of anti-inammatory (CA) (IL-10,
TGF-1, cortisol);
kcn Estimated 0.04 CA-units/h Maximum production rate of Anti-
inammatories
kcnd Estimated 48 N-units/D-units Controls relative e¤ectiveness of activated
phagocytes versus damage in producing
anti-inammatories
c 0.15-2.19 0.1/h Decay rate of the anti-inammatory me-
diator
[8, 12,
40, 49]
15
where n is the number of doses in the experiment and the other functions in 2.1-2.4 are given
by
R =
(knpePE + kndD + knnN
)
1 + (CA=c1)2
;
f(x) =
x
1 + (CA=c1)2
;
S(ton; toff ) = H(t  ton) H(t  toff )
=

0 if t < ton
1 if t  ton 

0 if t < toff
1 if t  toff
Using the parameter values given in Table 1, this system has three possible equilibrium states
in the regime that we are interested in, namely where all solutions are nonnegative. Two
of the three xed points are stable and the remaining one is a saddle whose stable manifold
separates the phase space of interest into two regions, each containing one of the stable
xed points. One of the stable states is specied by the background levels of the variables,
(PE; N; D;CA) = (0; 0; 0; CA0). These low levels are characteristic of the state in which the
system is at baseline, prior to any perturbation. Thus, when the mediators settle to this
state we correspondingly interpret the outcome as healthy. The other stable equilibrium is
classied as an unhealthy state in light of the fact that the values of the variables at this
state are above background levels, except for PE, which always decays asymptotically to
zero. When the mediators are pulled to this state it indicates that the response has not
properly resolved and, consequently, the outcome is unhealthy or inamed.
The observations we make in our simulations have biological interpretations related to
the characteristics of the acute inammatory response. When we emulate an administration
of endotoxin, the variables of the model react much like the mediators of the inammatory
response in the body in the presence of endotoxin, with their levels rising in the presence of
this pro-inammatory stimulus. After we induce this inammatory response in our model
with an injection of PE, the system either settles to the healthy state or rises to the unhealthy
state. If the dosage of PE is large enough, it can elicit such a response that the system remains
inamed and is unable to return to its background levels. We equate such an outcome with
persistent inammation, which is an unhealthy endpoint. Given these features of our system,
we interpret the existence of endotoxin tolerance in our model as a reduction in the response
16
of N to a low dose of PE after the system is preconditioned with an initial low PE dose.
Likewise, if a preconditioning dose of PE prevents the system from ending up at the unhealthy
state when an otherwise unhealthy dose is given, we infer this as the ability of the model
to display protection from mortality. Using the model Eqs. 2.1-2.4, with parameter values
from Tables 1 and 7, we are able to qualitatively reproduce the results of various published
scenarios of repeated endotoxin administration, which we now discuss.
2.3 MODEL SIMULATIONS OF EXPERIMENTAL SCENARIOS
ENDOTOXIN TOLERANCE SCENARIO
For our in silico simulations, we emulate the scenarios below using the dynamical systems
analysis software XPPAUT [36]. Eqs. 2.1-2.4 are integrated numerically using the Runge
Kutta algorithm with step size 0.01 for 200 time units (hours), taking into account the
simulated i.v. injections of PE at the specied times. Thus, the design of our in silico
endotoxin simulations can closely resemble actual endotoxin experimental scenarios, which
originally were carried out with mice. The XPPAUT code for this model is included with
the Supplementary Materials in section 2.7.
We start with the reproduction of proper responses to survivable and lethal endotoxin
doses, simulated by simply varying the load (1 mg/kg) of PE at time zero (t1 = 0 h).
Regarding endotoxin administration and mortality, it is generally accepted that doses at or
above 17 mg/kg cause a high mortality rate in mice [24]. Figs. 1a and b show the results of
the model simulations carried out with low (Fig. 1a) and high (Fig. 1b) PE doses. Having
established these basic responses, we now consider experiments involving repeated endotoxin
administration, most of which are based on experimental data in the literature.
2.3.1 Endotoxin tolerance scenarios
Published studies report that endotoxin tolerance can be induced in various ways, generally
involving the administration of low, repeated doses of endotoxin over periods of time ranging
from one day to a week [9, 11, 96, 105, 120]. Blood serum is collected at some time after the
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Figure 1: Basic endotoxin administration scenarios. The values of the parameters 1, t1, and  are set
to simulate a one dose instantaneous ( = :01) administration of PE at time zero (t1 = 0). (a) Doses less
than 1 = 17 mg/kg of PE cause a response, but all mediators eventually settle back to baseline in a healthy
resolution. Here we show a simulation done with a dose of 1 = 6 mg/kg of PE . (b) Doses greater than
or equal to 1 = 17 mg/kg of PE cause all mediators to remain elevated, indicating an unhealthy outcome.
The simulation results shown are carried out with a dose of 1 = 17 mg/kg of PE . Time courses for N, D,
and CA are shown for both scenarios.
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Table 2: Scenario 1 (adapted from the experiments of Sly et al., 2004)
Sly (2004) 0 hours 24 hours Experimental Results
Non-Preconditioned Saline 10 mg/kg 600 pg/ml TNF @ 27 hours
Preconditioned 1 mg/kg 10 mg/kg TNF levels very low @27 hours
Table 3: Scenarios 2a - 2c (adapted from the experiment of Wysocka et al., 2001)
Wysocka (2001) 0 hours 26 hours Experimental Results
Non-Preconditioned Saline 100 mcg 100 ng/ml TNF @ 27 hours
Preconditioned 2a 1 mcg 100 mcg < 20 ng/ml TNF @ 27 hours
Preconditioned 2b 5 mcg 100 mcg < 20 ng/ml TNF @ 27 hours
Preconditioned 2c 20 mcg 100 mcg < 20 ng/ml TNF @ 27 hours
Mouse weight is estimated at 20 grams: 1 mcg/mouse = 0.05 mg/kg,
5 mcg/mouse = 0.25 mg/kg,
20 mcg/mouse = 1.0 mg/kg, and
100 mcg/mouse = 5.0 mg/kg
last (challenge) endotoxin dose, and inammatory analytes (generally TNF ) are measured.
In all the above cited experiments, a reduced amount of TNF is seen in the group receiving
more than one dose of endotoxin (preconditioned) as compared to the amount of TNF found
in the serum of mice receiving only a single dose of endotoxin (non-preconditioned).
Scenarios 15 closely follow various experimental scenarios of repeated endotoxin ad-
ministration as they are outlined in the literature. Tables 2-6 summarize the designs and
results of these scenarios which are reproduced in our model simulations with respect to a
qualitative reduction in our pro-inammatory mediators, specically N. Scenarios 68 are
not explicitly found in the literature, yet we believe them to be relevant scenarios that merit
consideration. The parameter values appearing in Table 1 are used for all the scenarios
discussed in this section, with the exception of parameters that are used to set up i.v. PE
administrations for the various simulations: i,ti, and . The values for these parameters as
pertains to the di¤erent scenarios can be found in Table 7.
Scenarios 1-5 are based on those found in Tables 2-6. As an example, parameters for one
simulation may be set as follows: t1 = 0 hrs, 1 = 0 mg/kg, t2 = 24 hrs, 2 = 10 mg/kg, and
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Table 4: Scenarios 3a - 3c (adapted from the experiments of Rayhane et al., 1999)
Rayhane (1999) 0 hours 24 hours 48 hours 72 hours Experimental Results
Non-Preconditioned 3a Saline 100 mcg n/a n/a 35 ng/ml TNF @ 25.5 h;
2.5 ng/ml TNF @ 27 h
Preconditioned 3a 2.5 mcg 100 mcg n/a n/a 3 ng/ml TNF @ 25.5 h;
2 ng/ml TNF @ 27 h
Non-Preconditioned 3b Saline Saline 100 mcg n/a 35 ng/ml TNF @ 49.5 h;
2.5 ng/ml TNF @ 51 h
Preconditioned 3b 2.5 mcg 2.5 mcg 100 mcg n/a 1 ng/ml TNF @ 49.5 h;
.5 ng/ml TNF @ 51 h
Non-Preconditioned 3c Saline Saline Saline 100 mcg 35 ng/ml TNF @ 73.5 h;
2.5 ng/ml TNF @ 75 h
Preconditioned 3c 2.5 mcg 2.5 mcg 2.5 mcg 100 mcg 1 ng/ml TNF @ 73.5 h;
.5 ng/ml TNF @ 75 h
Mouse weight is estimated at 20 grams: 2.5 mcg/mouse = 0.125 mg/kg and
100 mcg/mouse = 5.0 mg/kg
Table 5: Scenario 4 (adapted from the experiments of Balkhy et al., 1999)
Balkhy (1999) 0 hours 24 hours 48 hours 72 hours Experimental Results
Non-Preconditioned Saline Saline n/a 300 mcg 3- to 6-fold reduction in
Preconditioned 50 mcg 50 mcg n/a 300 mcg the peak serum TNF-
levels @ 73 hours
Mouse weight is estimated at 20 grams: 50 mcg/mouse = 2.5 mg/kg and
300 mcg/mouse = 15 mg/kg
Table 6: Scenario 5 (adapted from the experiments of Berg et al., 1995)
Berg (1995) 0 hours 24 hours Experimental Results
Non-Preconditioned Saline 200 mcg No mice survived
Preconditioned 25 mcg 200 mcg All mice survived
Mouse weight is estimated at 20 grams: 25 mcg/mouse = 1.25 mg/kg and
200 mcg/mouse = 10 mg/kg
20
Table 7: Endotoxin administration parameter values and gure references for in silico simulations of
Scenarios 1-8. Scenarios 1-5 are based on those found in Tables 2 - 6. As an example, parameters for one
simulation may be set as follows: t1 = 0 hrs, 1 = 0 mg/kg, t2 = 24 hrs, 2 = 10 mg/kg, and  = :01
hrs. This is analogous to giving a saline (non-preconditioned) dose (1 = 0 mg/kg) to mice at time zero
(t1 = 0 hrs) and then giving a second dose (2 = 10 mg/kg) of endotoxin at 24 hours (t2 = 24 hrs) with both
doses given as instantaneous injections ( = 0:01 hrs) at the specied times. The system is then integrated
and one can look at time courses of the model variables. These parameters can be changed and the system
integrated again to give another set of time course for comparison.
1 t1 2 t2 3 t3 4 t4  Figure
mg/kg hrs mg/kg hrs mg/kg hrs mg/kg hrs hrs Ref
Scenario 1 2a-2d
Non-Preconditioned 0.0 0 10.0 24 n/a n/a n/a n/a 0.01
Preconditioned 1.0 0 10.0 24 n/a n/a n/a n/a 0.01
Scenario 2a-2c 3a-3c
Non-Preconditioned 0.0 0 5.0 26 n/a n/a n/a n/a 0.01
Preconditioned 2a 0.05 0 5.0 26 n/a n/a n/a n/a 0.01
Preconditioned 2b 0.25 0 5.0 26 n/a n/a n/a n/a 0.01
Preconditioned 2c 1.0 0 5.0 26 n/a n/a n/a n/a 0.01
Scenarios 3a-3c 4a-4c
Non-Preconditioned 3a 0.0 0 5.0 24 n/a n/a n/a n/a 0.01
Preconditioned 3a 0.125 0 5.0 24 n/a n/a n/a n/a 0.01
Non-Preconditioned 3b 0.0 0 0.0 24 5.0 48 n/a n/a 0.01
Preconditioned 3b 0.125 0 0.125 24 5.0 48 n/a n/a 0.01
Non-Preconditioned 3c 0.0 0 0.0 24 0.0 48 5.0 72 0.01
Preconditioned 3c 0.125 0 0.125 24 0.125 48 5.0 72 0.01
Scenario 4 5
Non-Preconditioned 0.0 0 0.0 24 15.0 72 n/a n/a 0.01
Preconditioned 4a 2.5 0 2.5 24 15.0 72 n/a n/a 0.01
Preconditioned 4b 0.125 0 0.125 24 0.125 48 5.0 72 0.01
Scenario 5 6a-6b
Non-Preconditioned 0.0 0 17.0 24 n/a n/a n/a n/a 0.01
Preconditioned 1.25 0 17.0 24 n/a n/a n/a n/a 0.01
Scenario 6 7a-7b
Non-Preconditioned 0.0 0 6.0 24 n/a n/a n/a n/a 0.01
Preconditioned 3.0 0 6.0 24 n/a n/a n/a n/a 0.01
Scenario 7 8a-8b
Non-Preconditioned 0.0 0 6.0 15 n/a n/a n/a n/a 0.01
Preconditioned 3.0 0 6.0 15 n/a n/a n/a n/a 0.01
Scenario 8 9a-9d
Non-Preconditioned 3.0 0 n/a n/a n/a n/a n/a n/a 0.01
Preconditioned 3.0 0 n/a n/a n/a n/a n/a n/a 24.0
21
 = :01 hrs. This is analogous to giving a saline (non-preconditioned) dose (1 = 0 mg/kg)
to mice at time zero (t1 = 0 hrs) and then giving a second dose (2 = 10 mg/kg) of endotoxin
at 24 hours (t2 = 24 hrs) with both doses given as instantaneous injections ( = 0:01 hrs) at
the specied times. The system is then integrated and one can look at time courses of the
model variables. These parameters can be changed and the system integrated again to give
another set of time course for comparison.
Scenario 1 is based on the experiments of Sly and colleagues [105], summarized in Table 2.
Fig. 2a, c and d show the time courses for the model variables obtained for this rst scenario
and Fig. 2b is a bar graph of selected time points from the numerical data shown in Fig.
2a. Scenario 2 follows the endotoxin tolerance experiments of Wysocka et al. [120], outlined
in Table 3, where tolerance is induced with a variety of preconditioning doses ranging from
0.05 to 1 mg/kg. A qualitative reproduction of their results by our model can be seen in the
time courses of Fig. 3. It is interesting to note that the preconditioning dose used in scenario
2b allows for the greatest reduction in N compared to doses used for scenarios 2a and 2c.
This indicates that for a xed preconditioning time interval, the size of the preconditioning
dose can determine the magnitude of the reduction that is detected, with a nonmonotonic
relationship between the two. We address this observation in more detail in Section 2.5.
Scenario 3 is based on the experiments done by Rayhane et al. [96]. Two of these
experiments are more complicated than those of Sly et al. and Wysocka et al., since several
preconditioning doses, rather than only one, are given before the challenging dose. In Table
4, the designs of the three separate tolerance experiments from Rayhane et al. are outlined
along with a summary of their results. Fig. 4 shows our results.
The experiment of Balkhy and Heinzel [9], scenario 4 outlined in Table 5, is slightly
di¤erent from the previous scenarios we have simulated, in that the nal endotoxin dose (15
mg/kg) is given 48 h after the last preconditioning dose, instead of only 24 or 26 h after. Fig.
5 shows the results of our simulations for this scenario. We note that if we had simulated
giving the challenge dose of 15 mg/kg earlier than 48 h after preconditioning (e.g. at 24 or
26 h after), this regimen would have led the system to the unhealthy state. This nding
highlights the importance of timing as well as dosage size to tolerance outcomes.
As mentioned previously, endotoxin, when given above a certain threshold dose, can be
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Figure 2: Numerical results of simulations following scenario 1 in Table 2, with administration parameters
set as in Table 7 for Scenario 1. (a) Time courses of N for the non-preconditioned (solid) and preconditioned
simulations (dashed), showing a maximum reduction of 60% as indicated by the downward arrow. In actual
experiments, the data cannot usually be viewed as continuous time course curves. Instead, bar graphs are
given showing the amount of certain analytes at a specied time after the challenge endotoxin administration,
comparing the non-preconditioned group to the preconditioned group. To relate our in silico results to this
convention, (b) shows a bar graph of the amount of N in both the non-preconditioned and preconditioned
simulations at several time points after the challenge endotoxin administration, where a reduction in N
is seen. (c)(d) Time courses of CA and D, respectively, for the non-preconditioned (solid curve) and
preconditioned simulations (dashed curve). The dotted vertical line in (c) denotes the time the challenge PE
dose was given.
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Figure 3: Numerical results of simulations following scenarios 2a2c in Table 3, with dosage amounts
converted from micrograms/mouse to milligrams/ kilogram in order to conform to the units of PE (mg/kg) in
our model. Administration parameters are set as in Table 7 for scenarios 2a2c. Time courses of N for the
non-preconditioned (solid) and preconditioned simulations (dashed) are shown for each scenario. Compared
to the non-preconditioned simulation, there is a maximum reduction in N of 44% in (a) scenario 2a, 73%
in (b) scenario 2b and 48% in (c) scenario 2c, indicated in each gure by the downward arrows. The time
courses of CA, for the non-preconditioned (large dots) and preconditioned (small dots) simulations, are also
shown on each graph with a separate axis on the right of each graph.
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Figure 4: Numerical results of simulations following scenarios 3a3c in Table 4, with dosage amounts
converted from micrograms/mouse to milligrams/kilogram in order to conform to the units of PE (mg/kg)
in our model. Model parameters are set as in Table 7 for Scenarios 3a3c. Time courses of N for the
non-preconditioned (solid) and preconditioned simulations (dashed) are shown for each scenario. Measured
against the non-preconditioned simulations, we see a reduction in N of 70% in (a) scenario 3a, 68% in (b)
scenario 3b, and 65% in (c) scenario 3c, indicated in each gure by the downward arrows. The time courses
of CA, for the non-preconditioned (large dots) and preconditioned (small dots) simulations, are also shown
on each graph with a separate axis on the right of each graph.
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Figure 5: Numerical results of simulations following scenario 4 in Table 5, with model parameters set
as in Table 7 for scenario 4. Time courses of N are shown for the non-preconditioned (solid) and the
preconditioned simulations (dashed). Balkhy and Heinzel report a 3- to 6-fold reduction of serum TNF
one hour after the challenge dose is given, compared to non-preconditioned results. Although our model
does not capture an immediate reduction in our pro-inammatory mediator, N, we do observe a signicant
reduction overall, as seen in this gure. The time courses of CA, for the non-preconditioned (large dots) and
preconditioned (small dots) simulations, are also shown with a separate axis on the right of the graph.
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lethal for mice. This threshold can depend on specic experimental conditions as well as the
strain of mouse used. However, experiments have shown that preconditioning mice with a
low, survivable PE dose can actually prevent animals from succumbing to a lethal challenge
dose [11, 105, 122]. We conduct a model simulation of this e¤ect using the experiment of
Berg et al. [11] as a guideline (Scenario 5, Table 6). A dose of 10 mg/kg proved to be lethal
in the mice that were used in Bergs experiment; however, based on our own studies, the
lethal dose in our model is centered at 17 mg/kg [20]. Thus, our potentially lethal challenge
dose in our simulations is 1 =17mg/kg of PE. Figs. 6a and b show the simulation time
courses for N and D, respectively, where we see that preconditioning enables a rescue from
an otherwise lethal insult.
2.3.2 Potentiation scenarios sub-lethal and lethal doses
Experimentally, when the time between initial exposure to endotoxin and the secondary
challenge is short relative to the magnitude of the endotoxin doses, an increase, rather than
a reduction, of inammation (i.e. TNF ) is observed upon repeated endotoxin administra-
tions. This phenomenon is referred to as potentiation [18]. As we will discuss in further
detail later, both the timing of the administration of the doses as well as their magnitudes
determine the nal outcome of tolerance or potentiation. The scenarios introduced in this
section demonstrate potentiation in several di¤erent forms. Scenarios 6 and 7 which are not
explicitly based on experiments found in the literature demonstrate sub-lethal and lethal
potentiation simulations, respectively. Figs. 7a and b show that in scenario 6 there is a
clear elevation in the amount of N in the preconditioned simulation, compared to that of
the non-preconditioned one, but the mediators eventually resolve to the healthy state. In
scenario 7, Figs. 8a and b show that the non-preconditioned simulation results in a healthy
outcome whereas the preconditioned one results in an unhealthy outcome. Comparing Sce-
narios 6 and 7 show that the timing and not just the amount of the second endotoxin dose
determines whether or not the potentiation leads to an increase in N that eventually settles
back to the healthy equilibrium, or to an increase that converges to the unhealthy state.
In order to experimentally simulate the kinetics of endotoxin release in animals during
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Figure 6: Numerical results of simulations based on scenario 5 in Table 6, with model parameters set
as in Table 7 for scenario 5. This scenario demonstrates that our model qualitatively captures the result
that a small preconditioning dose of endotoxin can prevent the negative outcome of an otherwise lethal
dose. (a)(b) Time courses of N and D, respectively, for the non-preconditioned (solid) and preconditioned
simulations (dashed). The time courses of CA,for the non-preconditioned (large dots) and preconditioned
(small dots) simulations, are also shown on the N graph with a separate axis on the right of the graph.
The non-preconditioned simulation clearly ends up at the unhealthy state, in which N and D remain high.
However, the simulation that was preconditioned settles to the low healthy state, showing rescue from an
otherwise lethal insult.
28
Figure 7: Numerical results of simulations for sub-lethal potentiation scenario. (a) Time courses of N for
the non-preconditioned (solid) and preconditioned simulations (dashed), showing an increase in the amount
of N with preconditioning compared to the non-preconditioned simulation. The time courses of CA, for the
non-preconditioned (large dots) and preconditioned (small dots) simulations, are also shown on the N graph
with a separate axis on the right of the graph. (b) Bar graph of selected time points from (7a), showing the
amount of increase in N.
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Figure 8: Numerical results of simulations for lethal potentiation scenario. (a)(b) Time courses of N
and D, respectively, for the non-preconditioned (solid) and preconditioned simulations (dashed). The time
courses of, CA, for the non-preconditioned (large dots) and preconditioned (small dots) simulations are also
shown on the N graph with a separate axis on the right of the graph. Unlike the non-preconditioned
simulation, the preconditioned simulation results in an unhealthy response.
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sepsis, a continuous, low-dose infusion of endotoxin is administered [90]. Scenario 8 demon-
strates that gradually administering a dose of 3 mg/kg PE over 24 h forces the system to the
unhealthy state, whereas the same dose given as an abrupt bolus does not. To approximate
the instantaneous administration of 3 mg/kg PE into the system, we set t1 = 0, 1 = 3, and
 = 0:01 (Fig. 9a). To simulate 3 mg/kg PE given over 24 h at a constant rate, we set  =
24. In setting  to a value of 24 we are simulating an endotoxin infusion that distributes a
total of 3 mg/kg PE gradually over 24 h (Fig. 9b). This is a fair comparison, because in
both cases, in the absence of decay of PE, the PE level at the end of the infusion would be 3
mg/kg. Figs. 9c and d show that the constant administration of PE, even though it is admin-
istered in very low amounts, causes the system to converge to the unhealthy state, whereas
the instantaneous dose does not. These results imply that insults that elicit a strong initial
pro-inammatory response properly counter-balanced by an anti-inammatory response are
more likely to be tolerated by the host. In contrast, those stimuli that cause an initially
weak but persistent response can be detrimental to the host.
2.4 THE IMPORTANCE OF THE DYNAMICS OF THE LATE
PROINFLAMMATORY AND ANTI- INFLAMMATORY MEDIATORS
TO TOLERANCE
A system of ordinary di¤erential equations becomes complicated very rapidly as the number
of equations increases. It can, therefore, be advantageous to attempt to reduce the number
of equations to a manageable number by applying a steady state assumption. This strategy
is most appropriately applied to variables that are transient, and is accomplished by set-
ting their derivatives to zero; for example, if x0 = f(x; y), then we apply the steady state
assumption to x by setting x = X(y) such that f(X(y); y) = 0, if such an X(y) exists. By
making such a substitution, one is assuming that the relevant variable reaches its steady state
quickly and does not deviate from it over time, although the particular value of its steady
state may vary as the other quantities in the system evolve. Based on the form of the model
in Section 2.2, it would be most convenient to reduce the number of equations in our model
by applying the steady state assumption to D, although in fact it behaves as a slow-acting
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Figure 9: Instantaneous versus continuous PE administration. (a) Time course of PE for the simulation
giving an instantaneous injection of 3 mg/kg PE into the system. (b) Time course of PE for the simulation
giving 3 mg/kg PE over 24 h at a constant rate. This is done by setting  = 24 in the PE equation. In setting
 to a value of 24 we are simulating an endotoxin infusion that distributes a total of 3 mg/kg PE over 24 h
rather than an instantaneous introduction of that amount.(c)(d) Time courses of N and D, respectively,
for the instantaneous administration simulation (solid) and continuous administration imulation (dashed)
time courses. The time courses of CA, for the instantaneous administration (large dots) and continuous
administration (small dots) simulations, are also shown on the N graph with a separate axis on the right
of the graph.
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pro-inammatory mediator. As it turns out, under the steady state assumption on D, the
model fails to reproduce the experimentally observed endotoxin tolerance results without
parameter modications that compromise the basic model performance or are outside of the
physiologic range.
As mentioned, we dene the existence of endotoxin tolerance in our model as a reduced
N response to a low dose of PE when the system is preconditioned with an initial low PE
dose. However, with D in steady state, we observe only potentiation of the N response
regardless of when the second dose is administered. On the other hand, parameters can be
changed to achieve tolerance, but these changes eliminate the possibility for the system to
reach an unhealthy state, which is necessary in order for the model to retain basic biological
delity. As previously mentioned, experiments have veried that a low preconditioning dose
of endotoxin can rescue mice from a normally lethal endotoxin dose [96, 105, 122]. However,
with D in steady state, a lethal PE dose always leads to an unhealthy state even after a low
preconditioning dose of PE is given and, in fact, does so more prominently when the system
is preconditioned.
Thus, dynamically modeling D allows for a number of outcomes that are not possible
otherwise within the bounds of the biological constraints imposed by past experimental
ndings. The fact thatD acts gradually and promotes the production of CA allows the model
to attain an extended CA elevation, without compromising the existence of an unhealthy state
in the system. This attribute of our model plays an important role in the reproduction of
tolerance scenarios. We explored this further by looking at the e¤ects that certain forms of
altered CA dynamics had on tolerance in our model (with dynamic D). First, appropriate
model parameter values were adjusted so that CA was only being produced by early immune
responders (N) and so that it had an early peak and a relatively quick decay. The time
course of CA then closely resembled that of a fast acting anti-inammatory cytokine, such as
IL-10. In this scenario, the regimes of healthy and unhealthy still exist; however, tolerance
does not occur. Indeed, preconditioning led to potentiation of theN response and sometimes
caused the otherwise sub-lethal challenge dose to be lethal, much like what happened when
D was assumed to be in steady state. Therefore, it appears that for tolerance to occur in
our model, CA cannot solely behave as an early antiinammatory mediator, like IL-10.
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On the other hand, another possible modication was to adjust model parameters so that
CA behaved as a later acting anti-inammatory, accumulating on a time scale comparable to
that of D. We found that signicant changes in this direction drastically shrank the basin
of attraction1 of the healthy state. In some ways, modifying CA in this way is comparable
to considering IL-10 -decient (knockout) mice, and indeed a similar sensitivity to small
endotoxin doses is seen experimentally in these animals [11, 120]. Tolerance e¤ects have been
seen in experiments with IL-10 knockout mice. It is likely, however, that such knockout mice
have a decreased susceptibility to pro-inammatory stimuli or an increased upregulation of
other anti-inammatory mediators to compensate for the absence of IL-10 early on in the
immune response, which our model does not incorporate. Indeed, simulation of our model
suggests that removal of early anti-inammatory mediators without compensation would
eliminate tolerance, since endotoxin doses small enough to be sub-lethal, given the decreased
basin of attraction of the healthy state, fail to activate CA su¢ ciently for tolerance to occur.
2.5 INSIGHT FROM THE MODELS RESPONSES TO ENDOTOXIN
ADMINISTRATION
Looking at these preconditioning phenomena from the point of view of the dynamics of a
mathematical model of the acute inammatory response, we are able to o¤er insight into
why these disparate results are seen experimentally. It is important to note that the devel-
opment of this model only took into account empirical observations about the interactions
of somewhat abstracted immune e¤ectors. However, none of the endotoxin administration
results that we have reproduced was built into the development of the equations. Rather,
our ndings emerge from the interactions of the dynamic variables and biological e¤ects of
repeated endotoxin administration. Thus, although petitio principii or circular reasoning
is a potential pitfall of such reduced models, the model we present was not constructed to
describe the specic paradigm of endotoxin tolerance.
The timing and magnitude of the endotoxin doses plays a crucial role in the types of
1The basin of attraction of a stable xed point, x, of a dynamical system is the set of all initial conditions
that dynamically approach xunder the ow of the vector eld as t!1. [108, 118]
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outcomes that are observed. In the model considered, the variable N is inhibited by CA,
the levels of which can remain elevated even after enough time has passed for N to start
returning to its resting value. Using scenario 1 as an example, Fig. 2c demonstrates how
the amount of CA varies between the nonpreconditioned and preconditioned simulations at
the time that the second PE dose is given (dotted vertical line). Comparing the amount of
the anti-inammatory mediator in the two simulations at this time point, we see that with
preconditioning there are signicantly higher levels of CA than without preconditioning,
which shows CA levels that are still at baseline. In scenarios 14, which lead to endotoxin
tolerance, the challenge endotoxin dose that follows the preconditioning regimen is given
during a time when the system is precisely in this state of relatively low N and elevated
CA. The build-up of the anti-inammatory mediator, induced by preconditioning, results in
a reduction of the overall inammation or build-up of N, incited by the challenge endotoxin
dose. Fig. 2c also shows that even though a short time after the challenge dose the levels of
the anti-inammatory mediator for the non-preconditioned simulation have risen above the
preconditioned simulation levels, this occurs too long after the nal endotoxin stimulus to
inuence the relative levels of N across the two experiments.
It is important to note that, despite the inhibitory e¤ects of CA, the full model ex-
hibits an attracting, unhealthy steady state that can be attained, for example, following the
introduction of a single, su¢ ciently large dose of endotoxin. For the rescue phenomenon
demonstrated in scenario 5 (Figs. 6a and b), we see that a preconditioning dose of endo-
toxin can prevent the system from reaching the unhealthy state upon subsequent exposure
to an otherwise lethal endotoxin dose. Such a rescue is possible because the preconditioning
changes the state in which the system lies when the lethal dose is encountered. Specically,
the anti-inammatory mediator rises enough and the pro-inammatory mediators are close
enough to equilibrium after the preconditioning dose so that when the previously lethal en-
dotoxin stimulus is given, the system lies in the basin of attraction of the healthy, baseline
state, rather than that of the unhealthy state.
This behavior is similar to the tolerance observed in scenarios 14. The results from
scenario 1 (Figs. 2a and c) are utilized in Figs. 10b and c to illustrate this by showing a
projection of the system onto the N-CA phase plane where trajectories for N and CA can
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be seen with respect to their nullclines (dN=dt = 0 and dCA=dt = 0).2 For comparison,
related time courses of N are shown in Fig. 10a. In addition to the elevation of CA above
equilibrium when the challenge endotoxin dose is administered, the proximity of N and
D to their equilibrium levels is equally important for both tolerance and rescue to occur,
since the (N; D) subsystem forms a positive feedback loop. As long as the level of N or
D remains too high, the introduction of the lethal endotoxin dose will place the system in
the basin of attraction of the unhealthy state. The potentiation phenomenon illustrated in
scenario 6 (Fig. 7a) follows similarly, stemming from a second endotoxin dose that comes
soon after the initial one. Figs. 11ac use the same strategy demonstrated with Figs. 10ac
this time using the results of scenario 6 to illustrate potentiation from the viewpoint of a
projection of the system to the N-CA phase plane.
Likewise, Fig. 12a shows the N-D-CA phase space to illustrate the rescue demonstrated
in scenario 5 (Figs. 6a and b). The elevated amount of CA in the system at the time of the
challenge dose blunts the e¤ect of the potentially lethal dose, enabling the trajectory of the
preconditioned simulation toremain in the basin of attraction of the healthy xed point. In
addition, Fig. 12b shows a similar rescue scenario in theN-D-CA phase space along with the
2-dimensional separatrix consisting of the stable manifold of the saddle point of the system.3
The code for calculating the separatrix manifold was written in MATLAB, based on an
algorithm presented by Krauskopf and Osinga [63]. The algorithm and its implementation
are given in detail in Chapter 3. The separatrix forms the border between the basins of
attraction of the healthy and unhealthy states. This surface is exact (and thus invariant; see
Strogatz [108] for more details) only in the limit of PE = 0. Nonetheless, since PE decays
quickly, this surface gives a reasonable estimate to the true separatrix location in (N-D-
CA) space for times that are not too close to endotoxin dose administration times. Thus,
the location of a trajectory a short time after a challenge dose, relative to the separatrix,
determines the long-term fate of the system.
2For a planar system dx=dt = f(x; y); dy=dt = g(x; y); the nullclines are the two curves f = 0 and
g = 0. Fixed points of the system occur precisely at intersections of the nullclines. In higher dimensions,
nullclines are actually nullsurfaces and are much harder to visualize. In Figs. 10 and 11, we project onto a
2-dimenstional phase plane and are, therefore, looking at slices of the CA and N nullsurfaces.
3We chose not to use exactly the same trajectories produced in Fig. 12a because they followed the
manifold too closely and it was di¢ cult to visualize what exactly was happening.
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Figure 10: Endotoxin tolerance (based on scenario 1) illustrated with the N   CA phase plane. The
specic markers represent the following: black circle = time point just prior to the administration of the
challenge endotoxin dose, red upside down triangle = 1 h after the challenge dose, green square = 2 h after the
challenge dose, yellow diamond = 13 h after challenge dose, and blue triangle = 26 h after challenge dose. In
(a) the symbols described above are positioned on the N time courses of the non-preconditioned (solid) and
preconditioned (dashed) simulations, where the preconditioned simulation time course falls below the non-
preconditioned simulation time course just after the yellow diamond marker. In (b), the N nullcline (red;
vertical line) and CA nullcline (green; almost horizontal line) are shown along with two curves representing the
trajectories of the nonpreconditioned (black; thick) and preconditioned (blue; thin) simulations of scenario 1.
The arrows signify which direction the trajectories are owing in the phase plane. Although both trajectories
end at the healthy xed point after running their courses, the preconditioned (blue; thin) trajectory actually
approaches the xed point faster, resulting in tolerance. Several points are marked on the non-preconditioned
and preconditioned trajectory with  or +, respectively, denoting specic times prior to and after the time
of the challenge endotoxin dose. These time points are shown again in (c) where they are color coded and
connected to stress which ones belong on the non-preconditioned and preconditioned curves shown in (b).
The black circle belonging to the curve of the non-preconditioned simulation shows that the trajectory is
sitting at the healthy xed point, where N and CA are at their background levels. In comparison, the black
circle belonging to the curve of the preconditioned simulation is sitting at a place in the phase plane where
CA is much greater than its baseline value. It is also a place where N is above its baseline, however, the
trajectory is beginning to turn to the left toward the healthy xed point and the challenge dose does not
push the trajectory too far in the N direction. Comparing the other symbols in (c) on the two curves, the
preconditioned trajectory is at a lower N level than the non-preconditioned curve at the same time just after
the yellow diamond (compare the positions of the blue triangles with respect to N). This indicates that
tolerance has occurred. Thus, the state the system is in at the time the challenge dose is given determines
the outcome of the simulation.
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Figure 11: Potentiation (based on scenario 6) illustrated with the N   CA phase plane. The N
time courses in (a) of the non-preconditioned (solid) and preconditioned (dashed) simulations illustrate
that at each of the time markers, the N level of the preconditioned simulation is signicantly above the
non-preconditioned simulation levels. The explanation given in the caption for Fig. 10 is very similar to
this panel, except that instead of the preconditioned trajectory outrunning the preconditioned simulation
trajectory, it now trails the non-preconditioned trajectory for all time, as seen in (b). In addition, when
comparing the symbols in panel (c), the levels of N (x-axis) are always greater in the preconditioned
simulation. Although the position of the preconditioned simulation trajectory just prior to challenge is a
place of elevated CA, the level of N is quite high as well, and when the challenge is given, the new starting
point of the preconditioned trajectory is pushed further to the right into high N territory. Consequently,
the preconditioned trajectory cannot draw level with, much less pass, the non-preconditioned simulation.
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Figure 12: Rescue scenario in the N   D   CA phase space. (a) Using our simulations for scenario
5, this gure illustrates the concept of protection or rescue in the N   D   CA phase space. The non-
preconditioned trajectory (bold) is pushed into the basin of attraction for the unhealthy xed point by the
injection of the 17 mg/kg PE dose at 24 h. The preconditioned trajectory, however, remains in the basin
of attraction of the healthy xed point. This is because the amount of CA in the system just prior to the
challenge dose is signicantly above baseline and the e¤ect of the 17 mg/kg hit of PE is, therefore, blunted.
(b) Using a slightly di¤erent but similar simulation to scenario 5, in which preconditioning again leads to
rescue, we now show a portion of the 2-dimensional separatrix consisting of the stable manifold of the saddle
point of the system (see text for more details). The preconditioned trajectory (black on yellow) stays on the
healthy side of the surface after the challenge dose, while the challenge dose pushes the non-preconditioned
trajectory (red) to the unhealthy side of the surface.
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In all of the above discussions, it is clear that timing is very important to achieve toler-
ance. Therefore, we further investigate the dependence of toleranceon the amount of time
between the preconditioning and challenge dose as well as the magnitude of preconditioning
by examining a range of preconditioning doses and times at which they are given. In scenario
1, it was shown that a preconditioning dose of 1 mg/kg endotoxin 24 h prior to the challenge
endotoxin dose of 10 mg/kg endotoxin produced endotoxin tolerance, marked by a decrease
in the level of the model variable, N, compared with the non-preconditioned simulation at
a particular point in time, namely 66 h after challenge.
However, if we vary the amount of the preconditioning dose as well as the amount of time
between the preconditioning dose and challenge dose, we see that there is a wide range of
preconditioning doses and times at which they can be administered that also show a decrease
in N at the time of comparison with the non-preconditioned simulation. Furthermore,
the relationship between the size of the preconditioning dose and the time that it is given
relative to the challenge dose is not obvious. In Fig. 13, we see that potentiation is ev-
ident for the range of preconditioning times that are close to the time the challenge dose
is administered (approximately 015 h before challenge). Tolerance is observed when this
interval is typically longer than 15 h. Interestingly, there is a brief interval (1520 h be-
fore challenge) during which smaller preconditioning doses typically allow for more tolerance
than larger doses do. For this case, the key point is that larger preconditioning doses elicit
more inammation than do smaller doses. Thus, for large doses, the inammation is still
high when the challenge dose is given, such that less tolerance is observed than for small
doses. There is, however, a range of these preconditioning times (20110 h before challenge)
during which the relationship between the magnitude of the preconditioning dose and the
amount of tolerance it elicits is not monotonic, due to a competition between the amount
of inammation and the amount of anti-inam-mation invoked by the preconditioning dose.
Finally, for the range of preconditioning times from 110 to 200 h before challenge, the larger
preconditioning doses exhibit more tolerance than the smaller doses. This is due to the fact
that the smaller anti-inammatory responses elicited by small preconditioning doses have
worn o¤ by these times, whereas for the larger preconditioning doses, the large degree of
inammation invoked has subsided by these times while the associated strong, prolonged
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anti-inammation persists.
Thus, early second stimulation with endotoxin leads to potentiation of inammation and
consequently enhances lethality. Alternatively, if the second stimulus comes too late, signif-
icant tolerance fails to be induced. In our simulations, the build-up of CA after a sub-lethal
preconditioning endotoxin dose is transient, and CA eventually settles back to equilibrium,
along with the other e¤ectors in the model. Thus, the preconditioned system response to
late challenge stimuli is similar to that seen in nonpreconditioned responses. In summary,
we expect the existence of a window of possible challenge dose times and preconditioning
magnitudes for which endotoxin tolerance is possible. In Chapter 4, we explore the nature
of tolerance in a more general setting from a purely mathematical viewpoint.
2.6 DISCUSSION
The preconditioning phenomena of potentiation and tolerance characterize acute inam-
mation in both rodents and humans [23, 122]; in humans, the latter phenomenon is often
referred to as immune paralysisor immune exhaustion, in which leukocytesderived from
patients with severe inammation as measured by circulating pro-inammatory cytokines
often produce low levels of these same inammatory agents [93, 94]. In this paper, we
show that an experimentally calibrated but highly reduced computational model for the
acute inammatory response [98] (also see Supplementary Materials in section 2.7) incorpo-
rates su¢ cient dynamic complexity to qualitatively reproduce a suite of experimental results
associated with multiple endotoxin administrations in mice. Our success in matching exper-
imental endotoxin tolerance results o¤ers support for the biological relevance of the reduced
model. Moreover, our simulations illustrate how the outcomes of endotoxin administration
experiments can emerge as a natural consequence of the interactions of di¤erent components
of the acute inammatory response and also highlight the importance of including a dynamic
late proinammatory component in the model. We nd that the relative time scales of the
onset and decay of pro- and antiinammatory mediators are key determinants of outcomes
in these experiments, as illustrated in the simulations and phase plane projections that we
present. Finally, the results of our simulations involving potentiated responses (Fig. 7), low-
41
Figure 13: Dependence of tolerance on preconditioning dose timing and magnitude. The solid, horizontal
line marks the normalized level of N of the non-preconditioned simulation at 66 h after a 10 mg/kg challenge
dose is given. Each individual curve shows the normalized level of N (recorded at 66 h after challenge) for
a particular preconditioning dosage amount as a function of the time at which the dose was given prior to
the challenge dose (from 0 to 200 h prior to challenge with 10 mg/kg endotoxin). Points on the curves that
fall below the black line indicate that tolerance has occurred: The N value for a preconditioned simulation
at 66 h after challenge is lower than that of the non-preconditioned simulation (represented by the solid,
horizontal line). Those which are above the solid line produce potentiation instead. (See Section 2.5for
further details.)
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dose protracted endotoxin infusion (Fig. 9), and variations in the timing and amplitude of
preconditioning doses (Fig. 13) yield predictions that remain to be veried experimentally.
Mathematical approaches to understanding endotoxin tolerance have not been exten-
sively represented in the literature. However, in the work of Mayer and colleagues [75] a
simple two equation mathematical model of the immune response is presented and toler-
ancelike behavior is mentioned. Their model consists of immune cells (E) and target cells
(T ) which represent bacteria, for instance, and are inhibited by the immune cells. Although
Mayer et al. do not consider endotoxin specically and do not model anti-inammatory
e¤ects, a form of tolerance is manifested in their model by a reduction in the growth of
their target cells when a secondary infection is initiated, compared to the growth of the
initial infection. This reduction is due to the fact that the concentration of the immune cells
they model is elevated when the secondary infection is introduced. In fact, the secondary
infection is initiated after the system has approached a steady state in which the immune
cell concentration is high and the primary infection has been cleared. This simulation di¤ers
substantially from the situation we consider, in which a positive resolution corresponds to a
return to the baseline rest state and endotoxin challenges come during transient excursions
from this state induced by endotoxin preconditioning.
Much of the experimental literature regarding endotoxin tolerance focuses on the roles
of IL-10 and Transforming Growth Factor-1 (TGF -1 ), two potent anti-inammatory
cytokines [42, 68, 95, 124]. The possible roles that they each may have in endotoxin tolerance
have been documented by Randow et al. [95] and others [18, 42, 105]. Our model suggests
that the timing of doses for which tolerance will occur strongly depends on the time course
of the antiinammatory mediators. For the experiments that we have reproduced, it is
necessary for an anti-inammatory inuence to arise early on in the response, as is seen with
IL-10, but also to remain elevated longer than IL-10. This latter feature might be true of
mediators like TGF -1 or possibly IL-6, which has been shown to have antiinammatory
characteristics and is typically a cytokine produced relatively late in the course of an immune
response [121].
It has been shown that preconditioning with IL-10 protects mice from lethal endotoxin
doses and also partially mimics endotoxin tolerance [3, 18, 48]. However, this nding does
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not contradict our ndings on the importance of a prolonged anti-inammatory response for
tolerance, since IL-10 preconditioning leads to a di¤erent time course of anti-inammatory
mediators than occurs with the intrinsic immune response to endotoxin preconditioning.
Indeed, if IL-10 preconditioning introduces a signicant resence of IL-10 in the host during
the time that a rather toxic dose of endotoxin is administered, then it will suppress the
pro-inammatory response and thus enhance tolerance. Moreover, IL-10 can either induce
or activate TGF -1 [68, 111], thereby prolonging the overall anti-inammatory e¤ect.
As with other recently developed mathematical models of the acute inammatory re-
sponse [20, 21, 65] the model used here was calibrated to be consistent with relevant ex-
perimental literature. However, we do not claim that the model with the parameters we
have chosen will be valid over a wide range of species, especially in regard to the di¤erences
in sensitivity to endotoxin. Mice can survive much higher doses of endotoxin than humans
can, for instance. Not all the parameter ranges and estimates could be acquired from mouse
data alone; however, whenever possible, we looked at literature and data regarding experi-
mental work done in mice. In order to reproduce experiments carried out with other species
such as humans, for example, it would be necessary to consult species specic data. See
Supplementary Materials for more details regarding parameter choices.
Since our model is based on a simplied response system, it has certain limitations.
For example, it is di¢ cult to match specic biological mediators to the variables we have
chosen, with the exception of endotoxin (PE), and the model cannot predict quantitative
measurements. However, we have tried to select parameters such that the time courses of
our variable, N, are qualitatively similar to those suggested by experimental data to exist
for early pro-inammatory mediators like TNF and activated phagocytes. For example, our
preliminary experimental data in rats suggest that the peak of activated neutrophils roughly
matches that of circulating TNF [66]. There are other apparent di¤erences between our
results and those in the literature. For instance, the reductions we show in N are not seen
at the peak of its production, whereas the literature suggests that the reduction in TNF
production is seen at its peak (90120 min after challenge) [101]. However, since our early
pro-inammatory mediator is not solely based on TNF, exact comparison with experimental
TNF data is simply not feasible. In addition, we demonstrate the induction of endotoxin
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tolerance by modeling the basic binding interaction of PE with immune e¤ector cells but
without any special alterations that a¤ect the clearance of PE. Despite these limitations,
our results highlight specic ways in which endotoxin tolerance and related phenomena can
emerge from the timing and the overall interplay between mediators of the acute inamma-
tory response and illustrate the utility of a reduced model for the computational testing of
hypotheses and generation of predictions related to this response.
2.7 SUPPLEMENTARY MATERIALS
The standard parameter values for the reduced endotoxin model equations 2.1-2.4 are sup-
plied in Table 8. These parameter values are selected to remain within the given ranges
and constraints, which are based on experimental literature as well as on unpublished data.
Details on the derivation of these ranges are given below. Parameters that could not be doc-
umented from existing data were estimated such that the subsystems presented in Reynolds
et al. [98] behave in a biologically appropriate manner for all physiologically relevant levels
of the anti-inammatory mediator and so that the modied endotoxin model presented here
also exhibits observed biological behaviors of immune mediators in the presence of endotoxin.
Many of the comments below refer to the subsystems of the pathogen model thoroughly dis-
cussed in [98]. Although the comments may not be explicitly relevant to the endotoxin model
discussed here, we include them since they explain how many of parameters which do appear
in the endotoxin model were estimated.
Units forN, CA, andD are not given explicitly because there is no single biological entity
or marker that these variables represent and thus there are no specic units that can quantify
these variables empirically. Hence, we use N-units,CA-units,or D-unitsbecause we
cannot be any more precise about them. Although CA (Anti-inammatory Mediator) has
characteristics of IL-10 and TGF -1, it would be inappropriate to assign real units to this
variable and quantitatively compare it to actual data from these or other anti-inammatory
mediators. Correspondingly, units of most parameters related to these variables are not in
conventional form, but rather in terms of the associated variable.
Comments:
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1. The range for the decay rate of pathogen endotoxin, pe, was calculated from various
half-lives of endotoxin given by Iversen et al., [51] on pg. 1160 and the control curve on
Fig. 1 (for rabbits), Warner et al., [117] in the abstract (for rats), and Yoshida et al.,
[123] in the abstract (for rabbits).
2. The second term of the pathogen endotoxin equation 2.1 allows for multiple endotoxin
doses to be given at di¤erent times during a simulation. The function S is the di¤erence
of two Heaviside step functions, which determines when an administration starts (ton)
and stops (toff). The value assigned to ti determines ton and ti+ determines toff for the
ith endotoxin dose. The parameter i, is the amount of the ith endotoxin dose to be given
and  governs the duration of time over which the dose is administered. The coe¢ cient
i= thus gives the dose of endotoxin to be administered per hour during the time interval
[ti , ti + ]. The summation in Eq. 2.1 allows for numerous doses to be given during
the simulation. Section 2.2 describes how the values for i, , and ti were chosen when
emulating various experimental scenarios involving repeated endotoxin administration.
3. We estimated the rate of activation of N by PE, knpe, in such a way so that the following
two stable states exist: healthy (levels of all mediators are low) and unhealthy (levels of
all mediators, excluding PE, are high). A lethal dose of endotoxin for mice was acquired
from the literature and we used this information to calibrate the model to give proper
responses to lethal and sublethal doses known for mice, specically [24]. Thus, both
of these states can be reached by simply varying the initial condition of PE: for a low
(single) initial condition of PE (less then 17 mg/kg) the system resolves to the healthy
state and for a high (single) initial condition of PE (17 mg/kg or more) the system
evolves to the unhealthy state, consistent with observed biological behaviors of immune
mediators in the presence of endotoxin.
4. In the model presented by Reynolds, et al. [98], the activated phagocytes/pathogen
(N/P ) subsystem was t such that for low pathogen growth rate (kpg) health is the only
stable state, and at a moderately high kpg septic death exists and is stable. Parameters
in this subsystem were rst estimated so that these general dynamics occurred for a
signicant range of the physiologically possible levels of the anti-inammatory mediator.
They were then adjusted so that both the reduced model with pathogen dynamics and
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the modied endotoxin model presented here exhibited observed biological behaviors
of immune mediators in the presence of pathogen or endotoxin, respectively. See also
comment 6.
5. In Reynolds et al. [98], the activated phagocytes/tissue damage (N/D) subsystem
was initially t such that for physiologically relevant levels of the anti-inammatory
mediator the system is bistable between health and aseptic death with a reasonable basin
of attraction for the health state. Adjustments were then made so that both the reduced
model with pathogen dynamics presented in Reynolds et al. and the altered endotoxin
model presented here exhibited observed biological behaviors of immune mediators in
the presence of pathogen or endotoxin, respectively. See also comment 6.
6. Once the anti-inammatory mediator (CA) was incorporated in the pathogen model of
Reynolds et al. [98] as a dynamic variable, the parameters were adjusted so that the
reduced pathogen model now has the following behavior (1) the model exhibits bistability
between the health and aseptic death states for low kpg with a plausible basin of attraction
for the health state, (2) for moderate to high kpg all three states (health, aseptic death,
and septic death) are stable, and (3) as kpg continues to increase, the health state and
the aseptic death state lose stability.
7. The parameter, knn, corresponding to the rate of activation of resting phagocytes by
those previously activated, was estimated to ensure n > (snrknn)=nr This inequality
must hold for the health state to be stable in the pathogen model of Reynolds et al. [98].
8. In Reynolds et al. [98], snr, the source of resting phagocytes (NR), was set to ensure
a stable concentration of resting phagocytes in the health state. It was adjusted to
balance nr, the decay rate of resting phagocytes . These parameters are related since
in the health state NR = snr=nr .
9. The range for the decay rate of the resting phagocytes, nr, was calculated from the
half-lives (6-20 hours) of circulating neutrophils presented in Coxon et al. [25].
10. The half-life of activated phagocytes, n, is longer than the half-life of resting phagocytes,
nr, due to delayed apoptosis in the activated population; therefore, n < nr [25].
11. In Reynolds et al. [98], the peak of the activated phagocyte response elicited from
pathogen, knp, is greater than that triggered by damage, knd; therefore, knd < knp . In
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the modied endotoxin model presented here, we adopted the same restriction so that
knd < knpe.
12. The minimum for d, which represents tissue repair, resolution, and regeneration, was
estimated from data in Wang et al., [116]. We used the half-life of HMG-1, since it is
a histone tethering protein leaked by damaged cells as a surrogate for the many danger
molecules that perpetuate the inammatory signal. Wang and colleagues give data for
HMG-1 levels during an inammatory response to bacterial lipopolysaccharide (LPS).
Therefore, we estimated the lower limit as the slope of the data shown in Fig. 1C of
Wang et al. [116] during the decay phase of HMG-1. It would be unrealistic to set d to
a value higher than the time constant of a recognized marker of cellular injury.
13. The value for c1 was set such that corresponds to  75% inhibition, i.e. , when CA
reaches maximum value in response to an insult. We set this to be approximately 75%
because Fig. 6B in Isler et al. [50] shows that when the anti-inammatory mediator,
IL-10, is blocked with anti-IL10 there is approximately a 75% increase in the production
of IL-12 (a pro-inammatory cytokine produced by activated phagocytes).
14. Organisms have constitutive levels of anti-inammatory e¤ectors. Therefore, the source
parameter, sc, was chosen to balance the corresponding half-life, c. These parameters
are related because at the health state CA = sc=c.
15. Anti-inammatory signals have downstream cellular e¤ects not explicitly modeled herein,
lasting longer than the e¤ector cytokines or molecules producing it. Therefore, the value
for c was set at the lower limit of reported half-lives of anti-inammatory e¤ectors,
which were estimated from pg. 130 of Bacon et al. [8], Table 1 on pg. 277 of Bocci [12],
pg. 291 of Fuchs et al. [40], and the abstract of Huhn et al. [49].
16. This Hill coe¢ cient for Eq. 2.3 was set to six so that the response of tissue damage to
activated phagocytes is not hypersensitive. A lower Hill coe¢ cient would not appropri-
ately represent this. In other words, it is biologically plausible that low levels of activated
phagocytes do not trigger signicant amounts of damage that could lead to a positive
feedback capable of sustaining aseptic death. Also, for values six and higher, there was
not a signicant di¤erence in the sensitivity of damage to the activated phagocytes. Con-
trary to the common inference regarding the use of Hill coe¢ cients in enzymatic kinetics,
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we are not implying that a cooperativity-based mechanism is at work.
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Table 8: Explanation of model parameters used in simulations
Name Range Value Used Description Comments
pe 0.620714.85 3/h Decay rate of pathogen endotoxin (PE) 1, 4, 5
i n/a Various (mg/kg) Amount of the ith PE dose administration 2
 n/a 0.01 or 24 hr Duration of PE injection: 0.01 corresponds
to instantaneous delivery (1/100 of an
hour) and 24 corresponds to constant de-
livery of a dose over 24 hours.
2
ti n/a Various (h) Time at which the ith PE dose is given 2
knpe Estimated 9/(mg/kg)/h Activation of phagocytes by pathogen en-
dotoxin (PE)
3, 4, 5
knn Estimated 0.01/N-units/h Activation of phagocytes by already acti-
vated phagocytes (or the cytokines that
they produce )
4, 5, 7
snr Estimated 0.08/NR-units/h Source of resting phagocytes 4, 5, 8
nr 0.069-0.12 0.12/h Decay rate of resting phagocytes
(macrophages and neutrophils)
4, 5, 9
n Less than nr 0.05/h Decay rate of activated phagocytes
(macrophages and neutrophils)
4, 5, 10
knd Less than knpe 0.02/D-units/h Activation of phagocytes by tissue damage
(D)
5, 11
kdn Estimated 0.35/D-units/h Max rate of damage production by acti-
vated phagocytes (and/or associated cy-
tokines/free radicals)
5
xdn Estimated 0.06 N-units Determines level of activated phagocytes
(N*) needed to bring damage production
up to half its maximum level
5
d 0.0174 (min) 0.02/h Decay rate of damage; combination of re-
pair, resolution, and regeneration of tissue
HMGB-1 release by damage
5, 12
c1 Estimated 0.28/CA-units/h Threshold for e¤ectiveness of the anti-
inammatory response
6, 13
sc Estimated 0.0125CA-units/h Source of anti-inammatory (CA) (IL-10,
TGF-1, cortisol);
6,14
kcn Estimated 0.04 CA-units/h Maximum production rate of Anti-
inammatories
6
kcnd Estimated 48 N-units/D-units Controls relative e¤ectiveness of activated
phagocytes versus damage in producing
anti-inammatories
6
c 0.15-2.19 0.1/h Decay rate of the anti-inammatory medi-
ator
6, 15
hill Estimated 6 Hill coe¢ cient in the Damage Equation 16
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3.0 AN IMPLEMENTATION OF AN ALGORITHM FOR GENERATING
2-D (UN)STABLE MANIFOLDS FOR 3-D ODE SYSTEMS
3.1 INTRODUCTION
Stable and unstable manifolds of xed points are important invariant geometric structures
in the theory of dynamical systems. Intersections of stable and unstable manifolds can
be the source of interesting, complex behavior. They can be valuable for visualizing the
separatrix of a saddle point between two stable xed points, showing how the phase space is
divided into regions containing points that have common convergence sets as time!1 or
time !  1. [43] Recall that in Chapter 2 we used the stable manifold to visualize how a
challenge dose of endotoxin can cause a trajectory that started in the basin of attraction of
the healthy xed point to be bumped to the other side of the manifold and heading toward
the unhealthy xed point.
With the 4D ODE model describing the acute inammatory response to endotoxin,
there were two stable states in the chosen parameter regime: one that represented a healthy
outcome and the other an unhealthy outcome, separated by an unstable saddle point. The
separatrix forms the border between the basins of attraction of the healthy and unhealthy
states. We wanted to visualize the threshold between these life and death outcomes; however,
in systems of n-dimensions, this threshold is in the form of an (n-1)-dimensional (stable)
manifold. Since the endotoxin tolerance system is four dimensions, it would be di¢ cult to
visualize the stable manifold of the saddle even if it were a two-dimensional structure since it
would be embedded in a four dimensional space. However, because the endotoxin variable,
PE, decays quickly we are able to consider only the other three variables: N, D, and CA.
(i.e. set the endotoxin equation to zero). Then, it is possible to visualize the resulting
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two-dimensional stable manifold of the saddle point that exists in a three dimensional space,
giving a reasonable idea of how the space is divided.
There are presently a number of algorithms that have been published in the literature
that use various approaches to generate two dimensional (un)stable manifolds of equilibrium
points. A thorough review of these methods, given by Krauskopf and colleagues in [64], not
only explains each method but also points out the di¢ culties that each faces. Generally, all
the methods approach the problem by growingthe manifold out from a small neighborhood
around the xed point. Specically, though, they di¤er in the way this is accomplished and
also in the way that the accuracy of the mesh is ensured. Furthermore, these methods can be
used to compute manifolds of dimension higher than two. For obvious visualization reasons,
however, demonstrations of the algorithms are usually done for two-dimensional manifolds
in three-dimensional space, as is done in this chapter.
Simply parameterizing the manifold by a collection of circles generated by the image
under the ow of the vector eld of an initial small circle around the xed point, while
intuitive, does not provide a nice enough mesh. This can be caused by one eigendirection
being stronger than the other. As a result, the subsequent curves produced by owing the
vector eld out from the initial circle soon become deformed, creating an insu¢ cient and
incomplete mesh. Instead, the manifold needs to be parameterized by more nicely formed
curves which are topologically equivalent to circles. These can be found if one considers the
geodesic distance between two points, x and y, on the manifold. As Krauskopf and colleagues
explain, the geodesic distance is "the arclength of the shortest path" in the manifold that
connects x and y. Parameterizing the manifold by curves called geodesics, which contain
points that are all at an equal geodesic distance from the xed point, is the correct method.
This parameterization only depends on the geometry of the manifold and not the underlying
dynamics of the system. Furthermore, the smoothness of the manifold guarantees that
the geodesic level sets are topologically equivalent to circles up to some maximum geodesic
length from the xed point. See [64] and [106] for more details.
The usual example case for testing the various algorithms is the computation of the
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stable manifold of the origin of the Lorenz system:
_x = (y   x);
_y = rx  y   xz;
_z = xy   bz
9>>>=>>>; (3.1)
with the following standard parameter values:  = 10; r = 28, and b = 22
3
. Abraham
and Shaw presented the rst handwritten drawing of this manifold [1], while Guckenheimer
and Worfolk rst published a computer generated image [45]. Since then, methods due
to Doedel, Dellnitz and Hohmann, Guckenheimer and Vladimirsky, Henderson, Johnston
and colleagues, and Krauskopf and Osinga have graced the dynamical systems literature.
[30, 31, 32, 33, 44, 46, 58, 63] However, what is lacking is the availability of a program that
allows users to generate manifolds for their own systems, as we wished to do for the endotoxin
tolerance model presented in Chapter 2. In the present chapter, the implementation of an
algorithm to generate a 2D (un)stable manifold of a saddle equilibria for 3D ODE systems
is discussed. The algorithm we implement is due to Bernd Krauskopf and Hinke Osinga
in their 1999 article published in Chaos [63]. We rst introduce the algorithm using the
notation used by Krauskopf and Osinga and then present the details of our implementation
of the algorithm, which was programmed using MatLab. [72]
3.2 THE ALGORITHM
In their 1999 article, Bernd Krauskopf and Hinke Osinga presented pseudo code for an
algorithm to generate a 2D mesh of an unstable manifold. The paper, as well as the review
paper [64] mentioned above, thoroughly explains how the algorithm works and demonstrates
its capabilities with impressive pictures of the manifold for the Lorenz system; however,
specic details were not given as to how some parts of the algorithm were computationally
and practically carried out in order to generate these gures. Moreover, there was no code
or software made available by which to utilize the method. Thus, we sought to convert the
pseudo code given in their paper into a usable MatLab program. In Chapter 2, since the
stable manifold was calculated for the endotoxin tolerance model, the implementation of this
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algorithm is presented in the context of the generation of a mesh for a 2D stable manifold
of a saddle equilibrium with alternatives for a 2D unstable manifold in parenthesis. The
explanations given in Krauskopf and Osingas work is done in the context of the unstable
manifold; however the di¤erences are minor, mainly having to do with integration being
carried out in forward or backward time.
First, we detail the input and output data.
 INPUT
f : the right-hand-side of the vector eld: _x = f(x), x 2 R3, f su¢ ciently smooth
x0 : the saddle point of f
Cr;  : initial discrete circle with radius , approximating the local (un)stable man-
ifold, W sloc(x0) (W
u
loc(x0)), in the (un)stable eigenspace. The (un)stable manifold
theorem guarantees that W sloc(x0) (W
u
loc(x0)) exists in a small neighborhood around
x0. The (un)stable manifold is tangent to the (un)stable eigenspace of the lineariza-
tion of _x = f(x) at x0. Thus, if  is chosen su¢ ciently small, then Cr will be a good
approximation toW sloc(x0) (W
u
loc(x0)). This comprises the starting data of the mesh
and is the foundation from which the next mesh points (i.e. next discrete circle) will
be calculated.
 : initial guess of the euclidean distance between one discrete circle and the next
concentric circle in the mesh. This value will potentially change depending on
the accuracy of the mesh. In other words,  might need to be decreased so that
the generated mesh is approximating the manifold accurately enough. Accuracy
specications are discussed later.
Larc : total arclength to be computed. In the end, because the arclength of the
manifold is approximated by summing all the various values of  used throughout
the computation, the manifold is calculated up to an approximation of this specied
arclength.
 OUTPUT
The overall output that the algorithm generates is a mesh onW s(x0) (W u(x0)) with
an approximated arclength from x0 close to Larc. Each discrete circle or band
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that comprises the mesh is stored in a matrix structure so that the manifold can be
generated from previously generated data (a much faster process!) or so that the
manifold can be continued from a specic band.
Starting with the saddle point, the global (un)stable manifold W s(x0) (W u(x0)) mesh
is grown out from the saddle in bands made up of successive discrete circles generated
by the algorithm, as demonstrated in gures that follow. In reality, the rst circle is the
saddle point a circle with radius zero. For a 2D (un)stable manifold of a saddle, there are
two linearly independent eigenvectors associated with the negative (positive) eigenvalues of
the linearization about the saddle from which the next substantial discrete circle, Cr, with
center, x0, is calculated. The points of this circle are then connected to the saddle point to
form the rst band of the manifold as shown in this rst picture.
Figure 14: Initial discrete circle around the Saddle Point
Each subsequent circle is found by using the previous discrete circle. Denote Cr as the
previously calculated discrete circle and let r 2 Cr. The following steps are carried out in
order to nd each point on the next discrete circle lying on W s(x0) (W u(x0)), all of which
are then connected to the points from the previous discrete circle, forming the next band of
the manifold:
 Calculate the half plane, Fr, perpendicular to the previous circle at point, r. The goal is
to nd, for each r, the point, br, on Fr that is  away from r. This was accomplished
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via a shooting method described in more detail in the next section.
Figure 15: The half plane, Fr, perpendicular to the previous circle at point, r
 Shooting from the point r as the rst initial condition, nd the intersection of the resulting
trajectory with Fr. For an (un)stable manifold, we integrate in backward (forward) time,
in order to generate the trajectories. Then, we choose the next initial condition on Cr
from which to shoot. This choice is based on the results of the previous shooting attempt.
When an intersection point is  away from r, then this point is the desired br that we
Figure 16: Example trajectories illustrating the shooting method for nding the next point on the plane
Fr in the mesh of the stable manifold
wanted to nd. Then, we move to the next point in Cr from which we repeat the process
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to nd the next br associated with the next r 2 Cr. This is done for each r 2 Cr until
a new discrete circle is formed This process and its implementation are given in more
detail in the next section.
 The previous process is done for each r 2 Cr until a new discrete circle, having x0 as its
center and being situated at a distance  from Cr, is formed. This new discrete circle,
Cb, is connected to Cr, forming another band of the manifold.
Figure 17: The rst two bands of the stable manifold, connected via a triangular mesh
 The new discrete circle then becomes the next Cr from which another discrete circle is
calculated. This is continued for the desired arclength. As a demonstration of the
capability of the program, we generate the stable manifold of the origin for the Lorenz
system 3.1.
The algorithm provides a method by which to calculate a mesh that is not a¤ected by
magnitude di¤erences in the negative (positive) eigenvalues and the accuracy of which can
be guaranteed. After each new mesh point is calculated, it is checked using an accuracy
subroutine to make sure it is accurately following the (un)stable manifold. The accuracy
check used by Krauskopf and Osinga is based on a method used in another of their papers and
is comparable to a similar technique due to Dana Hobson. [47] The accuracy is determined
by controlling the angle formed by three successive points in the mesh along with "the
product of this angle and the distance between the last two of the three points."[63, 47]
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Figure 18: A view of the stable manifold of the origin in the Lorenz system calculated with our Matlab
implementation of the algorithm given by Krauskopf and Osinga [63].
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Figure 19: A view of the stable manifold of the origin in the Lorenz system calculated with our Matlab
implementation of the algorithm given by Krauskopf and Osinga [63].
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Figure 20: A closeup of the mesh of the Lorenz manifold that was calculated with the present imple-
mentation of the algorithm due to [63]. Additions and deletions of mesh points can be seen.
This helps determine the value of , which might need to be decreased to maintain desired
accuracy. On the other hand, may be allowed to increase based on the accuracy estimates.
3.3 IMPLEMENTATION USING MATLAB
In this section, the MatLab m-le of our implementation of the algorithm in the previous
section is given along with ample comments distributed throughout explaining the various
steps. The algorithm grows the manifold, starting from the saddle point, by generating
concentric discrete circles that form bands of a specied geodesic distance from the saddle
point. Each circle of points must be computed before the next circle is generated. In
addition, there are accuracy checks to ensure the mesh correctly represents the manifold.
All lines of code are in a different font and numbered to the left. Comments about the
code are in bold and lettered (a., b., c., etc) under the lines of the code to which they refer.
1. function Manifold(basicsfile,rhsfilename, CircleNumber, SystemName)
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2. odefunction = str2func(rhsfilename);
3. save(odefunctionname.mat,odefunction);
a. basicsfile is the name of the m-le that contains information about the 3D ODE
systems, including eigenvectors and eigenvalues. The code for this le and for the
rhsfilename le described next, is given after the entire manifold code is presented.
b. rhsfilename is the name of the m-le containing the ODE system. This le is used
for carrying out the numerical integration.
c. CircleNumber refers to the number of the circle from which the algorithm should
start. If this is the rst time the algorithm is run, then this number would be zero.
However, if x number of bands have already been generated, then CircleNumber
can equal x and the algorithm runs from that set of points on, rather than from the
beginning.
d. SystemName is a user-supplied string to be used in the naming conventions for the
various data les generated by the algorithm.
e. In Line 2, the ODE lename is converted from string input into a function, so that,
later on, it can be passed to other functions, especially the integration function,
ode45. The ODE lename is also saved in a data le so that it can be loaded
outside of this program if necessary.
4. if CircleNumber == 0
5. [Saddle, eVects, eVals, negevals, negevects] = feval(basicsfile);
6. [Cr, steps, SaddleMatrix]= initcir(Saddle, negevects,...
rhsfilename, SystemName);
7. Cp = SaddleMatrix;
a. If the algorithm is to start from the saddle point (CircleNumber ==0) then the
basic information to run the algorithm is obtained from the basicsfile. This
includes the saddle point, eigenvalues and their eigenvectors and specically, the
negative eigenvalues and their eigenvectors which are used in the generation of the
stable manifold. (Positive eigenvalues and their eigenvectors are used for unstable
manifold generation.)
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b. The initcir routine (Lines 45-a) is called to calculate the initial circle around the
saddle: Cr will be a matrix whose columns are the points of the discrete circle around
the Saddle. It is calculated using the eigenvectors associated with the negative
eigenvalues (negevects). This is the initial discrete circle around the Saddle on the
stable eigenspace and hence really close to being on the stable manifold of the saddle.
c. Here, Cp, which denotes the "previous" circle, is the saddle point, which is the
"circle" prior to the initial discrete circle. In the initcir routine, the saddle is
"transformed" into a matrix, each column of which contains the saddle point. This
is done for computational reasons. It has dimensions (3 x steps) where steps is
the number of points generated in the initcir routine for the initial circle
8. DrawBand(:,:,1) = Cp;
9. DrawBand(:,:,2) = Cr;
10. CalcFromBand(:,:,1) = Cp;
11. CalcFromBand(:,:,2) = Cr;
12. drawwidth = lengthCr;
13. drawwidthfn = [SystemName, DW_0.mat];
14. save(drawwidthfn, drawwidth)
15. DrawBandFN = [SystemName, DrawCircle_0.img];
16. multibandwrite(DrawBand,DrawBandFN,bsq,precision,double);
17. width = length(Cr);
18. widthfilename = [SystemName,BW_0.mat];
19. save(widthfilename, width);
20. CalcFromFN = [SystemName, CalcFrom_0.img];
21. multibandwrite(CalcFromBand,CalcFromFN,bsq,precision,double);
a. Lines 8-21 above store the previous circle (saddle matrix here) and the current circle
and save data in a specic le name for use in recreating the image later and also,
for use in calculating from data from a specic circle. Cr and Cp will have the same
number of points. Later on, points might be added to Cr to rene the mesh and
maintain accuracy in calculating the next circle, Cb. This is the reason for saving
data in separate les: one for rendering an image of the mesh and one from which
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to calculate the next circles. So, the number of points in Cr and the number of
points in the updated Cr (drawwidth and width, respectively) are included in the
data le. The DrawBand les contain the data points before any points are added
to Cr and the CalcFrom les contain the data points of Cr in addition to any points
added later to rene the mesh. This is later denoted Updated_Cr. Here, Cr and
the updated Cr are the same; however, this is not always the case, so we set up the
data storing structure from the beginning.
22. CircleNumber = 1;
a. Increment the CircleNumber counter by one.
23. end (if CircleNumber == 0)
24. BigDelta =.25;
25. GeoDistance= BigDelta;
26. TotalGeoDist=20;
a. An initial guess is made for BigDelta, the distance between circles.
b. GeoDistance is the current total geodesic distance of the manifold, initially set to
the value of BigDelta; It is increased by the current value of BigDelta after each
circle is calculated.
c. TotalGeoDist is the total geodesic distance of the manifold to be calculated.
27. while GeoDistance < TotalGeoDist
28. filename=[SystemName,CalcFrom_,int2str(CircleNumber-1),.img ];
29. widthFN=[SystemName,BW_,int2str(CircleNumber-1),.mat];
30. load(widthFN);
31. CalcFromBand=multibandread(filename,[3,width,2],...
double,0,bsq,ieee-le);
32. Band(:,:,1) = CalcFromBand(:,:,1);
33. Band(:,:,2) = CalcFromBand(:,:,2);
a. Lines 28-33 load the data from the last two calculated circles to be used in the
calculation of the next circle.
34. [Cb, BigDelta,Next_BigDelta] = nextcir(Band,odefunction,BigDelta);
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35. Band(:,:,3) = Cb;
a. Calculate the next circle at a distance BigDelta from the last circle with a call to
the nextcir routine (Line 71).
b. Store the newly created circle in the third page of the matrix structure which stores
the circles, Cp, Cr, and now Cb.
36. MinMeshDistance = .2;
37. MaxMeshDistance = 2;
a. A minium and maximum distance between adjacent mesh points in a discrete circle
are specied. If the mesh points are too close to one another, then the algorithm will
get confused when nding the next circle. If the mesh points are too far from one
another, then there is a risk that the accuracy of the manifold will be compromised.
38. [Updated_Cr,Updated_Cb]=MeshQuality(Band,MinMeshDistance,...
MaxMeshDistance,BigDelta,odefunction,CircleNumber,SystemName);
a. A call to the MeshQuality routine (Line 364) checks the quality of the newly calcu-
lated mesh points and draws the mesh when the quality is acceptable. New points
might be added to the mesh or existing mesh points may be deleted.
39. BigDelta = Next_BigDelta;
40. GeoDistance = GeoDistance + BigDelta;
41. Band = zeros(3,length(Updated_Cb),3);
42. CircleNumber = CircleNumber + 1;
a. Set BigDelta to the value, Next_BigDelta, determined by the nextcir routine. The
new value of BigDelta might be larger or smaller than its previous value, depending
on the results of the Accuracy routine called from within the nextcir routine.
If one new point in the circle currently being calculated does not meet accuracy
requirements (explained more later), then BigDelta is decreased and the new circle
is re-calculated from the beginning. This must be done so that each point in the new
circle is the same distance from the previous circle. The new value for BigDelta is
stored in Next_BigDelta and returned when the nextcir routine exists properly.
b. Increment the current total geodesic distance, GeoDistance, by BigDelta.
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c. Reset the third page of the Band matrix structure to a (3 x length(Updated_Cb))
matrix of zeros. The MeshQuality routine called above returns the updated data
sets for the circles, Cr and Cb, in the variables Updated_Cr and Updated_Cb. These
are also stored in a le (with a lename specic to the circle number to which the
Cb data corresponds) and recalled at the beginning of this while loop. The data
from the le is read into the CalcFromBand variable on Line 31 above, and the rst
and second pages of Band are updated so that: (1) Cr is now Cp and stored in the
rst page, (2) Cb is now Cr and stored in the second page, and (3) the third page is
now ready to store the data of the next circle to be computed.
d. Increment the number of the circle we are on currently. This variable is mainly used
for creating lenames for data that are specic to a circles number in the mesh,
with circle 0 being the initial discrete circle around the xed point.
43. end (end the while loop)
44.                           
45. Now the initcir routine is examined in detail. It is a subfunction within the
Manifold.m le.
46. function [Cr, steps, SaddleMatrix] = initcir(Saddle, negevects,...
odefilename, SystemName)
a. This routine calculates the initial circle around the saddle point, approximating the
local (un)stable manifold, W sloc(x0) (W
u
loc(x0)), in the (un)stable eigenspace.
47. delta=1;
48. steps=20;
49. SaddleMatrix = zeros(3,steps+1);
a. delta is the radius of initial discrete circle; i.e. the distance from the saddle point.
b. The value of steps is the number of discrete points in the initial circle, a distance
of delta from the saddle.
c. Make a (steps x 3)-matrix that has the saddle point (vector) as each of its columns
so that the vector loop below this will work.
50. for j=1:steps+1
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51. SaddleMatrix(:,j)=Saddle(1,:);
52. end
a. Transpose the saddle row vector, Saddle(1,:), so that it is a column vector to
match dimensions for the SaddleMatrix.
53. theta = 0:2*pi/(steps):2*pi;
54. Cr = delta*(negevects(:,1)/norm(negevects(:,1))*cos(theta)
+ negevects(:,2)/norm(negevects(:,2))*sin(theta)) + SaddleMatrix;
a. The initial circle, Cr is formed using the saddle point and the 2 negative (positive)
eigenvalues, negevals (posevals), which were acquired from calling the basics
routine on Line 5, right before the call to this routine. Since this initial discrete
circle around the saddle is on the stable eigenspace it is close enough to be considered
"on" the stable manifold of the saddle. The formula for Cr is as follows:
Cr =delta 

negevects(:; 1)
norm(negevects(:; 1))
cos(theta)
+
negevects(:; 2)
norm(negevects(:; 2))
sin(theta)

+ SaddleMatrix
Using cosine and sine functions and dening theta as a vector containing values
from 0 to 2 in increments of 2
steps
, a set of discrete points all at a distance delta
from the saddle point is generated: i.e. a discrete circle having the saddle point as its
center and radius equal to delta. The variable Cr is a matrix whose columns store
the points of this rst discrete circle. Each column of SaddleMatrix contains the
saddle vector and this matrix has the same number of columns as the value of the
variable steps, which is the number of points being generated in this initial discrete
circle. (Also, the distance between any two mesh points in Cr is the same.)
55. i=1:steps;
56. Cr=Cr(:,i);
57. SaddleMatrix = SaddleMatrix(:,i);
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a. Here, we get rid of the last entry of Cr which is a repeat of the rst, and re-size
SaddleMatrix to agree with the dimension of Cr.
58. for j = 1:steps
59. fprintf(%2.0f -- , j);
60. end
61. fprintf(nn);
a. Simply print to the screen the number associated with each point around the circle.
62. initBand(:,:,1) = zeros(3,steps);
63. initBand(:,:,2) = SaddleMatrix;
64. initBand(:,:,3) = Cr;
a. Storing the last three circles in the 3-page matrix structure initBand. The rst
circle is a matrix of zeros. The second circle is a matrix, the columns of which
each contain the saddle point (vector). The third circle is the one just calculated
around the saddle point.
65. MinMeshDistance = .2;
66. MaxMeshDistance = 2;
a. These serve the same purpose (for the initial circle) as the variables of the same
name that are used in the main le.
67. figure(Position, [10, 400, 400, 300], Units, inches)
a. Set up a MatLab gure in which to draw the mesh.
68. [SaddleMatrix, Cr] = MeshQuality(initBand,MinMeshDistance,...
MaxMeshDistance, delta, odefilename, 0, SystemName);
a. Call the MeshQuality routine (Line 364) to ensure that the distance between mesh
points is within the lower (MinMeshDistance) and upper
(MaxMeshDistance) bounds. The MeshQuality routine is also a subroutine within
the Manifold.m le and is explained later.
69.                           
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70. The next routine to be explained is nextcir. It is also a subfunction within the
Manifold.m le. Recall that this routine was called on Line 34 above.
71. function [Cb,BigDelta,Next_BigDelta]=nextcir(Band,TheOdeFile,BigDelta)
a. The nextcir routine takes, as input: (1) the data points of the last 3 calculated
circles (stored in Band), (2) the le name (TheOdeFile) of the ODE system, (3)
and the value of BigDelta to calculate the next circle, Cb, which is a distance of
BigDelta away from the last circle, Cr.
72. AccuracyChecker = 0;
73. BDIncrease = 5;
a. Initialize the AccuracyChecker variable to 0. When the Accuracy routine is
called, if the next point in the mesh that was found passed the accuracy test,
then AccuracyChecker is set to 1 and the algorithm can start nding the next new
point in the mesh. Otherwise, if the new point does not pass the accuracy test,
AccuracyChecker is left at a value of 0 and the value of BigDelta is decreased.
Then, the algorithm starts over on calculating the current circle since all the new
points to be calculated must now be at a distance of (the new) BigDelta from
corresponding points on the previous circle.
b. The variable, BDIncrease, helps to keep track of whether or not the Accuracy
checker can increase BigDelta when nished.
74. while AccuracyChecker == 0
a. Continue the loop until the next point in the mesh is calculated and passes the
accuracy checks.
75. lengthCr = length(Band);
76. Rotated_Band = Band(:,:,2);
77. Cb = zeros(3, lengthCr);
a. Rotated_Band contains the data points from the last calculated circle and is manip-
ulated later on so that the point, r, we are currently considering in Cr, is always the
rst column of this matrix. Hence, the points from the last circle from which we
are computing the next circle, are "rotated" around to the rst column position in
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Rotated_Band. This is done so that it is simple to identify the position of points
relative to the current point, r. This helps greatly with indexing issues regarding
the shooting method described in the next subroutine, Shooting_For_b.
b. Cb is the (3 x lengthCr)-matrix that will contain the points, b, of the next new
circle in the mesh. Here it is initialized to hold zeros.
78. for k = 1:lengthCr
79. b = Shooting_For_b(Rotated_Band, BigDelta, TheOdeFile, k);
80. if b == [0;0;0]
81. disp(We didnt converge...now what??);
82. Cb = zeros(3, lengthCr);
83. AccuracyChecker = 1;
84. break;
85. end
a. Call the Shooting_For_b routine (Line 109) to nd the next point, b, in the mesh,
corresponding to the current point, r in Cr. This for loop runs through all the
points in Cr.
b. Unfortunately, there are times when the code in lines 80-85 does get executed. This
happens when the algorithm is unsuccessful in nding a next point. The break
statement exits out of this for loop and an error will result because Cb matrix was
not completely calculated. (The Cb matrix is reset to zeros and this will cause the
MeshQuality routine to have a heart attack and the program will exit.) Setting
AccuracyChecker to 1 ensures that we exit out of the while loop. The reasons
for why the algorithm may not nd appropriate mesh points is discussed in the
Shooting_For_b routine.)
86. fprintf(%2.0f ... , k);
87. Pkminus1 = Band(:,k,1);
88. Pk = Band(:,k,2);
89. Pkplus1 = b;
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90. [AccuracyChecker, Next_BigDelta, BDIncrease]
= Accuracy(Pkminus1, Pk, Pkplus1, BigDelta, BDIncrease);
a. If the code is successful, then the number, k, of the point that was found is printed,
so that the user knows the status of the algorithm.
b. The Accuracy routine (Line 341) is called to ensure that the point that was just
calculated passes the accuracy check. In order to do the accuracy check, the following
need to be passed to the Accuracy routine:
i. Pkminus1: the point in the kth position on the previously calculated circle, Cp.
Cp is stored in Band(:,k,1), the kth column of the 1st page of the Band matrix
structure.
ii. Pk: the point in the kth position on the current circle, Cr, from which we are
calculating the next circle. Cr is stored in Band(:,k,2), the kth column of the
2nd page of the Band matrix structure.
iii. Pkplus1: the point in the kth position on the newly calculated circle. This is
simply the point, b, that was just calculated during this kth step of the for loop.
c. These points are used to form an angle that measures how accurate the new mesh
point is. This is explained more below in the Accuracy routine. The Accuracy
routine returns (1) a value for the variable AccuracyChecker, (2) a value for the
next value of BigDelta (Next_BigDelta), and (3) an updated value for BDIncrease
which helps keep track of when BigDelta has been increased/decreased.
91. if AccuracyChecker == 1
92. disp(Its a good point!);
93. Cb(:,k) = b;
94. Prev_Band = Rotated_Band;
95. j=1:lengthCr-1;
96. Rotated_Band(:,j) = Prev_Band(:,j+1);
97. Rotated_Band(:,lengthCr) = Prev_Band(:,1);
98. elseif AccuracyChecker == 0
99. disp(We have to shrink BigDelta and reshoot.);
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100. BigDelta = Next_BigDelta;
101. BDIncrease = 5;
102. break;
103. end
a. If the Accuracy routine returns a value of 1 for the AccuracyChecker variable, then
the calculated point, b, is accepted as "a good point" and the kth column in the
Cb matrix is assigned the value of b. Rotated_Band is stored in a matrix called
Prev_Band so that the columns of Rotated_Band can be "shifted" or "rotated" in or-
der for the next point, r, of the Cr circle (which is currently stored in Rotated_Band)
can be in the rst column of Rotated_Band. As described previously, this helps with
indexing issues in the Shooting_For_b routine.
b. If the Accuracy routine returns a value of 0 for the AccuracyChecker variable, then
the calculated point, b, is not accepted. Instead, the value of BigDelta is given a
new smaller value (Next_BigDelta), which was returned by the Accuracy routine.
Then, the algorithm breaks out of the loop and restarts the circle over again with the
new value of BigDelta. The variable BDIncrease is reset to some number not equal
to zero. In the Accuracy routine if one of the angle conditions is larger than the
allowed minimum value, BDIncrease is set to zero and this tells the accuracy routine
that its not a good idea to increase BigDelta. On the other hand, if the angle
condition is less than (or equal) to the allowed minimum value, then BDIncrease
would have its initial value of 5 (6= 0), and this would tell the Accuracy routine
that it is alright to increase BigDelta (double it). For information on the angle
conditions, refer to the Accuracy routine explained below.
104. end (end the for loop in Line 78)
105. end (end the while loop in Line 74)
106. fprintf(nn); (print-to-screen a line break)
107.                           
108. The next routine to be explained is Shooting_For_b. It is also a subfunction within
the Manifold.m le. Recall that this routine was called on Line 79 above. This routine
is the heart of the algorithm, the part that nds new mesh points, b. This subroutine
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takes care of the majority of the steps highlighted in the Algorithm section above, such
as (1) dening the plane transversal to the last circle at r, the normal of which is dened
by the points to the right and left of r in the circle, and (2) actually shooting to nd the
point on the plane that is on the manifold and at a distance BigDelta from r.
109. function [b]=Shooting_For_b(Rotated_Band,BigDelta,OdeFile,pointnumber)
110. clear j;
111. r = Rotated_Band(:,1);
112. rLeft = Rotated_Band(:,end);
113. rRight=Rotated_Band(:,2);
114. N = rRight - rLeft;
115. save(r_BigDelta_N.mat, r, BigDelta, N);
a. j is a counter used in the while loop below. Its value is cleared from memory
each time this routine is called to ensure that the counter value starts at the value
assigned during the loop.
b. As mentioned previously, the rst column of Rotated_Band will always contain the
current point, r, from which we are calculating the next mesh point, b. The nextcir
routine guarantees this.
c. rLeft the point to the left of r in Cr will always be the last column of the
Rotated_Band matrix. The nextcir routine guarantees this.
d. rRight the point to the right of r in Cr will always be the second column of the
Rotated_Band matrix. Again, the nextcir routine guarantees this.
e. N is the normal vector of the plane, Fr, at r and is dened as the vector rRight -
rLeft and thus points in the direction to the right of the plane. This is important
in later calculations that determine on which side of the plane the endpoint of a
trajectory is. Note, rRight - rLeft is only an approximation to the normal vector,
since the actual vector is tangent to r. If the mesh points are close enough, then
this approximation is good enough.
f. The variables, r, BigDelta, and N are all saved in the le
r_BigDelta_N.mat to be recalled in other subfunctions where these variables are
needed. Another option would be to make these global variables.
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116. y0=r;
117. epsilon=.01;
118. BigDeltaUpperBnd = (1+epsilon)*BigDelta;
119. BigDeltaLowerBnd = (1-epsilon)*BigDelta;
a. y0 is the current initial condition of the ODE system from which the algorithm will
attempt to nd an appropriate intersection with the plane. The rst y0 is set to r.
Throughout the course of the while loop below, y0 will be set to many other values
while the algorithm searches for the point, b.
b. For practical numerical reasons, there are upper and lower bounds on BigDelta
since it is unlikely that the point b will be exactly BigDelta from r. Hence, an
"-neighborhood is dened around BigDelta, using the variable epsilon. The upper
bound is dened as BigDeltaUpperBnd and the lower bound is BigDeltaLowerBnd.
120. tspan=[0 -.2]
121. StopValue=0;
122. Init_Step = .01;
123. StopThis = 0;
a. tspan is the interval of time for which to integrate the ODE system in the attempt to
nd a trajectory that crosses the place at a distance BigDelta from r. The correct
amount of time needed will vary from system to system. Some experimentation
might be necessary. It is also helpful to plot some of the trajectories for a particular
set of shooting attempts for a particular r.
b. In the following while loop, when the next mesh point, b, is found, StopValue is set
to a value of 1 and the loop breaks. This means that we can move on with nding
the next point in Cb. Initially, StopValue is 0, meaning that b has not yet been
found.
c. Init_Step provides the initial integration step size for the numerical ODE solver
used below.
d. The variable, StopThis, which is initialized to a value of zero, is set to ensure that
the while loop below is not an innite loop and that if an appropriate point, b,
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cannot be found after the specied number of iterations, then this loop exits and, in
turn, the program exits. Now for the main while loop:
124. while StopValue==0
125. options = odeset(Events,@FrzeroEvent, InitialStep,...
Init_Step, Refine, RefiningNum);
126. [T,Y, TE, YE, IE] = ode45(OdeFile,tspan, y0, options);
a. options denes some of the options to be passed to the numerical integration
solver, ode45, specically it lets the solver know that there is an events function,
FrzeroEvent. The solver will then locate times and corresponding solutions where
these functions are zero.
b. The above integration step is the most important part of this algorithm. The numer-
ical integration solver, ode45, is "based on an explicit Runge-Kutta (4,5) formula,
the Dormand-Prince pair. It is a one-step solver - in computing y(tn), it needs only
the solution at the immediately preceding time point, y(tn   1) [72]." The line
[T; Y; TE; YE; IE] = solver(odefun; tspan; y0; options)
integrates the ODE system, specied in OdeFile, for the allotted amount of time,
tspan, starting from the initial condition, y0, using the options specied above. In
addition, since the options included an event function, it also nds where certain
functions, called event functions, are zero. The event function FrzeroEvent is
described below after the end of this subroutine.[72] T is the column vector of times
at which the solution, Y, of the ODE was calculated. The ith entry of T corresponds
to the solution point in the ith row of Y. TE is a vector of times at which the events
occur. The rows of YE contain the solution point at the corresponding time in TE
that the event occurred, and IE is the index of the event function for which the event
occurred.
c. There are 3 event functions: (See also the events function, FrzeroEvent, on Line
328 below this Shooting_For_b subroutine.)
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i. Event Function 1: The function that calculates the distance between a solution
point and the plane: If this function is zero, then this means that the solution
lies on the plane and an intersection of the solution trajectory and the plane
has occurred. However the integration does not stop because there may be
other intersections or there may be other events, described next, that need to be
recorded. If this is the ith even to occur, then the ith entry of IE will contain a
1.
ii. Event Function 2: The function that calculates whether the derivative of the
solution is zero with respect to the direction of the normal vector, N, of the plane.
Zeros of this function do not necessarily imply that the solution is on the plane.
It simply means that the vector tangent to the solution is pointing in the same
direction as the plane. This solution may, in fact, be far away from the plane.
However, it might be the case where the point we are seeking is located at the
point where the trajectory is tangent to the plane. A tangent intersection like
this will not necessarily be caught by the rst event function, so we have to
check for them this way. Again, integration is not stopped when such solutions
are found, so that other events, if any, can be detected. If this is the ith even to
occur, then the ith entry of IE will contain a 2.
iii. Event Function 3: The function that calculates the distance between the solution
and r and compares it to the value of BigDelta. If this function is zero, then the
solution point is at a distance BigDelta from r. However, like with ii. above,
this does not guarantee that this solution point is on the plane. It simply means
that a trajectory has entered the BigDelta (+/- epsilon) ball around r. This
check, however, is necessary because the trajectory originating at r sometimes
shoots straight out into the plane. For some reason, however, the other event
functions do not register these as intersections nor points of tangency, so these
obvious intersections are found by rst checking the distance between the solution
and r. If the solution is at a distance of BigDelta away, this event will locate
where/when that happens. Then, after the integration has nished, the distance
of this solution to the plane is checked. If it is "on" the plane, i.e. within a very
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small neighborhood of the plane, then this point is the point, b, we were seeking.
Again, integration is not stopped when such solutions are found, so that other
events, if any, can be detected. If this is the ith event to occur, then the ith entry
of IE will contain a 3.
127. for i=1:length(IE)
128. if IE(i)==3
129. YE1 = YE(i,:);
130. rydistance = norm(YE1-r);
131. FRdist = dot(N/norm(N), (YE1 - r));
132. if (abs(FRdist)<.00001
&& BigDeltaLowerBnd <= rydistance
&& rydistance <= BigDeltaUpperBnd);
133. b = YE1;
134. StopValue = 1;
135. break;
136. end
137. end
138. end
139. if StopValue==1;
140. break;
141. end
a. The IE vector is processed to nd if there were any entries that had the value of
3, corresponding to events occurring from the 3rd event function described in Line
126.c.iii. It is processed rst because it is an easy event to process, with only the
distance from the plane having to be checked. If the desired solution is found with
this check, no time is wasted on processing the other more involved event functions.
Recall that this event was mainly to troubleshoot the problem with shooting from r
and nding intersections of that trajectory with the plane dened at r.
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b. If the ith entry of IE equals 3, then set the candidate solution for b, YE1, equal to
the transpose of the corresponding ith row in the YE matrix. This is done so that
YE1 is a column vector containing the solution point that triggered the 3rd event
function.
c. rydistance is the distance (norm) between YE1 and r. FRdist calculates the dis-
tance between the plane and YE1, calculated as the dot product of the normal, N
(normalized), and the vector (YE1-r). If this function is close to zero, then YE1
is on the plane. Furthermore, as a double check conrming the event function
results, we again make sure that YE1 is within epsilon of BigDelta away from r,
(i.e. BigDeltaLowerBnd < rydistance < BigDeltaUpperBnd). Then, if this con-
rmed, YE1 is the point, b, weve been looking for. Thus, set b=YE1 and break out
of the for loop that is processing the IE vector. In addition, set the StopValue=1,
so the while loop will stop at the next break statement, which is made available
just after this for loop. If StopValue=1, then a break statement is executed and
the outer while loop is stopped. Then the nextcir routine carries on with the next
steps, which involve calling this routine once again...and again...and again....
142. flagIE=0;
143. for i=1:length(IE)
144. if IE(i)==1
145. flagIE =1;
146. break;
147. end
148. end
a. Now the IE vector is processed again to locate any entries having the value of 1.
Initially, the variable flagIE is set to zero, which means that no crossings of the
plane by the trajectory occurred. (i.e. no events occurred with the 1stevent function).
If an entry of IE is equal to 1, then flagIE is set to 1 to denote that a crossing
occurred. Since we only want to know if at least one crossing occurred, as soon as
an entry of IE is found with a value of one, the flagIE is set to one and we break
out of the processing for loop and continue along with the next steps in this routine.
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(Note: If r is the point from which we are shooting then the rst entry in IE will
always be a 1 since r is on the plane by denition of the plane.)
149. for i=1:length(IE)
150. if IE(i) == 2
151. YE1 = YE(i,:);
152. tanpointFRdist = dot(N/norm(N), (YE1 - r));
153. rydistance = norm(YE1-r);
154. if (abs(tanpointFRdist)<.00001
&& BigDeltaLowerBnd <= rydistance
&& rydistance <= BigDeltaUpperBnd)
155. b = YE1;
156. StopValue = 1;
157. break;
158. elseif (rydistance > BigDeltaUpperBnd)
159. break;
160. end
161. end
162. end
163. if StopValue==1;
164. break;
165. end
a. The IE vector is now processed for the 3rd and nal time to determine if any of
the events of the 2nd event function occurred. These are the solution points where
the vector tangent to the trajectory pointed in the same direction as the plane,
indicating a possible (but usually not) point of tangency with the trajectory and the
plane. These points still need to be checked.
b. The possible solution for b, YE1, is once again set to the transpose of the ith row of the
YEmatrix which contains the solution points at times when events occurred. The dis-
tance between this "tangent" point, YE1, and the plane is checked in tanpointFRdist
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formula. Also, the distance between YE1 and r is checked with the rydistance for-
mula.
c. If YE1 is on the plane (i.e. abs(tanpointFRdist<.00001) and is at a distance
BigDelta from r,
(i.e. BigDeltaLowerBnd  rydistance  BigDeltaUpperBnd),
then this is the point, b, we have been looking for. So, set b=YE1 and set StopValue
=1 so that the while loop will stop. A break statement is needed to exit the for
loop that was processing the entries of IE for values of 1. After the for loop, there
is a check to see if StopValue ==1, and if it is, a break statement is executed and
the outer while loop is stopped. Then the nextcir routine carries on with the
next steps, which involve calling this routine once again...and again...and again...
Note: the absolute value of tanpointFRdist is used to check distance from the
plane. This is done because the value of tanpointFRdist might be negative, since
the sign of tanpointFRdist is simply an indication of the direction in which the
(YE1-r) vector is pointing: negative implies it is pointing to the left of the plane,
positive implies it is pointing to the right of the plane. However, if the value of
tanpointFRdist is really small in absolute value, this is an indication that YE1 is
close enough to be considered onthe plane. However, numerically this small value
could be negative or positive, so that is why we use absolute value here to check the
distance.
d. Else, if YE1 is not on the plane and instead it is at a distance larger than BigDelta
away from r, then do not continue looking at any other solution points that satisfy
this "tangency" condition since the distance from r will only be larger. Again, recall
that these "tangent" points are checked b/c the event locator has trouble detecting
"obvious" intersections, usually those of the trajectory starting at r.
166. if flagIE == 0
167. TF = isnan(Y);
168. for k=1:length(TF(:,1))
169. if TF(k,:) == [0 0 0]
170. last_y = Y(k,:);
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171. else
172. break;
173. end
174. end
a. Recall that a value of 0 for flagIE, means that there were no direct intersections
of the current trajectory (having initial condition y0) with the plane. Also recall,
that Y is the solution matrix for this initial value problem, the rows of which are the
individual solution points. Thus, we now need to make sure all the points listed in
the Y vector are valid numbers and not "NAN" (Not a Number). This has to be done
because sometimes, solutions blow up and then entries of the solution vector, Y , do
not contain valid numbers.
b. TF is equal to a matrix whose entries are 1 (True) if the corresponding entry in Y
is NAN, and 0 (False) if the corresponding entry in Y is a valid number. So, this
for loop runs through the TF matrix and determines the index of valid entries in Y,
setting the variable last_y to be the transpose of the kth row of Y so that last_y
is a column vector. During the loop, if the kth row of TF is no longer a zero vector,
indicative of valid entries in the kth row of Y, then the for loop exists with a break
statement and the value given to last_y at the k-1 step is the last valid entry in
the Y vector. Otherwise, it might be the case that all entries of Y are valid, in which
case the same thing is accomplished and the loop exits via the counter, k.
175. SideNum = int2str(sign(dot(N/norm(N), (last_y - r))));
176. switch SideNum
177. case {-1}
178. leftEP = y0;
179. EPexistVal = exist(rightEP);
180. if EPexistVal ==1
181. rightEP = rightEP;
182. y0 = (leftEP + rightEP)/2;
183. else
184. if norm(y0-r)==0
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185. y0 = Rotated_Band(:, 2);
186. j = 2;
187. else
188. y0 = Rotated_Band(:, j+1);
189. j = j+1;
190. end
191. end
192. case {1}
193. rightEP = y0;
194. EPexistVal = exist(leftEP);
195. if EPexistVal == 1
196. leftEP = leftEP;
197. y0 = (leftEP + rightEP)/2;
198. else
199. if norm(y0-r)==0
200. y0 = Rotated_Band(:, end);
201. j = length(Rotated_Band);
202. else
203. y0 = Rotated_Band(:, j-1);
204. j = j-1;
205. end
206. end
207. end (end switch statement)
a. Since this portion of code is under the case where flagIE is zero, there were no
crossings of the current trajectory with the plane. Thus, we need to determine on
which side of the plane the last point of the trajectory lies, in order to determine the
next value for y0 on Cr from which to shoot. SideNum is calculated by taking the
sign of the dot product between (1) the normal vector of the plane, N, and (2) the
vector formed by, r, and the last point, last_y, of the present trajectory. SideNum
converts the value of this dot product into a string having either a value of -1 or 1.
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A value of -1 indicates that the point last_y, is on the left side of the plane, since
N points in the direction of rRight. (See Line 114 for its denition.) Likewise, a
value of 1 indicates that last_y is on the right side of the plane.
b. The above switch statement selects the next y0 on Cr from which to shoot based
on the value of SideNum and whether or not the current y0 is equal to r (i.e.
norm(y0,r)==0).
c. If SideNum = -1, then the trajectory ended up on the left side of the plane. Thus,
the ideal trajectory that will intersect the plane at the desired value, b, must start
from an initial condition to the right of the current y0. The, the current y0 becomes
the left hand end point, leftEP, of the interval in which the magicy0 will lie.
The right hand endpoint, rightEP, of this interval is chosen by keeping the current
rightEP if one exists (hence, the "exist" check). If a rightEP does not exist, then
we simply just select a new y0 and later on a rightEP will be set. The next y0 is
then selected to be a point in the current Cr mesh to the right of the current y0.
If the current y0=r, (i.e. norm(y0,r)==0), (and a rightEP does not exist), then
the next y0 to shoot from is selected as the point on the right of r, in Cr: y0 =
Rotated_Band(:, 2);. Note that the indexing variable, j, is set to 2, to indicate
that the current y0 is in the jth, position of Rotated_Band. However, if y06=r (and
a rightEP does not exist), then the next y0 to shoot from is selected as the point on
the right of y0, which will be the (j+1)th point from r.
d. Similarly, if SideNum= 1, then the trajectory ended up on the right side of the plane.
Thus, the trajectory that will intersect the plane must start from an initial condition
to the left of the current y0. And the current y0 becomes the right hand end point,
rightEP, of the interval in which the magicy0 will lie. The left hand endpoint,
leftEP, of this interval is chosen by keeping the current leftEP if one exists (hence,
the "exist" check). If a leftEP does not exist, then we simply just select a new
y0 and later on a leftEP will be set. If the current y0=r, (i.e. norm(y0,r)==0),
(and a leftEP does not exist), then the next y0 to shoot from is selected as the
point on the left of r, in Cr: y0 = Rotated_Band(:, end). Note that the indexing
variable, j, is set to the length of Cr (i.e. the number of points in Cr), to indicate
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that the current y0 is in the jth, position of Rotated_Band. However, if y06=r (and
a leftEP does not exist), then the next y0 from which to shoot is selected as the
point on the left of y0, which will be the (j-1)th point from r.
e. Note that if a leftEP and rightEP exist (or are dened) in either of the cases
above, this interval [leftEP rightEP] is bisected, and y0 is chosen as the midpoint.
Hence, this algorithm uses a shooting method coupled with bisection in order to nd
an appropriate point, b, on the plane at a distance BigDelta from r.
208. elseif flagIE==1
a. This "elseif" indicates that flagIE=1, which means there was at least one crossing
of the plane by the trajectory. So, this case is now processed.
209. YE = YE;
210. for i=1:length(TE)
211. if (IE(i)==2 jj IE(i)==3)
212. YE(:,i)=[ ];
213. TE(i)=[ ];
214. break;
215. end
216. end
a. The rows of the YE matrix hold the solutions at the time of an event. This is changed
here so that the solutions are now stored in the columns of the matrix.
b. Because this is the portion of the code for "if flag==1", we want to eliminate all
the other entries in YE corresponding to events for the 2nd and 3rd functions, only
keeping the entries of YE corresponding to solutions at times when the 1st event
occurred (i.e. when an actual crossing of the plane by the trajectory occurred). So
if the ith index of IE is either 2 or 3, then delete the ith column of YE and the ith
entry of the TE vector, which contains the times at which events occurred.
217. for i=1:length(TE)
218. y = YE(:,i);
219. rydistance = norm(y-r);
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a. Now, the ith intersection point, y=YE(:,i), is checked to see if it is within BigDelta
of r. As before, this distance is calculated by rydistance = norm(y-r);
220. if (rydistance < BigDeltaLowerBnd && i == length(TE))
221. TF = isnan(Y);
222. for k=1:length(TF)
223. if TF(k,:) == [0 0 0]
224. last_y = Y(k,:);
225. else
226. break;
227. end
228. end
a. If the distance between y and r, rydistance, is less than BigDeltaLowerBnd AND
the current value of the counter index, i, is the length of TE, (i.e., y is the last
entry in YE to be checked), then we need to determine on which side of the plane
the current trajectory ended. This is done, as before, by rst nding the last valid
entry in the Y matrix and setting last_y equal to this. Recall that TF is equal to
a matrix whose entries are 1 (True) if the corresponding entry in Y is NAN, and 0
(False) if the corresponding entry in Y is a valid number. So, this for loop runs
through the TF matrix and determines the index of valid entries in Y, setting the
variable last_y to be the transpose of the kth row of Y so that last_y is a column
vector. During the loop, if the kth row of TF is no longer a zero vector, indicative
of valid entries in the kth row of Y, then the for loop exists with a break statement
and the value given to last_y at the k-1 step is the last valid entry in the Y vector.
Otherwise, all entries of Y are valid, in which case the same thing is accomplished
and the loop exits via the counter, k.
229. SideNum = int2str(sign(dot(N/norm(N), (last_y - r))));
230. if norm(y0 - r) == 0
231. switch SideNum
232. case {-1}
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233. leftEP = r;
234. y0 = Rotated_Band(:,2);
235. j=2;
236. break;
237. case {1}
238. rightEP = r;
239. y0 = Rotated_Band(:,end);
240. j=length(Rotated_Band);
241. break;
242. end %switch
243. else
244. switch SideNum
245. case {-1}
246. leftEP = y0;
247. EPexistVal = exist(rightEP);
248. if EPexistVal ==1
249. rightEP = rightEP;
250. y0 = (leftEP + rightEP)/2;
251. else
252. y0 = Rotated_Band(:, j+1);
253. j = j+1;
254. end
255. break;
256. case {1}
257. rightEP = y0;
258. EPexistVal = exist(leftEP);
259. if EPexistVal == 1
260. leftEP = leftEP;
261. y0 = (leftEP + rightEP)/2;
262. else
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263. y0 = Rotated_Band(:, j-1);
264. j = j-1;
265. end
266. break
267. end (end switch)
268. end
a. Now, as before, SideNum is calculated. And a new y0 is chosen based on whether the
current trajectory ended up on the left or right of the plane, with special instructions
for selecting the next y0 when the current y0 is equal to r. See the comments for
the code similar to this in lines 175-207. Again, note that if a leftEP and rightEP
exist (or are dened) in either of the cases above, this interval [leftEP rightEP] is
bisected and y0 is chosen as the midpoint.
269. elseif(BigDeltaLowerBnd <= rydistance
&& rydistance <= BigDeltaUpperBnd)
a. This "elseif" statement means that the intersection point, y, that we are checking
is not only on the plane but at the right distance from r.
270. b = y;
271. StopValue = 1;
272. break;
a. So, y is the solution point, b, that we are seeking. Thus, set, b=y and set StopValue
to 1, so that the outer while loop exits and the nextcir routine carries on with the
next steps, which involve calling this routine once again...and again...and again...
273. elseif rydistance > BigDeltaUpperBnd
274. options=odeset(RelTol,1e-4,...
AbsTol,[1e-4 1e-4 1e-5],InitialStep,...
.0001,MaxStep,.0001);
275. [tback, yback] = ode45(OdeFile,...
[0 .001], y, options);
276. warning off MATLAB:ode45:IntegrationTolNotMet
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277. last_y = yback(end,:);
a. This "elseif" statement means that the intersection point, y, that we are checking
is at a distance greater than BigDeltaUpperBnd. So for cases like this, in order
to determine the next y0 from which to shoot, we need to know from which side
of the plane this trajectory came and not the side where it ended. Thus, we need
to take the intersection point, y, and integrate forward (backward for calculating
an unstable manifold) for a small amount of time. Then we set last_y to the
endpoint, yback, of this "sampling" trajectory, if you will, and check on which side
of the plane last_y lies. Once we have calculated, yback, and set last_y=yback, the
code is very similar to previous code for selecting the next y0. Essentially, because
this trajectory crossed the plane at a distance greater than BigDelta, it forms a
natural boundary (on the left or right depending on whether it came from the left or
right, respectively) for the left or right endpoint of the interval in which the magic
y0 lies.
278. SideNum = int2str(sign(dot(N/norm(N), (last_y - r))));
a. SideNum is calculated as before, but here it determines the side from which the
current trajectory came, instead of the side where it ended. Again, a value of -
1 indicates that the trajectory came from the left of the plane and a value of 1
indicates the trajectory came from the right of the plane.
279. if norm(y0-r)==0
280. switch SideNum
281. case {-1}
282. leftEP = r;
283. y0 = Rotated_Band(:,2);
284. j=2;
285. case {1}
286. rightEP = r;
287. y0 = Rotated_Band(:,end);
288. j=length(Rotated_Band);
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289. end %switch
290. else
291. switch SideNum
292. case {-1}
293. leftEP = y0;
294. EPexistVal = exist(rightEP);
295. if EPexistVal == 1
296. rightEP = rightEP;
297. y0 = (leftEP + rightEP)/2;
298. else
299. y0 = Rotated_Band(:,j+1);
300. j = j+1;
301. end
302. case {1}
303. rightEP = y0;
304. EPexistVal = exist(leftEP);
305. if EPexistVal == 1
306. leftEP = leftEP;
307. y0 = (leftEP + rightEP)/2;
308. else
309. y0 = Rotated_Band(:,j-1);
310. j=j-1;
311. end
312. end %switch
313. end %if normy0=0
a. A new y0 is chosen based on whether the current trajectory came from the left
or right of the plane, with special instructions for selecting the next y0 when the
current y0 is equal to r. See the comments for the code similar to this in lines
175-207. Again, note that if a leftEP and rightEP exist (or are dened) in either
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of the cases above, this interval [leftEP rightEP] is bisected and y0 is chosen as
the midpoint.
314. break;
315. end (end the if statement that checks rydistance)
a. If the current intersection point, y, meets any of these "rydistance" criteria in the
above if/elseif/elseif statement, then a new y0 would have been chosen and
we can breakout of the current for loop and continue with the steps of the while
loop. Otherwise, the "rydistance" criteria are checked for the next intersection
point in the YE matrix and we continue through the for loop.
316. end (end the for loop)
317. end (end the if/elseif statement regarding the value of flagIE)
318. StopThis = StopThis + 1;
319. if StopThis > 50
320. fprintf(We didnt converge! :( nn)
321. b=[0; 0; 0];
322. StopValue = 1;
323. break;
324. end
a. The value of the StopThis counter is increased by increments of 1 when the next
y0 has been selected. This is to ensure that the while loop wont go on forever.
The maximum number of iterations to calculate through the while loop is set to
50; Sometimes, a greater number will actually allow for an intersection to be found,
but mostly it just wastes time. If the value of StopThis gets above 50, then "We
didnt converge! :( " is printed to the screen to alert the user of failure and
the b is set to a vector of zeros, which will tell the nextcir routine after we exit
this routine, that something went wrong. Then, the program will abort. To exit the
while loop, since we failed, set StopValue=1 and break from the while loop. This
is somewhat redundant, but it makes sure we dont keep shooting for points.
325. end (end the while loop)
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326.                               
327. Below, is the events function, FrzeroEvent, that was mentioned earlier in Line 126:a-c.
Three event functions are specied in the value vector below. Zeros of these functions
are found while the ODE system is being integrated.
328. function [value,isterminal,direction] = FrzeroEvent(t,y)
329. load(r_BigDelta_N.mat);
330. load(odefunctionname.mat);
331. dydt = feval(odefunction,t,y);
332. v1 = [dydt(1), dydt(2), dydt(3)];
333. yN = v1/norm(v1);
334. NN = N/norm(N);
335. value = [N(1)*(y(1)-r(1)) + N(2)*(y(2)-r(2)) + N(3)*(y(3)-r(3));...
336. NN(1)*yN(1) + NN(2)*yN(2) + NN(3)*yN(3);BigDelta-norm(y-r)];
337. isterminal = [0; 0; 0];
338. direction = [0; 0; 0];
a. The values for r, BigDelta, and N are loaded from the le in which they were saved
previously. Also, the name of the ODE function is loaded from the
odefunctionname.mat le.
b. Line 331-333 evaluates the vector eld at the solution point, y, (dydt), stores this
value in the vector v1, and normalizes it so that the result, yN, is a unit vector,
pointing in the direction of v1. This is used in the 2nd event function, which
determines when the dot product of N and the derivative of the trajectory evaluated
at a solution is zero. This would indicate that y was a "tangency" point. See Lines
126.c.ii for more details.
c. value, as mentioned, is a vector containing the three event functions. The rst event
function is to detect crossings of the trajectory with the plane: i.e. when the dot
product of N with the vector (y-r) is zero. The second event function was described
in point b. above and the third event function determines when the trajectory is
at a distance BigDelta from r: i.e. when the di¤erence between BigDelta and the
distance between y and r (i.e. norm(y-r)) is zero.
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339.                           
340. Below, the Accuracy routine is explained.
341. function [AccuracyChecker, Next_BigDelta, BDIncrease] =
Accuracy(Pkminus1, Pk, Pkplus1, BigDelta, BDIncrease)
a. The Accuracy routine checks the angle formed by (1) the line through Pkminus1
and Pk and (2) the line through Pk and Pkplus1, where:
i. Pkminus1 is a point in Cp = Band(:,:,1),
ii. Pk is the corresponding point in Cr = Band(:,:,2), and
iii. Pkplus1 is the corresponding point in Cb =Band(:,:,3).
b. See [47, 63, 64] for more details about this accuracy check and the angles checked
342. alphaMin = 0;
343. alphaMax = 0.4;
344. BDalphaMin = .1;
345. BDalphaMax = 1.0;
346. alpha1 = (1/norm(Pkminus1 - Pk))* norm((Pk - Pkminus1)
+ (Pk - Pkplus1)*norm(Pkminus1 - Pk)/norm(Pk - Pkplus1));
347. BDalpha1 = BigDelta*alpha1;
a. Dene the minimum and maximum values for the alpha1 and BDalpha1 angles and
dene alpha1 and BDalpha1.
b. The denition of alpha1 is from [62], however, it was necessary to modify it since
it appears that the formula given in [62] is incorrect. Also, if the angle dened by
alpha1 is zero this means that Pkminus1, Pk, and Pkplus1 lie in a straight line,
which is the desired outcome. For values of alpha1 larger than zero, the three
points do not lie in a straight line; however up to some reasonable alpha1 max value
the curvatureof the line will be acceptable. In [62] and [63] a minimum value of
alpha1 is specied (0.2 for the Lorenz manifold); however, the minimum should be
0 and perhaps the maximum value can be within an acceptable range from 0.2 to
0.3. This particular aspect was not made clear in either of the above papers.
348. if (alpha1 < alphaMax && BDalpha1 < BDalphaMax)
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349. Next_BigDelta = BigDelta;
350. AccuracyChecker = 1;
351. if BDalpha1 > BDalphaMin
352. BDIncrease == 0;
353. end
354. if (BDalpha1 < BDalphaMin) && (BDIncrease ~= 0)
355. Next_BigDelta = 2*BigDelta;
356. end
357. elseif (alpha1 > alphaMax j BDalpha1 > BDalphaMax)
358. fprintf(alpha1 = %f and BDalpha1 = %f , alpha1, BDalpha1);
359. AccuracyChecker = 0;
360. Next_BigDelta = BigDelta/2;
361. end
a. Check if the angles are within the specied bounds. If they are not, then set
AccuracyChecker equal to zero and divide the value of BigDelta in half and then
store Next_BigDelta. When the Accuracy routine exits and returns to the nextcir
routine, Next_BigDelta will become the new value of BigDelta, and the nextcir
routine must start over with the very rst point in Cr to calculate the next circle.
Even though some good points may have previously been found, if one point fails
the accuracy test, then all have to be recalculated so that in the end, all the points
in the new circle are at the same distance from the previous circle. If the angles
are within the specied bounds, then AccuracyChecker is set to 1, and depending
on the value of BDIncrease, the value of BigDelta is doubled or left alone and
then stored in Next_BigDelta. When the Accuracy routine exits and returns to
the nextcir routine, b will be accepted as the next point in the circle, Cb, and the
nextcir routine attempts to nd the next point.
b. BDIncrease is either 0 or 5. It is initialized at the beginning of the nextcir routine
to a value of 5, on page 69, Line 73. If Line 351 is true for even one of the new
acceptable points in the current circle being calculated, then BDIncrease will be
set to 0. Then, when it comes time to set the new value of BigDelta (within
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the nextcir routine) after all the points of the new circle have been approved, if
BDIncrease is 0, BigDelta will not be doubled and instead simply remain the same.
If the value of BDIncrease is still 5 after all the points in the next circle have been
found, then this means that all the new points met the extra requirement and it
is OK to increase (double) BigDelta. So, BDIncrease is really just keeping track
of whether all the new acceptable points, b, meet a certain condition beyond the
acceptable angle requirement. Note, that this only comes into play when the main
accuracy angles are within in the prescribed bounds and b is accepted. Again, see
[47, 62, 63, 64] for more info.
362.                           
363. Next the MeshQuality routine is explained. This routine is a subroutine within the
Manifold m-le and it is responsible for the addition and deletion of mesh points de-
pending, on the distance between successive mesh points. Also, it stores the data from
the Cr and Cb circles, before any mesh points are added or deleted, as well as the data
from the updated Cr and Cb circles, denoted, Updated_Cr and Updated_Cb. It takes,
as input, the 3-d matrix Band which contains, Cp, Cr, and Cb and checks to see if points
in Cb are well spaced. If there are not enough points in Cb (i.e. the distance between
neighboring points is greater than the MaxMeshDistance), then points are added. This
is done by rst adding points to Cr and then calling the Shooting_For_b routine for
each of these new points in order to nd additional points for Cb, if needed. If the dis-
tance between neighboring points in Cb is smaller than the MinMeshDistance, then one
of them is deleted. To keep the dimensions of each page of the Band the same, a zero
vector is added to the matrix Cp in the position where the point in Cr was added. After
this routine is nished and the mesh is drawn, Cp is set to Cr and Cr is set to Cb and Cb
is reset to a bunch of zeros to get ready for drawing the next circle! This routine relies
on two other subroutines, NeighborDistance and DrawMesh, both of which are a part
of the Manifold.m le and appear after the MeshQuality routine.
364. function [Updated_Cr, Updated_Cb]=MeshQuality(Band,MinMeshDistance,...
MaxMeshDistance,BigDelta,TheOdeFile,CircleNumber,SystemName)
365. New_CpBand = Band(:,:,1);
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366. New_CrBand = Band(:,:,2);
367. New_CbBand = Band(:,:,3);
368. tempBand = Band;
a. The variables New_CpBand, New_CrBand, and New_CbBand are used below to store
not only the current data for Cp, Cr, and Cb, but also the extra points that might
need to be added. Each is rst initialized to the corresponding pages of the Band
matrix structure.
369. All_Done = 0;
370. while All_Done == 0
a. This begins the while loop that will determine if new points need to be added or
subtracted from the mesh. The reason that this might possibly be a continuous
thing (hence the loop) is that, even though points might be added or deleted the
rst time through, the distance between the new points and the old points in the
mesh (or between the points that are left over once some have been deleted) must
also meet the mesh distance requirements. So, on the rst time through the loop,
points are added or subtracted from the entire Cb mesh and then the updated Cb
mesh is checked again until all the points are an acceptable distance apart.
371. tempBand = New_CrBand;
372. NbrDist = NeighborDistance(New_CbBand);
373. NumOfPoints = length(NbrDist);
374. k=0;
a. The variable tempBand is used below to temporarily store points that are added to
the Cr mesh. Note that the points in Cr, because it is the previously calculated
circle, already have passed the mesh quality test. However, points need to be added
to the Cr mesh so that the algorithm has points from which to shoot, to nd a
corresponding new point, b, on Cb. Also, when the triangular surface mesh is drawn
between Cr and Cb, these extra points will be necessary. However, we also need
the oldversion of the Cr circle that doesnt contain the extra points, so that the
triangular surface mesh between Cp and Cr can be drawn.
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b. In order to nd the distance between neighboring mesh points of Cb, a call to the
NeighborDistance routine (Line 466) is made. This routine is explained below the
MeshQuality routine. NbrDist(i) is the distance between the points in the i and
(i+1)columns of New_CbBand. Also needed is the number of distances calculated,
or the number of points in New_CbBand, which is simply the length of the NbrDist.
The counter, k, is initialized to zero.
375. for i = 1:NumOfPoints
376. if NbrDist(i) > MaxMeshDistance
377. if i == NumOfPoints
378. fprintf(%2.0f - 1 , i);
379. ExtraPoint = (tempBand(:,i) + tempBand(:, 1) )/2;
380. New_CrBand = [New_CrBand(:,:) ExtraPoint];
381. Rotated_Band=[New_CrBand(:,end) New_CrBand(:,1:end-1)];
382. extra_b = Shooting_For_b(Rotated_Band,...
BigDelta, TheOdeFile, NumOfPoints);
383. if extra_b == [0;0;0]
384. extra_b;
385. Updated_Cr = Band(:,:,2);
386. Updated_Cb = zeros(3,length(Updated_Cr));
387. return;
388. end
389. New_CbBand = [New_CbBand(:,:) extra_b];
390. New_CpBand = [New_CpBand(:,:) [0; 0; 0]];
a. Now we check the distances found in the NbrDist vector. If the ith distance in the
NbrDist vector is larger than the MaxMeshDistance, then an extra point will need to
be added to Cr and we need to shoot from this point to nd a corresponding point,
b, using the Shooting_For_b routine. However, depending on which pair of mesh
points in Cr were too far apart, the point to be inserted will need to be calculated
and inserted carefully, since Cr is stored, after all, in a matrix with a rst entry and
a last entry. So...
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b. IF the ith position is the last position of the NbrDist vector, then the ExtraPoint
will be the point between the ith (or last) column of tempBand (which is just a
copy of New_CrBand) and the rst column. These points are added and divided by
two to get the ExtraPoint. Then New_CrBand is updated so that ExtraPoint is
inserted after the last column of the New_CrBand matrix. We dene RotatedBand
in a similar way as was done in the nextcir routine so that the point from which
we are shooting, ExtraPoint, is always in the rst column of this matrix. Then
the Shooting_For_b routine is called and the extra_b point is (hopefully) found.
There is a check to make sure that it is a valid extra point, meaning that if the
routine returned a zero vector for b, then an extra point could not be found and
the algorithm aborts, by way of setting the output data, Updated_Cb, to a matrix
of zeros. If a valid extra point is found, then the extra_b point is added after the
last column of the New_CbBand matrix. In addition, a column vector of zeros is
added to the New_CpBand in order to make sure that all three matrices, New_CpBand,
New_CrBand, and New_CbBand have the same dimension. This is important for
storing the data, etc. Also, the initial print statement will tell the user between
which points the extra point is being found. NumOfPoints gives the current index
of the point in New_CrBand from which were shooting.
391. elseif i ~= NumOfPoints %when i = 1...NumOfPoints-1
392. if i==1
393. fprintf(nn 1-2 -- );
394. else
395. fprintf(%2.0f-%2.0f -- , i,i+1);
396. end
397. ExtraPoint = ( tempBand(:, i) + tempBand(:, i+1) )/2;
398. pointnumber = NumOfPoints + k;
399. New_CrBand = [New_CrBand(:,1:i+k) ExtraPoint ...
New_CrBand(:,i+1+k:end)];
400. Rotated_Band=[New_CrBand(:, i+1+k:end)...
New_CrBand(:,1:i+k)];
96
401. extra_b = Shooting_For_b(Rotated_Band,...
BigDelta, TheOdeFile, pointnumber);
402. if extra_b == [0;0;0]
403. Updated_Cr = Band(:,:,2);
404. Updated_Cb = zeros(3,length(Updated_Cr));
405. return;
406. end
407. New_CbBand = [New_CbBand(:,1:i+k) extra_b ...
New_CbBand(:, i+1+k:end)];
408. New_CpBand = [New_CpBand(:,1:i+k) [0; 0; 0] ...
New_CpBand(:, i+1+k:end)];
409. k=k+1;
410. end
411. end
a. IF the ith position is NOT the last position of the NbrDist vector, then the extra
points are added to Cr, Cb, and Cp with di¤erent indexing. The previous set of code
was the "special" case when the point needed to be added between the rst and last
points of the mesh. However, here we need to keep track of any points that have
been added previously. That is what the k counter is for. The "+ k" in the lines
of code, makes up for the new points that have been added, so that the indexing is
correct.
b. For Cr, the ExtraPoint point is calculated as the point between the i and i+1
points of tempBand (which is a copy of the current New_CrBand).
c. The variable pointnumber gives the current index of the point in New_CrBand and
is simply the sum of the values of NumOfPoints and k. This Pointnumber which is
passed to the Shooting_For_b routine can be used in that routine to draw all the
shooting orbits of the initial conditions used to nd this particular b. This can be
a helpful troubleshooting strategy.
d. ExtraPoint is inserted in the New_CrBand between the i+k and i+1+k position of
the New_CrBand.
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e. RotatedBand is formulated as usual, with the ExtraPoint in the rst column.
f. As before in the previous -if- portion, a call to the Shooting_For_b routine is made
and the extra_b point is (hopefully) found. There is a check to make sure that it
is a valid extra point, meaning that if the routine returned a zero vector for b, then
an extra point could not be found and the algorithm aborts, by way of setting the
output data, Updated_Cb, to a matrix of zeros. Now, the di¤erence between the
previous -if- part and this -ifelse- part is that if a valid extra point is found, then
the extra_b point is added, not after the last column of the New_CbBand matrix, but
rather between the i+k and i+1+k columns. In addition, a column vector of zeros is
added to the New_CpBand in order to make sure that all three matrices, New_CpBand,
New_CrBand, and New_CbBand have the same dimension. The zero vector is added
between the i+k and i+1+k columns of the current New_CpBand. This is important
for storing the data, etc. Also, the initial fprintf statement will tell the user
between which points the extra point is being found.
412. end (end the for loop)
413. if k == 0
414. All_Done = 1;
415. end
a. Once the for loop exits, if the value of k is zero, this means that all the mesh
distances were in the correct range, and the while loop can be exited, by setting the
All_Done variable to 1.
416. end (end the while loop)
417. NbrDist = NeighborDistance(New_CbBand);
418. NumOfPoints = length(NbrDist);
419. Deleted= zeros(1,NumOfPoints);
a. NeighborDistance is called again on the New_CbBand to check for distances between
points that are smaller than MinMeshDistance. This check is done after points are
added, if any, so that if newly created points put the distance between adjacent
points to close together, they can be deleted.
98
b. Deleted is a vector the length of NumOfPoints, (which is calculated again on the
current New_CbBand) to keep track of any columns (in all three matrices for Cp,
Cr, and Cb) that need to be deleted after the drawing is done.
420. for i = 1:NumOfPoints
421. if NbrDist(i) < MinMeshDistance
422. Deleted(i) = i;
423. if i == 1
424. fprintf(nn-%2.0f , i);
425. New_CbBand = [New_CbBand(:,2) New_CbBand(:,2:end)];
426. elseif i == NumOfPoints
427. fprintf(-%2.0f , i);
428. New_CbBand = [New_CbBand(:,1:i-1) New_CbBand(:,1)];
429. else %when i == 2..NumOfPoints-1
430. fprintf(-%2.0f , i);
431. New_CbBand = [New_CbBand(:,1:i-1) New_CbBand(:, i+1) ...
New_CbBand(:, i+1:end)];
432. end
433. end
434. end
a. Now we check the distances found in the newly calculated NbrDist vector. If
the ith distance in the NbrDist vector is smaller than the MinMeshDistance, then
we set the ith column of New_CbBand equal to the point in the (i+1)th column.
Note that depending on what position we are at in the NbrDist vector, the syntax
for accomplishing this is di¤erent; in particular, when i=1 and i=NumOfPoints,
corresponding to the rst and last columns of the New_CbBand, respectively. Later,
we actually delete the repeatedcolumn from the matrix, using the Deleted matrix,
which is keeping track of the ith columns that are markedfor deletion. Until then,
though, all the points in the matrix are needed for the DrawMesh routine. A fprintf
statement lets the user know which points are being deleted, preceded by a minus
sign.
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435. DrawBand(:,:,1) = New_CrBand;
436. DrawBand(:,:,2) = New_CbBand;
437. DrawMesh(DrawBand);
a. Finally, the mesh can be drawn between Cr and Cb. A call to the DrawMesh routine
(Line 475) is called with the data from New_CrBand and New_CbBand passed in the
2-page matrix structure called DrawBand. The DrawMesh routine is described after
this routine and the NeighborDistance routine.
438. drawwidth = length(New_CbBand);
439. drawwidthfn = [SystemName, DW_, int2str(CircleNumber), .mat];
440. save(drawwidthfn, drawwidth)
441. DrawBandFN = [SystemName, DrawCircle_, int2str(CircleNumber), img];
442. multibandwrite(DrawBand, DrawBandFN,bsq,precision,double);
a. Write data to a le for later use to draw again. Note that the lename is specic
to the current circle number. Note also, that the variable drawwidth which has the
value of the length of the New_CbBand, is also stored and the lename is also specic
to the current circle number. Then, if one wants to re-draw the mesh after having
calculated 10 circles, say, then the circles do not have to be re-calculated, but can
simply recalled from the data stored in the specic circle number les. As long as
the le exists for a particular circle number, it can be drawn.
443. j=0;
444. if isempty(Deleted) == 0
445. for i = 1:length(Deleted)
446. if Deleted(i) ~= 0
447. k = Deleted(i);
448. New_CbBand(:,k-j) = [];
449. New_CrBand(:,k-j) = [];
450. New_CpBand(:,k-j) = [];
451. j=j+1;
452. end
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453. end
454. end
a. In order to calculate the next circle, the points in Cr and Cb that were removed(See
Line 420-434.a) now have to be deleted so as not to confuse things when we save the
data used to compute subsequent circles.
455. Updated_Cr = New_CrBand;
456. Updated_Cb = New_CbBand;
457. CalcFromBand(:,:,1) = Updated_Cr;
458. CalcFromBand(:,:,2) = Updated_Cb;
459. width = length(Updated_Cb);
460. widthfilename = [SystemName,BW_,int2str(CircleNumber), .mat];
461. save(widthfilename, width);
462. CalcFromFN = [SystemName, CalcFrom_, int2str(CircleNumber), .img];
463. multibandwrite(CalcFromBand,CalcFromFN,bsq,precision,double);
a. Assign the variables, Updated_Cr and Updated_Cb, to New_CrBand and
New_CbBand, respectively. This is necessary since Updated_Cr and
Updated_Cb are specied as the outputs of the MeshQuality routine. Then, save data
for Updated_Cr and Updated_Cb in a multipage matrix structure, CalcFromBand,
and save this to a le with a lename specic to the current circle number. The les
saved here are used to calculate the subsequent circles, so that if one wants to start
calculating the mesh from circle 3, circles 0-2 do not have to re-calculated. As long
as the le exists for a particular circle number, the mesh can be calculated, starting
from that circle number.
464.                           
465. Now described is the NeighborDistance routine which calculates the distance between
adjacent mesh points. The routine takes, as input, a matrix, Points, whose columns
represent a triple (x,y,z) and returns a vector, NbrDist, containing the distances be-
tween the adjacent points (column vectors). The distances are calculated one at time
starting with the distance between points 1 and 2, then 2 and 3 and so on up until
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NumOfNeighbors-1, which is the distance between the second-to-last point and the last
point in the Points matrix. The distance between the last point and the rst point of
the matrix, Points, is calculated separately after the loop. This routine is used in the
MeshQuality routine for determining whether the mesh points are at a proper distance
from one another.
466. function [NbrDist] = NeighborDistance(Points)
467. NumofNeighbors = length(Points);
468. NbrDist = zeros(1, NumofNeighbors);
469. for i = 1:(NumofNeighbors -1)
470. NbrDist(i) = norm(Points(:,i)-Points(:, i+1));
471. end
472. NbrDist(NumofNeighbors) = norm(Points(:, NumofNeighbors)-Points(:,1));
473.                           
474. The last routine in the Manifold m-le is DrawMesh, which basically connects the dots
of the mesh as a nice triangle surface. The routine takes, as input, a multi-page matrix
structure, Band. The rst page contains the New_CrBand matrix and the second page
contains the New_CbBand matrix, both before any points were deleted. See Lines 435-
437.a where this function is called. This function can also be a completely separate
m-le, which is useful to call for redrawing the mesh after a number of circles have
already been calculated.
475. function DrawMesh(Band)
476. steps = length(Band(:,:,2));
a. steps is the number of points (columns) of Cr (and hence also of Cb).
477. X = [Band(1,:,1) Band(1,:,2)];
478. Y = [Band(2,:,1) Band(2,:,2)];
479. Z = [Band(3,:,1) Band(3,:,2)];
a. X, Y, and Z are vectors that give the X-coords, Y-coords, and Z-coords of points in
Cr and Cb, concatenated together for use with the trisurf function for graphing
the triangle mesh. The rst stepspoints are from Cr and the steps+1to steps
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+ stepspoints are from Cb. This indexing is used in the next part when dening
the facematrix TRI.
480. TRI = zeros(steps,3);
481. TRI2 = zeros(steps,3);
482. for j=1:steps-1;
483. TRI(j,:) = [j steps+j steps+j+1];
484. end
485. TRI(steps,:)= [steps 2*steps steps+1];
486. for j=1:steps-1;
487. TRI2(j,:) = [j j+1 steps+j+1];
488. end
489. TRI2(steps,:)= [steps 1 steps+1];
a. Now, we form the triangles with vertices from Cr and Cb. TRI is a (steps x 3)-
matrix that denes the triangles whose vertices are indexed by the matrices X, Y,
and Z. For instance, the rst row of TRI is [1 21 22] if steps=20. This vector, [1
21 22], says that the rst vertex of the rst triangle is the 3-vector dened by
i. the 1st elements in the matrices X, Y, and Z
ii. the 21st elements in the matrices X, Y, and Z and lastly,
iii. the 22nd elements in the matrices X, Y, and Z.
This equates to the rst pointof the Cr circle, the rst pointof the Cb circle and
second pointof the Cb circle. Then the indices are increased in increments of 1
each time through the loop, moving "around the circle". This indexing works for
the rst steps-1points, but the last triangle reuses the rst point of the second
circle which is indexed in X, Y, and Z as the steps+1 points, so this point is placed
in the last row of TRI after the loop. NOTE: steps is the number of points in Cr.
b. TRI2 denes the other set of triangles of the mesh in a similar manner. Together,
the two sets of triangles form the band between the previous circle, Cr, and the new
circle Cb.
490. trisurf(TRI, X, Y, Z);
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491. hold on
492. trisurf(TRI2,X,Y,Z);
493. hold on
494. drawnow
495. xlabel(X); ylabel(Y); zlabel(Z);
a. trisurf takes the matrix TRI that denes the triangles by vertices indexed through
X, Y, and Z and creates a surface of triangles.
496. This concludes the Manifold.m le code
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Two separate les that must be dened in order to run the Manifold.m le are the
"basics" le and the "rhs" (i.e. right hand side) le. Below, these les specic to the
Lorenz system are given. First the basics code:
1. function [Saddle, eVects, eVals, negevals, negevects] = lorenzbasics
2. syms X Y Z
3. sigma = 10; q = 28; beta = 8.0/3;
4. Xprime = sigma*(Y-X);
5. Yprime = q*X - Y - X*Z;
6. Zprime = X*Y - beta*Z;
7. Jack = jacobian([Xprime; Yprime; Zprime],[X, Y, Z]);
8. Saddle = [0.0, 0.0, 0.0];
9. JackAtSaddle = subs(Jack, [X, Y, Z], Saddle);
10. [eVects,eVals] = eig(JackAtSaddle);
11. eVals=diag(eVals);
12. [negevals, negevects] = evf(eVals, eVects);
13. v1 = negevects(:,1);
14. v2 = negevects(:,2);
15. N = cross(v1, v2);
16. v3 = cross(v1,N);
17. negevects(:,1) = v1;
18. negevects(:,2) = v3;
19.                           
20. function [negevals, negevects] = evf(eVals, eVects)
21. k = length(eVals);
22. j1=1; j2=1; j3=1;
23. for i=1:k
24. if eVals(i) < 0
25. negevals(j1)=eVals(i);
26. negevects(:,j1)=eVects(:,i);
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27. j1=j1+1;
28. elseif eVals(i) > 0
29. posvals(j2)=eVals(i);
30. posevects(:,j2)=eVects(:,i);
31. j2=j2+1;
32. else
33. zeroevals(:,j3)=eVals(i);
34. j3=j3+1;
35. end
36. end
a. The basics le must specify the following information:
i. The equations of the system and the parameter values (in this le the system
and parameters are dened as symbolic variables/parameters so that algebraic
computations can be done)
ii. The xed point of interest (In this case it is labeled Saddle)
b. The "basics" le uses MatLab provided subroutines for nding the jacobian matrix
(jacobian) and evaluating it at the xed point (subs), as well as nding the eigen-
values and eigenvectors (eig). A subroutine within the basics le, evf, sorts the
eigenvalues and specically returns the negative eigenvalues and associated eigenvec-
tors for the Lorenz system; however, all the eigenvalues and eigenvectors are found.
The code would just need to be modied slightly to return the positive eigenvectors.
Note also that a normalized eigenvector is created with respect to the cross product
of the two eigenvectors (associated with the two negative (positive) eigenvalues) and
used as one of the eigenvectors to be returned by the basics le. This is so that
the initial circle calculated in the Manifold.m code is a circle and not an ellipse.
The "rhs" le must be in the form required by MatLab ode solver functions, such as
ode45, which is used in the Manifold.m le. A dydt vector is formed and the variables of
the system are indices of y: y(1), y(2), y(3), for the x, y, and z notation used in the
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basics le and in equations 3.1. Below is the simple code for the rhs le for the Lorenz
system:
1. function dydt = lorenzrhs(t,y)
2. sigma = 10.0; q = 28.0; beta = 8.0/3;
3. dydt = zeros(3,1);
4. dydt(1) = sigma*(y(2) - y(1));
5. dydt(2) = q*y(1) - y(2) - y(1)*y(3);
6. dydt(3) = y(1)*y(2) - beta*y(3);
3.4 LIMITATIONS AND CHALLENGES
Despite the success with the Lorenz system, the implementation is not fail proof. Unfortu-
nately, in fact, the code discussed above does not currently reproduce the Lorenz pictures
that it once generated and which are displayed here. Hence, the m-le will not be made
available with this thesis. This inadequacy may be due in part to the fact that the m-le
may be dependent on the version of MatLab in which it was written (ver 6.5R13, student
version). Even so, in the original computation, a start and stop hand tweeking process
was necessary in order to generate as many rings of the lorenz manifold as possible. The
length of integration time, for instance, along with other algorithm parameters all contribute
to whether the code is able to nd the next point in the mesh. Many angles have been
examined in the troubleshooting process. However, since the development of the code was
not the focal point of the dissertation, more research time was not dedicated to further
troubleshooting.
There is also a problem that occurs after the algorithm nds a point, b, but the angle
requirement repeatedly fails, no matter how small BigDelta was made. This might be a
result of the initial circle not being close enough to the xed point (i.e. delta was too large)
and small inaccuracies grew into larger ones later on. In addition, the algorithm is not
particularly fast, and as the mesh is grown, more and more mesh points are added so that it
takes longer and longer to calculate subsequent circles. It can be especially time consuming,
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for example, when the 100th mesh point of the next circle is being calculated and the angle
accuracy condition fails. Then, BigDelta has to be shrunk and the algorithm has to start
all over with point 1, in the calculation of the next circle.
The most di¢ cult aspect of the implementation of this algorithm is choosing the next
point, y0, on Cr from which to shoot in order to nd the next point, b, in the mesh. If
every trajectory intersected the half plane, this would be rather simple (depending on the
accuracy and success of the event locator in nding the intersections!); however, as was shown
in the code above, many trajectories simply "time out" on one side of the plane without ever
crossing it. Then, it has to be determined where the trajectory landed at the end of the
integration time. In some cases, it is necessary to nd out where the trajectory was coming
from in order to choose the next correct point. This decision tree was something not
explicitly outlined in [63] and which proved to be the most challenging aspect of the design
of the code.
Another issue found along the way included the manner in which data was stored and
saved for future use. The multiband matrices that MatLab provides is a nice way to organize
and keep track of data, and the multiband read and write functions make it easy to save
this data in .mat les that can be loaded for later use. Also, nding an appropriate way
to determine when a solution point along a trajectory met some requirement (e.g. was a
certain distance from the point, r, or from the plane) was an especially di¢ cult task. The
rst version of the Manifold code included a type of "manual" check at each time step along
the solution to determine if an event occurred, which, not surprisingly, took an enormous
amount of time, since very small time steps needed to be taken. It was obvious that
something more sophisticated would be necessary. Then, the option of dening an event
function for an event locator for the ode solvers was found. The event locator nds the
time and corresponding solution of when/where specied events occurred with respect to
the integrated system. Once the proper event functions were dened, this proved to be
a huge improvement, both in accuracy and time. Even so, time spent "processing" the
event locations that the event functions returns may be a source of ine¢ ciency (See Lines
127-165.a-d in the previous section describing the Manifold.m code.) Furthermore, in some
cases, no events occur, which means having to determine the next y0 in another way.
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We were able to use the algorithm for illustration in the above mentioned endotoxin
tolerance paper and it was decided not to pursue any further troubleshooting of the algorithm
as it would not benet the direction of the thesis. However, there is currently no tool for
public use for calculating and displaying two dimensional manifolds of three dimensional
ODE systems, so future research could include making this a reality. It denitely remains
an interesting problem to examine and some of the other algorithms mentioned in the rst
section, specically [44], might prove to be more conducive to being programmed.
As mentioned previously, all the methods mentioned in the introductory paragraphs can
theoretically be used to produce manifolds of degree greater than two. The di¢ culty is in
the visualization of such methods and much research is ongoing in this area. In addition,
Osinga in [87] demonstrates the visualization of an example of a 2-dimensional manifold of
a 4-dimensional ODE system, projecting the manifold onto a plane in R4 and coloring the
points on the manifold according to geodesic distance from the saddle point. Features of
the particular system explored are taken advantage of to enhance the visualization and its
interpretation. In general, such problems remain a challenge. Hence, there are many parts
of this eld that remain open for exploration.
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4.0 MATHEMATICAL EXPLORATION OF TOLERANCE
4.1 INTRODUCTION
In Chapter 2 we analyzed biological phenomena known as endotoxin tolerance and potenti-
ation via a small ODE model of the acute inammatory response. An excitatory variable
(N) could have a damped response (tolerance) when given an excitatory stimulus (PE)
prior to a challenge stimulus, compared to the response in the absence of a preconditioning
input. On the other hand, the response with a preconditioner could instead be enhanced
(potentiation). In the course of exploring this, it became evident that such behavior would be
interesting to examine from a purely mathematical perspective since it deals with transient
behavior in an ODE system, a topic not well covered in the dynamical systems literature.
Most dynamical systems behaviors are studied in the asymptotic limit or around xed points,
where linearization can be employed.
The work presented in this chapter shows novel results that explore the behavior of
transients under certain conditions. Related, perhaps, to this exposition is research on
isochronicity, which deals with behaviors that occur within the same interval of time. [100, 41]
For instance, Sabatini in [100] denes a critical point classied as a center to be isochronous
if every nontrivial cycle within a neighborhood of the critical point has the same period. As
Sabatini comments, the "intuitive idea of isochronicity is related to phenomena occurring at
equal time intervals, so that one does not have to restrict to study the behaviour of solutions
in the neighborhood of a critical point." Studying the behavior of solutions away from a
critical point proves a necessary aspect of the work presented in this chapter. However,
the research aiming to locate isochronous sections of autonomous di¤erential systems deals
mostly with systems which are oscillatory in nature [100, 41, 52] Hence, this body of work
110
on isochronous sections was not used in the results of this chapter, but it could be a potential
source for additional insight in the future.
In the sections that follow, the tolerance behavior is examined in both linear and nonlin-
ear 2-dimensional ODE systems. The rst section establishes mathematical denitions and
notation for exploring tolerance (and potentiation). Then, theorems for general 2D ODE
systems are presented. These extend the tolerance "window" by continuity arguments.
Following these initial theorems are results showing su¢ cient or necessary conditions for tol-
erance to occur in very particular situations. Some of these results are used in later sections.
Afterward, the general 2D linear case is explored. This case is complete, containing theo-
rems that pinpoint exactly where tolerance will or will not occur in a system given an initial
condition. Next, the general 2D nonlinear case is presented, which is a more di¢ cult case
than the linear one, since exact analytical solutions are not available, in general. However,
there are statements that are made, via the concept of inhibition and the use of isoclines to
narrow down the possibility of the presence of tolerance. Specic examples are used here
to illustrate this approach. Finally, two purely numerical approaches for locating tolerance
are shown, the rst of which is not restricted to 2D systems.
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4.2 PRELIMINARY DEFINITIONS
Consider the ODE system
_x = f(x; y)
_y = g(x; y);
9=; (4.1)
where x; y 2 R, f and g are locally Lipschitz.
(A1) Assume (0; 0) is a stable xed point of (4.1), the eigenvalues of which are real and
negative. (eliminates spirals and centers)
Let (t) be the solution to the initial value problem of (4.1) with initial value
(0) = (x0; y0), x0 > 0.
Similarly, let  (t) be the solution to the initial value problem of (4.1) with initial value
 (0) = (~x0; ~y0)  (s) + (x0; 0) for some 0  s <1.
(A2) Assume (t) and  (t) are nonnegative for all t  0 and that both (x0; y0) and (~x0; ~y0)
lie in the basin of attraction for (0; 0) in the rst quadrant.
Figure 21: The original trajectory '(t) and the curve of all possible (~x0; ~y0) points, formed by shifting
the graph of '(t) in the x-direction by an amount of x0.
Note that (~x0; ~y0) is essentially a shifting of the point (s) in the x-direction by the
amount, x0. We refer to this as the shiftamount. Here and throughout, we assume that
this shift amount is the value of x0, the rst component of the initial condition, (0). Thus,
for di¤erent values of s ranging from 0 to 1, a curve of possible (~x0; ~y0)s is formed as
illustrated by Figure 21. Now, we dene what it means for (4.1) to exhibit tolerance and
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potentiation for a given pair < (x0; y0); s > and make a few other denitions and remarks
that will be useful throughout this chapter:
Denition 1. The system (4.1) is said to exhibit tolerance for < (x0; y0); s >, if there exists
 > 0 such that  1() < 1().
Denition 2. On the other hand, if  1(t)  1(t) for all t 2 [0;1), then (4.1) is said to
exhibit potentiation for < (x0; y0); s > or, equivalently, that (4.1) does not exhibit tolerance
for < (x0; y0); s >. The latter will be the preferred terminology.
Remark 1. Note that for xed (x0; y0), every < (x0; y0); s > denes a unique point, (~x0; ~y0).
Thus, at times it might be stated that "(~x0; ~y0) produces (or does not produce) tolerance in
(4.1)," which will be equivalent to saying that (4.1) exhibits (or does not exhibit) tolerance
for < (x0; y0); s >.
Denition 3. For < (x0; y0); s >, for which tolerance is exhibited, dene s as the jump
time.
Denition 4. For  > 0 such that  1() < 1(), dene  as the compare time.
Denition 5. Dene (t) as the original solution or trajectory.
Denition 6. Dene  (t) as the competing solution or trajectory.
Remark 2. The notation (x0; y0)  t is the image of the point (x0; y0) under the ow of (4.1)
for time t. The set of points, f(x0; y0)  tjt  0g, is then the solution curve or trajectory of
the initial value problem with initial value (x0; y0). This set is also referred to as the graph
of the solution.
Remark 3. Whenever the existence of tolerance is mentioned, it is with respect to the rst
component, x, of a system unless otherwise stated.
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4.3 THEOREMS EXTENDING THE WINDOW OF TOLERANCE
Denition 1 of tolerance includes only the presence of one time point,  > 0 where  1() <
1(). However, a continuity argument can extend this window, from a single time point to
an open interval,(t1; t2), around the compare time,  . Furthermore, it will be shown that
at t = t1,  1(t1) is actually equal to 1(t1) and this will lead to the result that the value
of the vector eld, in the (negative) x-direction, at  1(t1), i.e. f( (t1)), will be less than
the value of the vector eld, in the (negative) x-direction, at 1(t1) , i.e. f((t1)). This is
the content of Proposition 1 below, which will be used in Corollaries 3 and 5, of Theorem
2 and Theorem 4, respectively and which will also be important in Section 4.6. Figure 22
illustrates Proposition 1 with time courses of relevant solutions.
Figure 22: Time courses illustrating Proposition 1
Proposition 1. Assume (A1) and (A2). If (4.1) exhibits tolerance for < (x0; y0); s > in x,
at  > 0, then there exists an open neighborhood (t1; t2) around  such that  1(t^) < 1(t^) for
every t^ 2 (t1; t2) and  1(t1) = 1(t1). Furthermore, f( (t1))  f((t1)).
Proof. By the denition of (~x0; ~y0), the initial condition of  (t) ;we know that ~x0 > x0 or,
equivalently,  1(0) > 1(0). Since (4.1) exhibits tolerance in x at  > 0, then  1() < 1().
Consider the set
  = ftj 1(t) = 1(t); 0 < t < g.
Since 1(t) and  1(t) are continuous, by the intermediate value theorem, there exists 0 <
  <  such that  1(
) = 1(
). Hence,   is not empty. Since (0; ) is a bounded interval,
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let t = sup
t>0
 . Since   is not empty, there exists an increasing sequence of time values, tn,
such that tn ! t as n!1 and tn 2   for all n. Thus, by continuity of the solutions  1 and
1,  1(t
) = 1(t
). Since t = sup
t>0
 , we have that 0 < t   . However, we just established
that  1(t
) = 1(t
), yet earlier it was shown that  1() < 1(). Hence t
 is strictly
less than  : t <  . Since   is not empty, we may conclude that t 2  . Furthermore,
using the continuity of the solutions  1 and 1 again, we have that  1(t^) < 1(t^) for all
t^ 2 (t;  + )  (t1; t2) for some  > 0. Furthermore, since  1(t^) < 1(t^) for all t^ 2 (t1; t2)
and  1(t1) = 1(t1), it can be concluded that f( (t1))  f((t1)).
Figure 23: Left Panel: Illustration of Theorem 2 in the phase plane. Right Panel: Illustration of
Theorem 2 with time courses of relevant solutions.
Proposition 1 above extends the window of tolerance with respect to the compare time,
 > 0, where  1() < 1(). Theorem 2 below extends the window to tolerance with respect
to the jump time, s > 0, where tolerance is known to exist for a particular< (x0; y0); s >. An
open neighborhood, (s1; s2), around s is found such that there exists a compare time, tp > 0,
for every jump time, sp 2 (s1; s2), where tolerance is exhibited for < (x0; y0); sp >. Corollary
3 then extends the neighborhood around the particular compare time, tp, associated with
the jump time, sp, by using Proposition 1. Figure 23 illustrates Proposition 2 in the phase
plane (left panel) and with time courses of relevant solutions (right panel).
Theorem 2. Assume (A1) and (A2). If (4.1) exhibits tolerance for < (x0; y0); s > in x,
then there exists an open interval, (s1; s2), around s such that (4.1) exhibits tolerance in x
for < (x0; y0); sp > for all sp 2 (s1; s2).
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Proof. Assume the set up as above with the two initial value problems involving (t) and  (t)
(in particular, assumptions (A1) and (A2)), and also consider the new IVP with solution  ^(t)
to (4.1) with initial condition  ^(0) = (1(sp); 2(sp))+(x0; 0)  (x^0; y^0), where 0 < sp = s+p
for some p 2 R. We wish to show that for jpj su¢ ciently small there exists tp > 0 such that
 ^1(tp) < 1(tp).
By Proposition 1, since (4.1) exhibits tolerance for < (x0; y0); s >, there exists a neigh-
borhood (t1; t2) such that  1(t) < 1(t) for all t 2 (t1; t2). Since the RHS of (4.1) is locally
Lipschitz (with Lipschitz constant L) and continuous in x and y, then given  > 0, there
exists  > 0 such that if jj(~x0; ~y0)  (x^0; y^0)jj <  then jj (t)   ^(t)jj < eLt, on the interval
for which  and  ^ solve their respective initial value problems ( ;  ^ continuously depend on
initial conditions). Thus, if jj(~x0; ~y0)   (x^0; y^0)jj <  then we need jj(s + p)   (s)jj < .
Since  is continuous with respect to t, there exists p > 0 such that if jpj < p then
jj(s+ p)  (s)jj < , as needed.
Therefore, if k(~x0; ~y0)  (x^0; y^0)k < , or equivalently jpj < p then j 1(t)   ^1(t)j < eLt
and for a particular t value, tp, we can say that j 1(tp)    ^1(tp)j < eLtp  ^. So, let
tp 2 (t1; t2), the interval in which  1(t) < 1(t). Let  be such that ^ = 12(1(tp)    1(tp)).
Then, by the above, there exists p > 0 such that if jpj < p , then j 1(tp)    ^1(tp)j < ^ =
1
2
(1(tp)   1(tp)). Hence,
 ^1(tp) =  ^1(tp) +  1(tp)   1(tp) < j ^1(tp)   1(tp)j+  1(tp)
= j 1(tp)   ^1(tp)j+  1(tp)
<
1
2
(1(tp)   1(tp)) +  1(tp)
= ^+  1(tp)
= ^+ 1(tp)  d; where d = 1(tp)   1(tp) > 0
=
1
2
d+ 1(tp)  d
< 1(tp)
Therefore, there exists a t value, namely tp, where  ^1(tp) < 1(tp). (Also, we need to make
sure that p is small enough so that (x^; y^) is in the basin of attraction of (0; 0). This is possible
since (4.1) depends continuously on initial conditions.) Thus, let (s1; s2)  (s   p; s + p).
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Then, for all p 2 (s1; s2) there exists tp > 0 such that  ^1(tp) < 1(tp), completing the proof
of Theorem 2.
Corollary 3. With respect to the results of Theorem 2, there exists an open interval around
tp, (tp1 ; tp2), such that  ^1(t) < 1(t) for all t 2 (tp1 ; tp2).
Proof. This follows immediately by using Proposition 1 on < (x0; y0); sp >.
Similarly to the previous statements, Theorem 4 below extends the window of tolerance
given that (4.1) exhibits tolerance for a given < (x0; y0); s >. However, this theorem extends
the window of tolerance around the initial condition, (x0; y0), of (t), where tolerance is know
to exist for < (x0; y0); s >, rather than around the jump time, s, or the compare time,  . An
open ball, Br, of radius, r, is found around (x0; y0), such that for any point, (xp; yp), in Br,
(4.1) exhibits tolerance for < (xp; yp); s >: i.e. there exits a compare time, tp > 0 such that
 ^1(tp) < ^1(tp), where ^(0) = (xp; yp) and  ^(0) = ^(s) + (xp; 0). Corollary 5 then extends
the neighborhood around the particular compare time, tp, associated with < (xp; yp); s >,
by using Proposition 1.
Theorem 4. Assume (A1) and (A2). If (4.1) exhibits tolerance for < (x0; y0); s > in x, then
there exists an open ball, Br, of radius, r, around (x0; y0) such that if (xp; yp) 2 Br((x0; y0))
then (4.1) exhibits tolerance in x for < (xp; yp); s >.
Proof. Assume the set up as above with the two initial value problems involving (t) and  (t)
(in particular, assumptions (A1) and (A2)), and also consider two new IVPs with solutions
^(t) to (4.1) with initial condition ^(0) = (x0; y0) + (p1; p2)  (xp; yp) and  ^(t) to (4.1) with
initial condition  ^(0) = (^1(s); ^2(s))+(xp; 0)  (~xp; ~yp). We wish to show that there exists
tp  0 such that  ^1(tp) < ^1(tp).
Given  > 0, since (4.1) is locally Lipschitz (with Lipschitz constant L) and continuous
in x and y, there exists p > 0 such that if jj(~x0; ~y0) (~xp; ~yp)jj <  then jj (t)   ^(t)jj < eLt,
on the interval for which  and  ^ solve their respective initial value problems. (solutions of
(4.1) continuously depend on initial conditions).
Thus, if k(~x0; ~y0)  (~xp; ~yp)k < , then j 1(t)   ^1(t)j < eLt and for a particular t value,
tp, we can say that j 1(tp)    ^1(tp)j < eLtp  ^. Fix tp > 0 such that 1(tp) >  1(tp).
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Let  be such that ^ = 1
2
(1(tp)    1(tp)). Then, if k(~x0; ~y0)   (~xp; ~yp)k <  we have that
j 1(tp)   ^1(tp)j < ^ = 12(1(tp)   1(tp)). Then,
 ^1(tp) =  ^1(tp)   1(tp) +  1(tp)
 j ^1(tp)   1(tp)j+  1(tp)
< ^+ 1(tp)  d, where d = 1(tp)   1(tp) > 0, since 1(tp) >  1(tp)
=
1
2
d+ 1(tp)  d
= 1(tp) 
1
2
d
So, since we have established that 1(tp)  12d >  ^1(tp) we have
^1(tp)   ^1(tp) > ^1(tp)  (1(tp) 
1
2
d)
  j^1(tp)  1(tp)j+
1
2
d
Since (t) depends continuously on initial conditions then given p > 0, there exists p > 0
such that if k(x0; y0)  (xp; yp)k < p then j1(t)  ^1(t)j < ^p, where ^p = peLtp . Thus, let
p > 0 be such that ^p = 12d so that if k(x0; y0)  (xp; yp)k < p, then j^1(tp)  1(tp)j < 12d
and  j^1(tp)  1(tp)j >  12d. Hence, continuing from the last inequality, we have
^1(tp)   ^1(tp) >  j^1(tp)  1(tp)j+
1
2
d
>  1
2
d+
1
2
d
= 0.
Hence, ^1(tp) >  ^1(tp). Therefore, there exists a t value, namely tp, where  ^1(tp) < ^1(tp).
Also, make sure that  and p are small enough to ensure (xp; yp) and (~xp; ~yp) lie in the basin
of attraction for (0; 0). Let Br((x0; y0))  Bp((x0; y0)). Finally, note that for (x0; y0) on
the x-axis, we only wish to consider those points that are both in Br((x0; y0)) and in the
rst quadrant. Then, for every (xp; yp) 2 Br((x0; y0)) \ R2+, there exists tp > 0 such that
 ^1(tp) < ^1(tp).
Corollary 5. With respect to the results of Theorem 4, there exists an open neighborhood
around (tp1 ; tp2), such that  ^1(t) < ^1(t) for all t 2 (tp1 ; tp2).
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Proof. This follows immediately by using Proposition 1 on < (xp; yp); s >.
This concludes the continuity arguments for extending the window of tolerance in a
system when there exists a < (x0; y0); s > for which tolerance is known to occur. Next, we
present a number of results that were observed during the initial stages of this mathematical
tolerance research.
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4.4 FIRST OBSERVATIONS
"We must start by admitting that almost nothing beyond general statements can be made
about most nonlinear systems...and that any other tool in the workshop of applied math-
ematics...can and should be brought to bear on a specic problem." ~Guckenheimer and
Holmes [43]
Indeed, truer words have not been written about the study of nonlinear systems and
this "disclaimer" is adopted here and particularly in section 4.6. In fact, the problem we
are seeking to elucidate is immune to the use of the powerful tool of linearization since
what is being studied is a transient behavior and not one occurring particularly close to
xed points. The goal, as encouraged by Guckenheimer and Holmes, is to showcase every
possible dynamical systems tool available in order to generate results about the existence
of tolerance in general 2D nonlinear systems. The hope is that the unique nature of the
problem and the creativity of the methods used to explore it will, not only be interesting,
but insightful as well.
Overall, we are interested in necessary and su¢ cient conditions for tolerance to be exhib-
ited in (4.1). This section covers several results about tolerance that were initially observed,
and which are mostly for specic cases. Some of these results, however, are used in subse-
quent sections that show more general results. Recall the following assumptions:
(A1) (0; 0) is a stable xed point of (4.1), the eigenvalues of which are real and negative.
(eliminates spirals and centers)
(A2) (t) and  (t) are nonnegative for all t  0 and both (x0; y0) and (~x0; ~y0) lie in the
basin of attraction for (0; 0) in the rst quadrant.
The next proposition is specic to general 1-dimensional ODE systems and shows that
tolerance cannot be exhibited for any < (x0; y0); s > in a 1D system.
Proposition 6. Assume (A1) and (A2) for a 1-dimensional system _x = f(x), x 2 R: 0 is a
locally stable xed point of _x = f(x) and x0 and ~x0 lie in the basin of attraction for 0 on the
real line. Assume also that f is locally Lipschitz on [0;1). Then, _x = f(x) cannot exhibit
tolerance.
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Proof. Let (t); t  0; be the solution to the initial value problem
_x = f(x)
(0) = x0 > 0:
Let  (t); t  0; be the solution to the initial value problem
_x = f(x)
 (0) = ~x0  (s) + x0 for some 0  s <1:
Since x0 and ~x0 are in the basin of attraction of 0, then both (t) and  (t)! 0monotonically
for all t  0. Since (t) ! 0 monotonically for all t  0, (T ) < (t) for every T > t.
Further, since ~x0 > x0 by denition and  (t) ! 0 monotonically for all t  0, there exists
t > 0 such that  (t) = (0) = x0 and  (t) > (t) for all t  t. Hence, for all  > 0; () =
 (t + ). Since t +  >  and (t)! 0 monotonically, (t + ) < () =  (t + ). This,
along with the result that  (t) > (t) for all t  t, implies  (t) > (t) for all t 2 [0;1).
Therefore, tolerance cannot be exhibited in _x = f(x) where x 2 R. Instead _x = f(x) exhibits
potentiation for every < x0; s >.
The following proposition expands the results of Proposition 6 for solutions (t) and  (t)
of 2D systems which converge monotonically in the 1st component to (0; 0) and which are
subsets of the same solution curve. Figure 24 illustrates this situation. This result will be
used later in Section 4.6.1.
Proposition 7. Assume (A1) and (A2). Assume 1(t) and  1(t) ! 0 monotonically for
all t  0. Given < (x0; y0); s >, if there exists t^ > 0 such that ( t^) = (s) + (x0; 0) 
 (0)  (~x0; ~y0), then (~x0; ~y0) does not produce tolerance in (4.1).
Proof. For a given < (x0; y0); s >, let t^ > 0 such that ( t^) =  (0)  (~x0; ~y0). This
implies that (t) and  (t) are both subsets of the same larger solution curve of the vector
eld dened by (4.1). Therefore, assuming 1(t) and  1(t) ! 0 monotonically for all t  0
and knowing, by denition, that  1(0) > 1(0), the same arguments made in Proposition 6
can be made for 1(t) and  1(t), resulting in the fact that  1(t) > 1(t) for all t 2 [0;1).
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Figure 24: Illustration of the case when (t) and  (t) converge monotonically in the 1st component
and lie on the same solution curve. (t) (black) and  (t) (orange) are actually separate trajectories being
compared even though they belong to the same solution curve (t)[ (t). Note that 1(0) <  1(0) and that
at some time point  > 0,  1() = 1(0). Also, note that both (t) and  (t) are monotonically decreasing
in the x-direction.
Hence, given < (x0; y0); s >, if 1(t) and  1(t) ! 0 monotonically and there exists t^ > 0
such that ( t^) =  (0)  (~x0; ~y0), then (~x0; ~y0) does not produce tolerance in (4.1).
The next proposition is a formal statement describing the "rescue" tolerance scenario
presented in Chapter 2. A non-preconditioned trajectory (i.e. (t)) does not decay toward
(0; 0) but instead ows toward a higher xed point, yet the preconditioned trajectory (i.e.
 (t)) decays to (0; 0). Hence, there exists a compare time,  > 0, where tolerance occurs.
(See Figs. 6a and 6b.) In other words, even though (x0; y0) is not in the basin of attraction
for (0; 0), it is possible that the bumped point, (~x0; ~y0), is. The proof of proposition 8 can
be generalized to n-dimensional systems, since it only examines the one component of an
ODE system (e.g. the x-component in our current setup.)
Proposition 8 (Su¢ ciency). Assume (A1) and that  and  are nonnegative for all t  0.
If 1(t) ! p > 0 as t ! 1 (i.e. (x0; y0) is not in the basin of attraction for (0; 0)), yet
 1(t)! 0 as t!1, then (4.1) exhibits tolerance for < (x0; y0); s >.
Proof. Since  1(t)! 0 as t!1,  1(t) is continuous, and p > 0, there exists, by continuity,
a  > 0 such that  1() < p. Thus,  1(t) < 1(t) for all t   .
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Proposition 9 below addresses a very specic case when the initial condition, (x0; y0), of
the original trajectory, (t), begins on an invariant x-axis. It is shown that such a case is
equivalent to the case of a 1-dimensional ODE system, addressed above in Proposition 6.
Proposition 9. Assume (A1) and (A2). If (x0; y0) = (x0; 0), (i.e. (x0; y0) is on the x-axis
away from (0; 0)) and g(x; 0) = 0 in (4.1) for all x > 0. (i.e. the x-axis is invariant), then
(4.1) cannot exhibit tolerance for < (x0; y0); s >, s  0.
Proof. This statement corresponds with Proposition 6 which states that tolerance cannot
occur in a 1-D ODE. Let (x0; y0) = (x0; 0). Since (x0; y0) is on the x-axis (away from (0; 0))
and g(x; 0) = 0 in (4.1) for all x > 0, the solution (t) = f(x0; 0)  t, jt  0g will remain on
the x-axis for all t  0 as it approaches (0; 0) as t ! 1. Similarly,  (t) will also remain
on the x-axis for all t  0. Hence, the problem reduces to the 1-D case and thus, tolerance
cannot be exhibited for any < (x0; 0); s > when the x-axis is invariant.
Therefore, we list another assumption:
(A3) If (x0; y0)  (x0; 0), assume that g(x; 0) 6= 0 for all (x; 0), x > 0.
The next two propositions highlight specic conditions that are su¢ cient for tolerance
to exist. The rst of these propositions is for the case when the original trajectory, (t),
is assumed to have its initial condition, (~x0; ~y0), on the x-axis. Assumption (A3) above is
assumed for this proposition, so that (t) does not remain on the x-axis for all t > 0. These
assumptions, along with assumptions (A1) and (A2) given on page 120, imply that, in this
case, the graph of  forms a closed region, S, with the x-axis. S is dened to not include
the actual graph of . See the left panel of Figure 25.
Proposition 10 below considers this case, when the initial condition, (~x0; ~y0), of the
original trajectory,  (t), lies in the region, S. This case is possible given the way the
(~x0; ~y0)-curve is dened, if graph of  is of a certain shape. (See, for example, the left panel
of Figure 25.) If (~x0; ~y0) meets this condition in this special case, then (~x0; ~y0) will produce
tolerance in (4.1) with respect to < (x0; 0); s >.
Proposition 10. Let (x0; y0)  (x0; 0) and assume (A1), (A2), and (A3). Dene (~x0; ~y0) 
(s) + (x0; 0), for some s > 0 and dene the region, S, as the bounded set bounded by the
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Figure 25: Figure illustrating Proposition 10. Left Panel: An example original trajectory, (t), with
intial condition, (x0; 0), shown along with the (~x0; ~y0)-curve which intersects the region, S, shown in light
blue. An example of a competing trajectory,  (t), with initial condition(~x0; ~y0) 2 S, is shown in red. Also,
note that the maximum value in the x-direction for (t) is marked with a vertical blue line and denoted,
M  maxt0 1(t). Right Panel: The time courses of both 1(t) (black) and  1(t) (red). M  maxt0 1(t) is
labeled with a horizontal blue line, showing that  1(t) is bounded above by M . The time point,  , marks
the time where 1(t) =M , showing that at this time,  1(t) < M and hence, less than 1(t).
x-axis and the graph of , but not including the graph of . S is bounded since, (1) (t)  0,
for all t  0, (2) (t) ! (0; 0) as t ! 1, and (3) (x0; y0)  (x0; 0). If (~x0; ~y0) 2 S, then
(4.1) will exhibit tolerance for < (x0; 0); s >. (An example of a possible region, S, is shown
as the light blue area in the left panel Figure 25.)
Proof. Let (~x0; ~y0) 2 S. From assumption (A2), (t) and  (t) are nonnegative for all t  0.
Then, since trajectories cannot cross because of uniqueness of solutions,  (t) = f(~x0; ~y0)tjt 
0g is contained in the bounded set S. Let M = maxt0f1(t)g which exists because 1(0) = x0,
1(t) ! 0 as t ! 1 and  is continuous. Then, because  (t) is contained in S and (t)
cannot intersect with  (t),  1(t) < M for all t  0, i.e.  1(t) is bounded above byM . Thus,
if we let  > 0 be the time when 1() = M then 1() >  1(). Hence, for every s such
that (~x0; ~y0) 2 S, (4.1) exhibits tolerance for < (x0; y0); s >.
The right panel of Figure 25 shows the time courses of both 1(t) and  1(t). This
illustrates the following: Since the solution  1(t) is bounded above by the maximum value,
M , of 1(t), occurring at time,  , then the value of  1(t) at  will be less thanM and hence,
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less than 1(t). Thus, at  ,  1() < 1(). Notice that there is a value t
 <  (not labeled)
where 1(t
) =  1(t
) and for which  1(t) < 1(t) for all t > t
. This t value is the time
where 1(t
) (the black curve) intersects  1(t
) (the red curve) in the right panel of Figure
25.
The second proposition is similar to Proposition 10, but now (~x0; ~y0) is actually a point
on the graph of , other than (x0; y0) itself. In the left panel of Figure 25, an intersection
such as this can be seen. Since the (~x0; ~y0)-curve is not a solution curve, this intersection
does not violate any uniqueness properties of an ODE system that has a locally Lipschitz
right hand side, such as (4.1). First, a few notational conventions are made.
Formally, dene the (~x0; ~y0)-curve as the set
P = f(~x0; ~y0)j(~x0; ~y0) = (s) + (x0; 0); s  0g ,
and note that the graph of  is the set of points
graph() = f(x; y)j(x0; y0)  t; t  0g .
If (P \ graph()) 6= ;, this implies that the solution (t) intersects the (~x0; ~y0)-curve at some
time,  . Now, for the proposition:
Proposition 11. Assume (A1), (A2), and (A3). Let
 (0) = (~x0; ~y0) 2 P \ graph()n(x0; y0).
Then, (~x0; ~y0) will produce tolerance in (4.1) with respect to < (x0; y0); s >.
Proof. Assume (A1), (A2), and (A3) and that P \ graph()n(x0; y0) 6= ;. Let  (0) =
(~x0; ~y0) 2 P \ graph()n(x0; y0). This implies that
 (0) = (~x0; ~y0) = (s) + (x0; 0)
= (),
for some s,  > 0, by denition of (~x0; ~y0) and the fact that (~x0; ~y0) 2 P \graph()n(x0; y0) 6=
;. Let M = maxt0f1(t)g which exists because 1(0) = x0, 1(t) ! 0 as t ! 1 and  is
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continuous. Then, there exists tM such that 1(tM) = M and 1(t) < M for all t > tM .
Thus,
1( + tM) < 1(tM)
and
1( + tM) =  1(tM)
Hence,  1(tM) < 1(tM).
In conclusion, (4.1) exhibits tolerance for < (x0; y0); s > at the compare time, tM .
Now we present a proposition that gives a condition which can be checked when (x0; y0) =
(x0; 0) and _x > 0 at (x0; y0), to determine if the (~x0; ~y0)-curve and (t) intersect other than
at, possibly, (x0; y0). First, we give some notation. Let
< xf ; xg >=< f(x0; y0); g(x0; y0) >
be the vector at (x0; y0) dened by the vector eld (4.1). For (0; 0) (a stable xed point of
(4.1), denote the slow/weak eigenvector of (0; 0) as v =< v1; v2 >. Recall the formal set
denitions for the (~x0; ~y0)-curve and the graph of , given, respectively, by the following:
P = f(~x0; ~y0)j(~x0; ~y0) = (s) + (x0; 0); s  0g , and
graph() = f(x; y)j(x0; y0)  t; t  0g .
Proposition 12. Assume (A1), (A2), (A3) and that (0) = (x0; y0) = (x0; 0). Also, assume
that _x > 0 at (x0; y0). Using the notation given above, if
xfv2 > v1xg (4.2)
then there exists an s > 0 such that (~x0; ~y0)  (x0; 0) + (s) will produce tolerance for (4.1)
with respect to < (x0; y0); s >.
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Proof. Assume (A1), (A2), (A3) and that (0) = (x0; y0) = (x0; 0). Also, assume that
_x > 0 at (x0; y0). Arrange for the slow/weak eigenvector, v, to be such that: v1  0.
Then, by (A1) given on page 120, v2 > 0. Also, from (A2), (t) is nonnegative for all
t  0 and (t) ! (0; 0) as t ! 1. Thus, (t) approaches (0; 0) along the slow/weak
eigenvector, v. Furthermore, near zero, (t) has a slope approaching < v1; v2 >. We know
that xf > 0 because _x > 0 at (x0; y0), and since (t) is nonnegative for all t  0, we know
that xg > 0 at (x0; y0). Since P is simply a translation of the graph of  in the x-direction
by an amount of x0, if the slope of (t) at/near (0; 0) is steeper (greater) than the slope of
(t) at (x0; y0), then P will intersect the graph of (t) in at least one point other than at
(x0; y0). In other words, if v2v1 >
xg
xf
or equivalently, xfv2 > v1xg, there will exist (~x0; ~y0) such
that (~x0; ~y0) 2 P \ graph()n(x0; y0). This relationship between < v1; v2 > and < xf ; xg >
is Condition 4.2 stated above. Proposition 11 can then be used to conclude that there exists
an s > 0 such that (~x0; ~y0)  (x0; 0) + (s) will produce tolerance for (4.1) with respect to
< (x0; y0); s >.
This concludes the First Observations section and we now consider general two dimen-
sional linear ODE systems.
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4.5 TOLERANCE IN GENERAL 2D LINEAR ODE SYSTEMS
4.5.1 Setup
In this section, we specically consider 2D linear ODE systems and arrive at necessary and
su¢ cient conditions for the existence of tolerance. Consider the linear system
_x = Ax, (4.3)
where A 2 M2x2, x 2 R2+ = [0;1)  [0;1). Throughout this section, we will assume as
before that:
(A1) (0; 0) is a stable xed point of (4.3), the eigenvalues of which are real and negative.
(eliminates spirals and centers)
(A2) (t) and  (t) are nonnegative for all t  0 and both (x0; y0) and (~x0; ~y0) lie in the
basin of attraction for (0; 0) in the rst quadrant.
Let 1 and 2 be the real, negative eigenvalues of A. To arrive at necessary and su¢ cient
conditions for the existence of tolerance, there are three cases that must be considered
regarding the eigenvalues and eigenvectors of A. The rst two cases are when the two
eigenvalues are identical: 1 = 2 =  < 0. The second case considers distinct eigenvalues:
1 6= 2. Within these cases some have subcases as well. Recall that by denition ~x0  x0,
a condition that will be used in the cases below. Now we address the rst case:
4.5.2 Case 1:
1 = 2 =  < 0 and  has two linearly independent eigenvectors
For this case,  is an eigenvalue of A with multiplicity two, for which two linearly
independent eigenvectors can be found. Let v and w be linear independent eigenvectors of .
Then, any initial condition can be uniquely written as a linear combination of v and w. For
the initial condition (x0; y0), we may write (x0; y0) = c1v + c2w = (c1v1 + c2w1; c1v2 + c2w2),
with c1; c2 2 R. Thus, the solution, (t), to the IVP _x = Ax, (0) = (x0; y0) is
(t) = c1ve
t + c2we
t = (c1v + c2w)e
t = (c1v1 + c2w1; c1v2 + c2w2)e
t = (x0; y0)e
t (4.4)
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Similarly, consider the initial condition (~x0; ~y0) dened to be (~x0; ~y0)  (x0; 0) + (s) for
some s  0. We may also uniquely write (~x0; ~y0) = d1v + d2w = (d1v1 + d2w1; d1v2 + d2w2),
with d1; d2 2 R. The solution  (t) to the IVP _x = Ax,  (0) = (~x0; ~y0) is
 (t) = d1ve
t+ d2we
t = (d1v+ d2w)e
t = (d1v1+ d2w1; d1v2+ d2w2)e
t = (~x0; ~y0)e
t. (4.5)
Furthermore, since we know that ~x0  x0, we have that
d1v1 + d2w1  c1v1 + c2w1. (4.6)
Consider the di¤erence between 1(t) and  1(t). Using equations (4.4) and (4.5),we
have the following:
1(t)   1(t) = c1v1et + c2w1et   (d1v1et + d2w1et)
= (c1v1 + c2w1   d1v1   d2w1)et
 0,
by (4.6) and the fact that et > 0 for all t  0. Thus,  1(t)  1(t) for all t  0, and the
following has been shown:
Theorem 13. Assume (A1), (A2), and that 1 = 2 =  < 0. Given < (x0; y0); s > and
hence,(~x0; ~y0), if  has two linearly independent eigenvectors, then _x = Ax cannot exhibit
tolerance for < (x0; y0); s >. (i.e.  1(t)  1(t) for all t  0.)
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4.5.3 Case 2:
1 = 2 =  < 0 and  has only one eigenvector
In this case,  is an eigenvalue of A with multiplicity two, for which only one eigenvector
(up to a scalar multiple) can be found. Let v be an eigenvector of . We wish to nd the
fundamental solution set. One solution to (4.3) is x(1)(t) = vet. In order to obtain a second
solution to form a generalized solution, it is necessary to nd a generalized eigenvector that
is linearly independent of v. Let v be the generalized eigenvector with respect to v, which
is found by solving the following equation:
(A  I)v = v,
where I is the 2x2 identity matrix. Then, a second solution to (4.3) is x(2)(t) = vtet+vet.
The intial condition, (x0; y0), can be uniquely written as a linear combination of v and v:
(x0; y0) = c1v + c2v = (c1v1 + c2v1; c1v2 + c2v2),with c1; c2 2 R.
Then, the solution (t) to the IVP _x = Ax, (0) = (x0; y0) is
(t) = c1ve
t + c2(vte
t + vet)
= (c1v1e
t + c2(v1te
t + v1e
t); c1v2e
t + c2(v2te
t + v2e
t)). (4.7)
Similiary, the initial condition, (~x0; ~y0), can be uniquely written as a linear combination of
v and v:
(~x0; ~y0) = d1v + d2v = (d1v1 + d2v1; d1v2 + d2v2),with d1; d2 2 R,
and the solution  (t) to the IVP _x = Ax,  (0) = (~x0; ~y0) is
 (t) = d1ve
t + d2(vte
t + vet)
= (d1v1e
t + d2(v1te
t + v1e
t); d1v2e
t + d2(v2te
t + v2e
t)). (4.8)
Furthermore, since we know that ~x0  x0, we have that
d1v1 + d2v1  c1v1 + c2v1. (4.9)
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In the following calculations, we will be interested in the rst components of v and v.
For Case 2, there are two subcases that need to be considered. The rst subcase deals with
the possibility that the rst component of v is zero, implying that the rst component of v is
nonzero. Otherwise, v and v would not be linearly independent. Since is v nonzero, it can
then be arranged for its rst component to be 1. The second subcase is for when the rst
component of v is nonzero. Then, designating the rst component of v as the free parameter,
we can choose it to be zero and arrange for v2 > 0. Thus, we consider two subcases: (a)
v1 = 0 and v1 = 1 (b) v1 = 1 and v1 = 0.
4.5.3.1 Case 2a:
v1 = 0 and v1 = 1
For this rst subcase of Case 2, (4.9) becomes
d2  c2. (4.10)
Consider the di¤erence between 1(t) and  1(t). Using equations (4.7) and (4.8) and that
in this case v1 = 0 and v1 = 1, we have the following:
1(t)   1(t) = c1v1et + c2(v1tet + v1et)  (d1v1et + d2(v1tet + v1et))
= c2e
t   d2et
= (c2   d2)et
 0,
by (4.10) and the fact that et > 0 for all t  0. Thus,  1(t)  1(t) for all t  0. Therefore,
the following has been shown:
Theorem 14. Let < (x0; y0); s > and, hence, (~x0; ~y0), be given. Assume (A1), (A2), that
1 = 2 =  < 0 and that  has only one eigenvector. Let v be an eigenvector of  and
let v be the generalized eigenvector, linearly independent of v, found by solving the equation
(A   I)v = v, where I is the 2x2 identity matrix . If v1 = 0 and v1 = 1, then _x = Ax
cannot exhibit tolerance for < (x0; y0); s >. (i.e.  1(t)  1(t) for all t  0.)
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4.5.3.2 Case 2b:
v1 = 1 and v1 = 0
In this second subcase of Case 2, (4.9) becomes
d1  c1. (4.11)
Consider the di¤erence between 1(t) and  1(t). Using equations (4.7) and (4.8) and that
in this case v1 = 1 and v1 = 0, we have the following:
1(t)   1(t) = c1v1et + c2(v1tet + v1et)  (d1v1et + d2(v1tet + v1et))
= c1e
t + c2te
t   (d1et + d2tet)
= (c1   d1)et + (c2   d2)tet
= (c1   d1 + (c2   d2)t)et. (4.12)
Since (4.11) does not give a relationship between d2 and c2, two cases will have to be con-
sidered: (c2   d2)  0 and (c2   d2) > 0.
Case 2b.i: (c2   d2)  0
In this case, we then have that (c2   d2)t  0 for all t  0. Also, (4.11) implies that
(c1   d1)  0. Thus, (c1   d1 + (c2   d2)t)  0 for all t  0. Since et > 0 for all t  0, we
have that (c1   d1 + (c2   d2)t)et  0 for all t  0, implying from (4.12) that  1(t)  1(t)
for all t  0. Therefore, the following has been shown:
Theorem 15. Let < (x0; y0); s > and, hence, (~x0; ~y0), be given. Assume (A1), (A2), that
1 = 2 =  < 0 and that  has only one eigenvector. Let v be an eigenvector of  and
let v be the generalized eigenvector, linearly independent of v, found by solving the equation
(A  I)v = v, where I is the 2x2 identity matrix . If v1 = 1, v = 0 and (c2  d2)  0, then
_x = Ax cannot exhibit tolerance for < (x0; y0); s >. (i.e.  1(t)  1(t) for all t  0.)
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Case 2b.ii: (c2   d2) > 0
In this case, since v1 = 1 and v1 = 0, we have from equations (4.7) and (4.8) that the
rst components of solutions (t) and  (t) are, repectively,
1(t) = c1v1e
t + c2(v1te
t + v1e
t) = c1e
t + c2te
t = (c1 + c2t)e
t (4.13)
 1(t) = (d1v1e
t + d2(v1te
t + v1e
t)) = d1e
t + d2te
t (4.14)
We are assuming in this subcase that (c2   d2) > 0, and we know that tet > 0 for t > 0.
Thus, we have
(c2   d2)tet > 0, (4.15)
for t > 0. Recall that at t = 0,  1(0) > 1(0), by denition. Continuing the string of
equations from (4.12) and factoring out the quantity (c2   d2)t, we have:
1(t)   1(t) = (c1   d1 + (c2   d2)t)et
=

c1   d1
(c2   d2)t + 1

(c2   d2)tet. (4.16)
We would like to know when, if ever, (4.16) is greater than zero, which would then imply
that  1(t) < 1(t). Thus, because of (4.15), we are actually interested in when

c1   d1
(c2   d2)t + 1

> 0. (4.17)
The inequality (4.17) is true if and only if
(c1   d1) + (c2   d2)t > 0
, (c2   d2)t > (d1   c1)
, t > d1   c1
c2   d2 .
(Note: d1 c1
c2 d2  0, by (4.11) and the assumption for this case that (c2   d2) > 0.
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Furthermore, from (4.11), we know that (c1   d1)  0. This, along with the fact that
(c2   d2)t > 0 for t > 0, implies that
c1   d1
(c2   d2)t  0
)

c1   d1
(c2   d2)t + 1

 1.
Hence, when t > d1 c1
c2 d2 ,
0 <

c1   d1
(c2   d2)t + 1

 1
) 0 <

c1   d1
(c2   d2)t + 1

(c2   d2)tet  (c2   d2)tet
) 0 < 1(t)   1(t)  (c2   d2)tet.
Thus, the following theorem has been proven:
Theorem 16. Let < (x0; y0); s > and, hence, (~x0; ~y0), be given. Assume (A1), (A2), that
1 = 2 =  < 0 and that  has only one eigenvector. Let v be an eigenvector of  and
let v be the generalized eigenvector, linearly independent of v, found by solving the equation
(A   I)v = v, where I is the 2x2 identity matrix . If v1 = 1, v = 0 and (c2   d2) > 0,
then there exists T > 0 such that the 2D linear system _x = Ax will exhibit tolerance for
< (x0; y0); s > for all t > T . (i.e.  1(t) < 1(t) for all t > T ). Furthermore,
T =
d1   c1
c2   d2 ,
and the di¤erence between 1(t) and  1(t) at t > T will be less than or equal to (c2 d2)tet.
Therefore, max
t>T

(c2   d2)tet
	
=d2 c2
e
, which occurs at t =  1

, is the greatest degree of
tolerance that is possible.
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4.5.4 Case 3:
1 6= 2
For this case, where 1 and 2 are distinct, negative eigenvalues of A, assume without loss
of generality that 2 < 1 < 0. Let v be an eigenvector of 1, and let w be an eigenvector of
2. Since 1 and 2 are distinct, v and w are linearly independent eigenvectors. Then, any
initial condition can be uniquely written as a linear combination of the eigenvectors v and w.
For the initial condition (x0; y0) we may write (x0; y0) = c1v+c2w = (c1v1+c2w1; c1v2+c2w2),
with c1; c2 2 R. Then, the solution, (t), to the IVP _x = Ax, (0) = (x0; y0) is
(t) = c1ve
1t + c2we
2t = (c1v1e
1t + c2w1e
2t; c1v2e
1t + c2w2e
2t) (4.18)
Similarly, consider the initial condition (~x0; ~y0) dened to be (~x0; ~y0)  (x0; 0) + (s) for
some s  0. We may also uniquely write (~x0; ~y0) = d1v + d2w = (d1v1 + d2w1; d1v2 + d2w2),
with d1; d2 2 R. The solution  (t) to the IVP _x = Ax,  (0) = (~x0; ~y0) is
 (t) = d1ve
1t + d2we
2t = (d1v1e
1t + d2w1e
2t; d1v2e
1t + d2w2e
2t): (4.19)
Then, since we know that ~x0  x0, we have that
d1v1 + d2w1  c1v1 + c2w1. (4.20)
As was necessary in Case 1, we consider similar subcases for Case 3 (a) v1 = 0 and w1 = 1
(b) v1 = 1 and w1 = 0 and (c) v1 = w1 = 1.
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4.5.4.1 Case 3a:
v1 = 0 and w1 = 1
For this case, (4.20) becomes
d2  c2 (4.21)
Consider the di¤erence between 1(t) and  1(t). Using equations (4.18) and (4.19) and that
in this case v1 = 0 and w1 = 1, we have
1(t)   1(t) = c2e2t   d2e2t
= (c2   d2)e2t.
By (4.21), we have that (c2   d2)  0. Thus, because e2t > 0 for all t  0, we have that
1(t)   1(t)  0 for all t  0. Therefore, the following has been shown:
Theorem 17. Assume (A1), (A2), and that 2 < 1 < 0. Given < (x0; y0); s > and, hence,
(~x0; ~y0), if v1 = 0 and w1 = 1 for eigenvectors v and w of 1 and 2, respectively, then
_x = Ax cannot exhibit tolerance for < (x0; y0); s >. (i.e.  1(t)  1(t) for all t  0.)
4.5.4.2 Case 3b:
v1 = 1 and w1 = 0
For this second subcase of Case 2, (4.20) becomes
d1  c1 (4.22)
Using equations (4.18) and (4.19) and that v1 = 1 and w1 = 0, we have
1(t)   1(t) = c1e1t   d1e1t
= (c1   d1)e1t.
By (4.22), we have that (c1   d1)  0 and we know that e1t > 0 for all t  0. Thus, we
conclude 1(t)   1(t)  0 for all t  0, and the following has been shown:
Theorem 18. Assume (A1), (A2), and that 2 < 1 < 0. Given < (x0; y0); s > and, hence,
(~x0; ~y0), if v1 = 1 and w1 = 0 for eigenvectors v and w of 1 and 2, respectively, then
_x = Ax cannot exhibit tolerance for < (x0; y0); s >. (i.e.  1(t)  1(t) for all t  0.)
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4.5.4.3 Case 3c:
v1 = w1 = 1
We rst nd conditions such that  1(t)  1(t) for all t  0 (i.e. when (4.3) does not
exhibit tolerance). At t = 0, this is clearly true, because ~x0  x0 directly implies that
 1(0)  1(0). In this subcase we have that v1 = w1 = 1. Thus, we may rewrite 4.20 as
d1 + d2  c1 + c2 (4.23)
As before, consider the di¤erence between 1(t) and  1(t). Using equations (4.18) and
(4.19), the fact that v1 = w1 = 1, and (4.23), we have
1(t)   1(t) = c1e1t + c2e2t   d1e1t   d2e2t
= (c1   d1)e1t + (c2   d2)e2t
 (c1   d1)e1t + (d1   c1)e2t; by (4:23)
= (c1   d1)e1t   (c1   d1)e2t
= (c1   d1)(e1t   e2t):
Since 2 < 1 < 0, then e1t   e2t > 0. If (c1   d1)  0, then 1(t)    1(t)  0, which
implies that  1(t)  1(t) for all t  0. Similarly, (4.23) can be used to show
d2   c2  c1   d1 (4.24)
So, we use (4.24) in the 3rd line of the following inequality:
1(t)   1(t) = c1e1t + c2e2t   d1e1t   d2e2t; v1 = w1 = 1
= (c1   d1)e1t + (c2   d2)e2t
 (d2   c2)e1t + (c2   d2)e2t; by (4:24)
= (d2   c2)e1t   (d2   c2)e2t
= (d2   c2)(e1t   e2t):
Since 2 < 1 < 0, then e1t   e2t > 0. If (d2   c2)  0, then 1(t)    1(t)  0, which
implies that  1(t)  1(t) for all t  0. With this, we have proven the following theorem:
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Theorem 19. Assume (A1), (A2), and that 2 < 1 < 0. Also, assume that v1 = w1 = 1,
for eigenvectors v and w of 1 and 2, respectively. Given < (x0; y0); s > and, hence,
(~x0; ~y0), if c1  d1 OR if c2  d2, then _x = Ax cannot exhibit tolerance for < (x0; y0); s >.
(i.e.  1(t)  1(t) for all t  0.) Thus, it is necessary that c1 > d1 AND c2 < d2 for
tolerance to be exhibited.
Now we show that for Case 3c the necessary conditions c1 > d1 AND c2 < d2 from
Theorem 19 are also su¢ cient for tolerance to be exhibited in the 2D linear system _x = Ax.
Assume that c1 > d1 AND c2 < d2. Using equations (4.18) and (4.19) and the fact that
v1 = w1 = 1,
1(t)   1(t) = c1e1t + c2e2t   d1e1t   d2e2t
= (c1   d1)e1t + (c2   d2)e2t.
Factoring out the quantity (c1   d1)e2t from the right hand side gives:
1(t)   1(t) =

e(1 2)t +
c2   d2
c1   d1

e2t(c1   d1):
We know that (c1   d1) > 0 and (c2   d2) < 0, since we assumed c1 > d1 and c2 < d2. Thus,
e2t(c1   d1) > 0
and
(c2   d2)
(c1   d1) < 0:
Therefore,
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1(t)   1(t) =

e(1 2)t +
(c2   d2)
(c1   d1)

e2t(c1   d1)
> 0
,

e(1 2)t +
(c2   d2)
(c1   d1)

> 0
, e(1 2)t > (d2   c2)
(c1   d1)
, ln e(1 2)t > ln (d2   c2)
(c1   d1)
, t >
ln (d2 c2)
(c1 d1)
(1   2)
Thus, we have proven the following theorem:
Theorem 20. Assume (A1), (A2), and that 2 < 1 < 0. Also, assume that v1 = w1 = 1
for eigenvectors v and w of 1 and 2, respectively. Given < (x0; y0); s > and, hence,
(~x0; ~y0), if c1 > d1 AND c2 < d2 then there exists T > 0 such that the 2D linear system
_x = Ax will exhibit tolerance for < (x0; y0); s > for all t > T . (i.e.  1(t) < 1(t) for all
t > T ). Furthermore,
T =
ln d2 c2
c1 d1
1   2 .
4.5.5 Eigenvector Congurations and Regions of Tolerance
Now we consider the eigenvector congurations of 2D linear systems for the cases that
accommodate solutions that begin and remain in the rst quadrant and that converge to
(0; 0) as t ! 1. Of the cases discussed above, only cases 2b.ii and 3c yield the possibility
of tolerance. For the relevant eigenvector congurations of these cases, we analyze the
rst quadrant to determine where the nonnegativity requirement is satised for solutions
originating there. In each of the eigenvector congurations shown in Figure 26, there are
several regions of the rst quadrant that will be considered. Once the pertinent regions
have been identied, we then determine where tolerance will and will not occur.
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Remark 4. In the following analysis to determine relevant regions, we do not consider
(x0; y0) on the y-axis, since this would imply that x0 = 0, yet it was assumed that x0 > 0.
(see page 112)
Figure 26: Regions in the rst quadrant for all relevant eigenvector congurations
Figure 27 shows a pictoral summary of the results via example trajectories originating
in the di¤erent regions of the various eigenvector congurations. These results are made
explicit in the following analysis. In all the cases, since the initial condition (x0; y0) under
consideration is in the rst quadrant, it is clear that the solution of the IVP, (t), at t = 0
is (0) > 0, thus we consider the solutions for all t > 0.
4.5.5.1 Eigenvector Conguration (a): Eigenvector conguration (a) of Figure 26a
illustrates the only possible eigenvector conguration in Case 2b.ii for which there exist
solutions that begin and remain in the rst quadrant. We rst show where in the rst
quadrant such solutions exist. Recall that in this case, the matrix A in (4.3) has one
eigenvalue, , of multiplicity two, having only one independent eigenvector, v. A generalized
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Figure 27: Eigenvector congurations for 2D systems which accomodate solutions that begin and remain
in the rst quadrant and converge to (0; 0) as t  !1.
eigenvector, v, was found so as to construct a general solution, given an intial condition. For
initial conditions (x0; y0) = c1v + c2v = (c1v1 + c2v1; c1v2 + c2v2) and (~x0; ~y0) = d1v + d2v =
(d1v1 + d2v1; d1v2 + d2v2),with c1; c2; d1; d2 2 R, the rst component of the solutions to the
inital value problems are given by equations (4.13) and (4.14), respectively. Furthermore,
in conguration (a), v1 = 1, v2 > 0, v1 = 0, and v2 > 0. In addition, recall (4.11): d1  c1.
Let (x0; y0) be in Region 1a of the rst quadrant bounded by v and the y-axis, seen in
Figure 26a. We show that the rst component of the solution, (t), of the IVP with initial
condition (x0; y0) will remain positive for all t > 0. This will be su¢ cient since it would
guarantee that 2(t) > 0 for all t > 0, because (t) cannot cross the v-eigenvector. Clearly,
at t = 0, 1(0) > 0. In Region 1a, for any (x0; y0) = c1v + c2v, we have that c1 > 0 and
c2 > 0. Therefore,
c1 + c2t > 0, 8t > 0
) (c1 + c2t)et > 0, 8t > 0
) 1(t) > 0, 8t > 0,
by equation (4.13), which denes 1(t).
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Now, consider (x0; y0) in Region 2a of eigenvector conguration (a), shown in Figure 26a.
We show that the rst component of the solution, (t), of the IVP with this initial condition
will eventually be negative in the rst component. This will be su¢ cient to conrm that
the solution does not stay in the rst quadrant. In this region, for any (x0; y0) = c1v + c2v,
we have that c1 > 0 and c2 < 0. Therefore, since e > 0 for all t > 0,
1(t) = (c1 + c2t)e
t < 0, 8t > 0
, c1 + c2t < 0, 8t > 0
, c2t <  c1, 8t > 0
, t >  c1
c2
Note that because c2 < 0, the inequality changes in the last line when division by c2 is made.
In addition  c1
c2
> 0, since c1 > 0 and c2 < 0. Therefore, 1(t) < 0 for all t >
 c1
c2
. In other
words, for eigenvector conguration (a), solutions starting in Region 2a will eventually be
negative in the rst component.
Thus, in eigenvector conguration (a), seen in gure 28, there is one region in which to
consider initial conditions to explore the existance of tolerance.
 REGION 1a: (x0; y0) in the rst quadrant above v
The conclusion regarding tolerance for this case (Case 2b.ii) was given by Theorem 16,
which shows (along with Theorem 15) that the condition (c2   d2) > 0 is necessary and
su¢ cient in this case for tolerance to be exhbited in (4.3). In the left panel of Figure 29 an
arbitrary point in Region 1a is shown in the context of eigenvector conguration (a), with
lines drawn (portions dashed), showing the addition of scalar multiples of the eigenvector v
and the generalized eigenvector, v, in the creation of the point (x0; y0). Although the gener-
alized eigenvector, v, is used to write the intial conditions, there is only one eigendirection,
so trajectories can cross v. Since in this case, v = 0, the blue line along the y-axis represents
v. The lines showing the creation of (x0; y0) are referred to as the c1-line and c2-line. They
divide the rst quadrant into four di¤erent regions as shown in the right panel of Figure 29.
In these regions, there are relationships between the coe¢ cients c1and c2 and the coe¢ -
cients of other points in the rst quadrant written as a linear combination of the eigenvectors,
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Figure 28: Eigenvector conguration (a) with the rst quadrant divided into three regions where initial
conditions yield solutions that begin and remain in the rst quadrant.
Figure 29: Left Panel: Eigenvector conguration (a) with an arbitrary initial condition (x0; y0) labeled
in Region 1a (x-axis) along with lines drawn (portions dashed), showing the additon of the two eigenvectors
in the creation of (x0; y0). Right Panel: The rst quadrant of eigenvector conguration (a) divided into
three regions by the c1- and c2-lines associated with the point (x0; y0) = c1v + c2w lying in Region 1a.
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namely, the coe¢ cients of the bumped initial condition, (~x0; ~y0) = d1v + d2v. If (~x0; ~y0) 2
Ia, then using the c1-line and c2-line lines for reference, we see that d1 < c1 and d2 < c2 in
region I1a. Applying this reasoning to each region, we have by (4.11) and Theorems 15 and
16:
1. For (~x0; ~y0) 2 I1a, d1 < c1 and d2 < c2. Since d1 < c1, tolerance cannot be exhibited for
any (~x0; ~y0) 2 I1a, for (x0; y0) in Region 1a.
2. For (~x0; ~y0) 2 II1a, d1 < c1 and d2  c2. Either of these relationships imply that tolerance
cannot be exhibited for any (~x0; ~y0) 2 II1a, when (x0; y0) in Region 1a.
3. For (~x0; ~y0) 2 III1a, d1 > c1 and d2  c2. Since d2  c2, tolerance cannot be exhibited
for (~x0; ~y0) 2 III1a, for (x0; y0) in Region 1a.
4. For (~x0; ~y0) 2 IV1a, d1  c1 and d2 < c2. Since both d1  c1 and d2 < c2, tolerance
will be exhibited for (~x0; ~y0) 2 IV1a, when (x0; y0) is in Region 1a.
Hence, for eigenvector conguration (a), if (x0; y0) is in the rst quadrant above the
eigenvector, v, then tolerance will be exhibited only when (~x0; ~y0) 2 IV1a, which is the green
area shown in the right panel of Figure 29. Note that, of course, (~x0; ~y0) 2 I1a contradicts
the denition of (~x0; ~y0), since in this region, ~x0 < x0, yet ~x0 is dened to be greater than
x0. This is also the case for (~x0; ~y0) 2 II1a; however, we are just considering the regions as
a whole and once the regions have been classied, we determine which regions are relevant
with respect to where the (~x0; ~y0)-curve is. In the Examples section (4.5.6), Example 1 shows
an example of a trajectory, whose initial condition lies in Region 1a, and its corresponding
(~x0; ~y0)-curve, a portion of which lies in the region marked IV1a.
Panels (b)-(d) of Figure 26 depict the only possible eigenvector congurations for Case
3c, for which solutions exist that begin and remain in the rst quadrant. For these cong-
urations, there are two eigenvalues for the matrix, A, of (4.3), each having a corresponding
eigenvector. Thus, WLOG assume 2 < 1 < 0, with v and w the linear independent eigen-
vectors of 1 and 2, respectively. In this case (Case 3c) it has been arranged for v = [1 v2]T
and w = [1 w2]T . (T  transpose) In other words, v1 = w1 = 1. Furthermore, for ini-
tial conditions (x0; y0) = c1v + c2w = (c1v1 + c2w1; c1v2 + c2w2) = (c1 + c2; c1v2 + c2w2) and
(~x0; ~y0) = d1v+d2w = (d1v1+d2w1; d1v2+d2w2) = (d1+d2; d1v2+d2w2),with c1; c2; d1; d2 2 R,
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the solutions to the inital value problems are given by equations (4.18) and (4.19), respec-
tively.
Remark 5. Note that x0 > 0, implies that c1 + c2 > 0 ) c1 >  c2 and that y0 > 0, implies
that c1v2 + c2w2 > 0) c1v2 >  c2w2.
Remark 6. Note that because 2 < 1 < 0 in this case, we have that (1   2) > 0 and
consequently, that e(1 2)t > 1 for all t > 0.
The above remarks will be used throughout the analysis of eigenvector congurations
(b)-(d) in determining relevant regions that satisfy the nonnegativity assumption (A2).
4.5.5.2 Eigenvector Conguration (b): We rst determine which of the regions shown
in Figure 26b are relevant with respect to solutions that remain in the rst quadrant for all
t > 0. In eigenvector conguration (b), we have that v2 > 0, w2 < 0, since it is assumed
that v1 = w1 = 1.
We group Regions 1b and 2b of Figure 26b, since the proofs are the same. Thus, consider
an arbitrary inital condition, (x0; y0), in Region 1b or Region 2b. In either region, c1 > 0
and c2 > 0. Because of the position of the eigenvectors in this conguration, 1(t) > 0 for
all t > 0. Therefore, it must be shown that 2(t) > 0 for all t > 0. Since c1 > 0 and v2 > 0,
Remarks (5) and (6) give the following:
c1v2e
(1 2)t >  c2w2 (4.25)
) c1v2e1t >  c2w2e2t (4.26)
) c1v2e1t + c2w2e2t > 0 (4.27)
for all t > 0. This implies from equation (4.18) that 2(t) > 0 for all t > 0. In other words,
for eigenvector conguration (b), solutions starting in Region 1b or Region 2b will remain
nonnegative for all t  0.
Now consider an arbitrary intial condition in Region 3b shown in Figure 26b. It is
su¢ cient to show that 1(t) > 0 for all t > 0 since the nonnegativity of 2(t) is guaranteed
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Figure 30: Eigenvector conguration (b) with the rst quadrant divided into three regions where initial
conditions yield solutions that begin and remain in the rst quadrant.
by the position of the eigenvectors v and w, through which the solution cannot cross. In
Region 3b, c1 > 0 and c2 < 0. Since c1 > 0, Remarks (5) and (6) give the following:
c1e
(1 2)t >  c2
) c1e1t >  c2e2t
) c1e1t + c2e2t > 0
for all t > 0, which implies from equation (4.18) that 1(t) > 0 for all t > 0.
Thus, for eigenvector conguration (b), seen in gure 30, there are three regions in which
to consider initial conditions:
 REGION 1b: (x0; y0) on the x-axis
 REGION 2b: (x0; y0) in the rst quadrant below the v eigenvector and above the
x-axis
 REGION 3b: (x0; y0) in the rst quadrant above the v eigenvector
REGION 1b: First, we look at the case when the initial condition is on the x-axis.
In the left panel of Figure 31, an arbitrary point on the x-axis is shown in the context of
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Figure 31: Left Panel: Eigenvector conguration (b) with an arbitrary initial condition (x0; y0) labeled
in Region 1b (x-axis) along with lines drawn (portions dashed), showing the additon of the two eigenvectors
in the creation of (x0; y0). Right Panel: The rst quadrant of eigenvector conguration (b) divided into three
regions by the c1- and c2-lines associated with the point (x0; y0) = c1v + c2w lying in Region 1b.
eigenvector conguration (b), with lines drawn (portions dashed), showing the addition of
scalar multiples of the two eigenvectors in the creation of the point (x0; y0). The right panel
of Figure 31 shows the three regions formed in the rst quadrant by the c1-line and c2-line.
Using this and Theorems 19 and 20 we have:
1. For (~x0; ~y0) 2 I1b, d1 < c1 and d2 < c2. Since d2 < c2, tolerance cannot be exhibited for
any (~x0; ~y0) 2 I1a, when (x0; y0) in Region 1b.
2. For (~x0; ~y0) 2 II1b, d1  c1 and d2  c2. Either of these relationships imply that tolerance
cannot be exhibited for any (~x0; ~y0) 2 II1b, when (x0; y0) in Region 1b.
3. For (~x0; ~y0) 2 III1b, d1 > c1 and d2 > c2. Since d1 > c1, tolerance cannot be exhibited
for (~x0; ~y0) 2 III1b, when (x0; y0) in Region 1b.
Hence, for eigenvector conguration (b), if (x0; y0) is on the x-axis, there are no regions
in the rst quadrant where both d1 < c1 and d2 > c2 and, thus, for any (~x0; ~y0) there can be
no tolerance.
REGION 2b: Let (x0; y0) be in the rst quadrant below the v eigenvector (but not
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Figure 32: Left Panel: Eigenvector conguration (b) with an arbitrary initial condition (x0; y0) labeled
in Region 2b along with lines drawn (portions dashed) showing the additon of the two eigenvectors in the
creation of (x0; y0). Right Panel: The rst quadrant of eigenvector conguration (b) divided into four regions
by the c1- and c2-lines associated with the point (x0; y0) = c1v + c2w lying in Region 2b.
on the x-axis) in eigenvector conguration (b). Figure 32 shows an arbitrary point in this
region, with lines drawn (portions dashed), showing the addition of the two eigenvectors in
the creation of the point (x0; y0). The right panel of Figure 32 shows the four regions formed
in the rst quadrant by the c1-line and c2-line. Using this and Theorems 19 and 20 we have:
1. For (~x0; ~y0) 2 I2b, d1 < c1 and d2  c2. Since d2  c2, tolerance cannot be exhibited for
any (~x0; ~y0) 2 I2b, when (x0; y0) is in Region 2b.
2. For (~x0; ~y0) 2 II2b, d1  c1 and d2  c2. Either of these relationships imply that tolerance
cannot be exhibited for any (~x0; ~y0) 2 II2b, when (x0; y0) is in Region 2b.
3. For (~x0; ~y0) 2 III2b, d1  c1 and d2 > c2. Since d1  c1, tolerance cannot be exhibited
for (~x0; ~y0) 2 III2b, when (x0; y0) is in Region 2b.
4. For (~x0; ~y0) 2 IV2b, d1 < c1 and d2 > c2. Since both d1 < c1 and d2 > c2, tolerance
will be exhibited for (~x0; ~y0) 2 IV2b, when (x0; y0) is in Region 2b.
Hence, for eigenvector conguration (b), if (x0; y0) is in the rst quadrant below the v
eigenvector (but not on the x-axis), then tolerance will be exhibited only when (~x0; ~y0) 2 IV2b,
which is the green area shown in Figure 32. In the Examples section (4.5.6), Example 2 shows
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Figure 33: Left Panel: Eigenvector conguration (b) with an arbitrary initial condition (x0; y0) labeled
in Region 3b along with lines drawn (portions dashed) showing the additon of the two eigenvectors in the
creation of (x0; y0). Right Panel: The rst quadrant of eigenvector conguration (b) divided into four regions
by the c1- and c2-lines associated with the point (x0; y0) = c1v + c2w lying in Region 3b.
an example of a trajectory, whose initial condition lies in Region 2b and, its corresponding
(~x0; ~y0)-curve, a portion of which lies in the region marked IV2b.
REGION 3b: Let (x0; y0) be in the rst quadrant above the v eigenvector in eigenvector
conguration (b). Figure 33 shows an arbitrary point in this region, with lines drawn
(portions dashed), showing the addition of the two eigenvectors in the creation of the point
(x0; y0). The right panel of Figure 33 shows the four regions formed in the rst quadrant
by the c1-line and c2-line. Using this and Theorems 19 and 20 we have:
1. For (~x0; ~y0) 2 I3b, d1 < c1 and d2  c2. Since d2  c2, tolerance cannot be exhibited for
any (~x0; ~y0) 2 I3b, when (x0; y0) is in Region 3b.
2. For (~x0; ~y0) 2 II3b, d1  c1 and d2  c2. Either of these relationships imply that tolerance
cannot be exhibited for any (~x0; ~y0) 2 II3b, when (x0; y0) is in Region 3b.
3. For (~x0; ~y0) 2 III3b, d1  c1 and d2 > c2. Since d1  c1, tolerance cannot be exhibited
for (~x0; ~y0) 2 III3b, when (x0; y0) is in Region 3b.
4. For (~x0; ~y0) 2 IV3b, d1 < c1 and d2 > c2. Since both d1 < c1 and d2 > c2, tolerance
will be exhibited for (~x0; ~y0) 2 IV3b, when (x0; y0) is in Region 3b.
Hence, for eigenvector conguration (b), if (x0; y0) is in the rst quadrant above the v
149
eigenvector, then tolerance will be exhibited only when (~x0; ~y0) 2 IV3b, which is the green re-
gion shown in the right panel of Figure 33. In the Examples section (4.5.6), Example 3 shows
an example of a trajectory, whose initial condition lies in Region 3b, and its corresponding
(~x0; ~y0)-curve, a portion of which lies in the region marked IV3b.
4.5.5.3 Eigenvector Conguration (c) For conguration (c), we also rst determine
which of the regions shown in Figure 26c are relevant with respect to solutions that remain
in the rst quadrant for all t > 0. In this eigenvector conguration, we have that v2 > 0,
w2 > 0, since it is assumed that v1 = w1 = 1.
We group Regions 1c and 2c of Figure 26c, since the proofs are the same. Thus, consider
an arbitrary inital condition, (x0; y0), in Region 1c or Region 2c. In either region, c1 > 0
and c2 < 0. Because of the position of the eigenvectors in this conguration, it is su¢ cient
to show that 2(t) > 0 for all t > 0, which will then imply that 1(t) > 0 for all t > 0, as
well. Since c1 > 0 and v2 > 0, Remarks (5) and (6) give the following:
c1v2e
(1 2)t >  c2w2
) c1v2e1t >  c2w2e2t
) c1v2e1t + c2w2e2t > 0
for all t > 0. This implies from equation 4.18 that 2(t) > 0 for all t > 0.
Now consider an arbitrary intial condition in Region 3c shown in Figure 26c. All solutions
originating in this region will be bounded by the eigenvectors v and w and will remain in
the rst quadrant for all t > 0.
For an an arbitrary intial condition in Region 4c shown in Figure 26c, we will show that
solutions starting in this region do not remain in the rst quadrant for all t > 0. It is
su¢ cient to show that 1(t) < 0 for some t > 0. In Region 4c, c1 < 0 and c2 > 0. We
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determine when 1(t) < 0 or equivalently, when the following inequality holds:
c1e
1t + c2e
2t < 0
, c1e1t <  c2e2t
, c1e(1 2)t <  c2
, e(1 2)t >  c2
c1
, ln e(1 2)t > ln
 c2
c1

, t >
ln

 c2
c1

(1   2) .
Note that

 c2
c1

> 0 since c1 < 0 and c2 > 0 in this region. Hence, it has been shown that
solutions starting in Region 4c do not remain in the rst quadrant.
Thus, for eigenvector conguration (c), seen in Figure 34, there are three regions in which
to consider initial conditions:
 REGION 1c: (x0; y0) on the x-axis
 REGION 2c: (x0; y0) in the rst quadrant below the v eigenvector and above the
x-axis
 REGION 3c: (x0; y0) in the rst quadrant above the v eigenvector and below the w
eigenvector
REGION 1c: First, we look at the case when the initial condition is on the x-axis.
In the left panel of Figure 35, an arbitrary point on the x-axis is shown in the context of
eigenvector conguration (c), with lines drawn (portions dashed), showing the addition of
the two eigenvectors in the creation of the point (x0; y0). Using this and Theorems 19 and
20 we have:
1. For (~x0; ~y0) 2 I1c, d1 < c1 and d2 > c2. Since both d1 < c1 and d2 > c2, tolerance
will be exhibited for (~x0; ~y0) 2 I1c, when (x0; y0) is in Region 1c.
2. For (~x0; ~y0) 2 II1c, d1  c1 and d2 > c2. Since d1  c1, tolerance cannot be exhibited for
any (~x0; ~y0) 2 II1c, when (x0; y0) is in Region 1c.
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Figure 34: Eigenvector conguration (c) with the rst quadrant divided into three regions where initial
conditions yield solutions that begin and remain in the rst quadrant.
Figure 35: Left Panel: Eigenvector conguration (c) with an arbitrary initial condition (x0; y0) labeled
in Region 1c (x-axis) along with lines drawn (portions dashed) showing the additon of the two eigenvectors
in the creation of (x0; y0). Right Panel: The rst quadrant of eigenvector conguration (c) divided into three
regions by the c1- and c2-lines associated with the point (x0; y0) = c1v + c2w lying in Region 1c.
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Figure 36: Left Panel: Eigenvector conguration (c) with an arbitrary initial condition (x0; y0) labeled
in Region 2c along with lines drawn (portions dashed) showing the additon of the two eigenvectors in the
creation of (x0; y0). Right Panel: The rst quadrant of eigenvector conguration (c) divided into four regions
by the c1- and c2-lines associated with the point (x0; y0) = c1v + c2w lying in Region 2c.
3. For (~x0; ~y0) 2 III1c, d1 > c1 and d2 < c2. Either of these relationships imply that
tolerance cannot be exhibited for (~x0; ~y0) 2 III1c, when (x0; y0) is in Region 1c.
Hence, for eigenvector conguration (c), if (x0; y0) is on the x-axis, then tolerance will
be exhibited only when (~x0; ~y0) 2 I1c, which is the green region shown in the right panel of
Figure 35.
REGION 2c: Let (x0; y0) be in the rst quadrant below the v eigenvector (but not on
the x-axis) in eigenvector conguration (c). The left panel of Figure 36 shows an arbitrary
point in this region, with lines drawn (portions dashed), showing the addition of the two
eigenvectors in the creation of the point (x0; y0). The right panel of Figure 36 shows the four
regions formed in the rst quadrant by the c1-line and c2-line. Using this and Theorems 19
and 20 we have:
1. For (~x0; ~y0) 2 I2c, d1 < c1 and d2 > c2. Since both d1 < c1 and d2 > c2, tolerance
will be exhibited for (~x0; ~y0) 2 I2c, when (x0; y0) is in Region 2c.
2. For (~x0; ~y0) 2 II2c, d1  c1 and d2 > c2. Since d1  c1, tolerance cannot be exhibited for
(~x0; ~y0) 2 II2c, when (x0; y0) is in Region 2c.
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Figure 37: Left Panel: Eigenvector conguration (c) with an arbitrary initial condition (x0; y0) labeled
in Region 3c along with lines drawn (portions dashed) showing the additon of the two eigenvectors in the
creation of (x0; y0). Right Panel: The rst quadrant of eigenvector conguration (c) divided into four regions
by the c1- and c2-lines associated with the point (x0; y0) = c1v + c2w lying in Region 3c.
3. For (~x0; ~y0) 2 III2c, d1  c1 and d2  c2. Either of these relationships imply that
tolerance cannot be exhibited for any (~x0; ~y0) 2 III2c, when (x0; y0) is in Region 2c.
4. For (~x0; ~y0) 2 IV2c, d1 < c1 and d2  c2. Since d2  c2, tolerance cannot be exhibited
for any (~x0; ~y0) 2 IV2c, when (x0; y0) is in Region 2c.
Hence, for eigenvector conguration (c), if (x0; y0) is in the rst quadrant below the v
eigenvector (but not on the x-axis), then tolerance will be exhibited only when (~x0; ~y0) 2 I2c,
which is the green region shown in the right panel of Figure 36. In the Examples section
(4.5.6), Example 4 shows an example of a trajectory whose initial condition lies in Region
2c and its corresponding (~x0; ~y0)-curve, no points of which lie in the region marked I2c.
REGION 3c: Let (x0; y0) be in the rst quadrant above the v eigenvector and below
the w eigenvector in eigenvector conguration (c). The left panel of Figure 37 shows an
arbitrary point in this region, with lines drawn (portions dashed) showing the addition of the
two eigenvectors in the creation of the point (x0; y0). The right panel of Figure 37 shows the
four regions formed in the rst quadrant by the c1-line and c2-line. Using this and Theorems
19 and 20 we have:
1. For (~x0; ~y0) 2 I3c, d1 < c1 and d2  c2. Since d2  c2, tolerance cannot be exhibited for
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any (~x0; ~y0) 2 I3c, when (x0; y0) is in Region 3c.
2. For (~x0; ~y0) 2 II3c, d1 < c1 and d2 > c2. Since both d1 < c1 and d2 > c2, tolerance
will be exhibited for (~x0; ~y0) 2 II3c, when (x0; y0) is in Region 3c.
3. For (~x0; ~y0) 2 III3c, d1  c1 and d2 > c2. Since d1  c1, tolerance cannot be exhibited for
(~x0; ~y0) 2 III3c, when (x0; y0) is in Region 3c.
4. For (~x0; ~y0) 2 IV3c, d1  c1 and d2  c2. Either of these relationships imply that tolerance
cannot be exhibited for any (~x0; ~y0) 2 IV3c, when (x0; y0) is in Region 3c.
Thus, for eigenvector conguration (c), if (~x0; ~y0) is in the rst quadrant above the v
eigenvector and below the w eigenvector, then tolerance will be exhibited only when (~x0; ~y0) 2
II3c, which is the green region shown in the right panel of Figure 37. In the Examples section
(4.5.6), Example 5 shows an example of a trajectory, whose initial condition lies in Region
3c, and its corresponding (~x0; ~y0)-curve, no points of which lie in the region marked II3c.
4.5.5.4 Eigenvector Conguration (d) For the last conguration, we again determine
which of the regions shown in Figure 26d are relevant with respect to solutions that remain
in the rst quadrant for all t > 0. In eigenvector conguration (d), we have that v2 > 0,
w2 > 0, since it is assumed that v1 = w1 = 1.
Consider an arbitrary intial condition in Region 1d shown in Figure 26d. All solutions
originating in this region will be bounded by the eigenvectors v and w and will remain in
the rst quadrant for all t > 0.
Now consider an arbitrary intial condition, (x0; y0), in Region 2d shown in Figure 26d.
It is su¢ cient to show that 1(t) > 0 for all t > 0, which would imply that 2(t) > 0 for all
t > 0, given the position of the eigenvectors in this conguration. In Region 2d, c1 > 0 and
c2 < 0. Since c1 > 0 and v2 > 0, Remarks (5) and (6) give the following:
c1e
(1 2)t >  c2
) c1e1t >  c2e2t
) c1e1t + c2e2t > 0
for all t > 0. This implies from equation (4.18) that 1(t) > 0 for all t > 0.
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Lastly, consider an arbitray initial condition, (x0; y0), in Region 3d shown in Figure 26d.
We will show that 1(t) < 0 for some t > 0, which will imply that solutions starting in
Region 3d do not remain in the rst quadrant. In Region 3d, c1 < 0 and c2 > 0. We
determine when 1(t) < 0 or equivalently, when the following inequality holds:
c1e
1t + c2e
2t < 0
, c1e1t <  c2e2t
, c1e(1 2)t <  c2
, e(1 2)t >  c2
c1
, ln e(1 2)t > ln
 c2
c1

, t >
ln

 c2
c1

(1   2) .
Note that

 c2
c1

> 0 since c1 < 0 and c2 > 0 in this region. Hence, it has been shown that
solutions starting in Region 3d do not remain in the rst quadrant.
Thus, for eigenvector conguration (d), seen in Figure 38, there are two regions in which
to consider initial conditions:
 REGION 1d: (x0; y0) in the rst quadrant below the v eigenvector and above the w
eigenvector
 REGION 2d: (x0; y0) in the rst quadrant above both the eigenvectors
REGION 1d: Let (x0; y0) be in the rst quadrant below the v eigenvector and above
the w eigenvector in eigenvector conguration (d). The left panel of Figure 39 shows an
arbitrary point in this region, with lines drawn (portions dashed), showing the addition of the
two eigenvectors in the creation of the point (x0; y0). The right panel of Figure 39 shows the
four regions formed in the rst quadrant by the c1-line and c2-line. Using this and Theorems
19 and 20 we have:
1. For (~x0; ~y0) 2 I1d, d1 < c1 and d2  c2. Since d2  c2, tolerance cannot be exhibited for
any (~x0; ~y0) 2 I1d, when (x0; y0) is in Region 1d.
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Figure 38: Eigenvector conguration (d) with the rst quadrant divided into two regions where initial
conditions yield solutions that begin and remain in the rst quadrant.
Figure 39: Left Panel: Eigenvector conguration (d) with an arbitrary initial condition (x0; y0) labeled
in Region 1d along with lines drawn (portions dashed) showing the additon of the two eigenvectors in the
creation of (x0; y0). Right Panel: The rst quadrant of eigenvector conguration (d) divided into two regions
by the c1- and c2-lines associated with the point (x0; y0) = c1v + c2w lying in Region 1d.
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Figure 40: Left Panel: Eigenvector conguration (d) with an arbitrary initial condition (x0; y0) labeled
in Region 2d along with lines drawn (portions dashed) showing the additon of the two eigenvectors in the
creation of (x0; y0). Right Panel: The rst quadrant of eigenvector conguration (d) divided into four regions
by the c1- and c2-lines associated with the point (x0; y0) = c1v + c2w lying in Region 2d.
2. For (~x0; ~y0) 2 II1d, d1  c1 and d2  c2. Either of these relationships imply that tolerance
cannot be exhibited for any (~x0; ~y0) 2 II1d, when (x0; y0) is in Region 1d.
3. For (~x0; ~y0) 2 III1d, d1  c1 and d2 > c2. Since d1  c1, tolerance cannot be exhibited for
(~x0; ~y0) 2 III1d, when (x0; y0) is in Region 1d.
4. For (~x0; ~y0) 2 IV1d, d1 < c1 and d2 > c2. Since both d1 < c1 and d2 > c2, tolerance
will be exhibited for (~x0; ~y0) 2 IV1d, when (x0; y0) is in Region 1d.
Hence, for eigenvector conguration (d), if (x0; y0) is in the rst quadrant below the v
eigenvector and above the w eigenvector, then tolerance will be exhibited only when (~x0; ~y0) 2
IV1d, which is the green region shown in the right panel of Figure 39. In the Examples section
(4.5.6), Example 6 shows an example of a trajectory, whose initial condition lies in Region
1d, and its corresponding (~x0; ~y0)-curve, no points of which lie in the region marked IV1d.
REGION 2d: Let (x0; y0) be in the rst quadrant above above both the eigenvectors
in eigenvector conguration (d). The left panel of Figure 40 shows an arbitrary point in
this region, with lines drawn (portions dashed), showing the addition of the two eigenvectors
in the creation of the point (x0; y0). The right panel of Figure 40 shows the four regions
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formed in the rst quadrant by the c1-line and c2-line. Using this and Theorems 19 and 20
we have:
1. For (~x0; ~y0) 2 I2d, d1 < c1 and d2  c2. Since d2  c2 tolerance cannot be exhibited for
any (~x0; ~y0) 2 I2d, when (x0; y0) is in Region 2d.
2. For (~x0; ~y0) 2 II2d, d1  c1 and d2  c2. Either of these relationships imply that tolerance
cannot be exhibited for any (~x0; ~y0) 2 II2d, when (x0; y0) is in Region 2d.
3. For (~x0; ~y0) 2 III2d, d1  c1 and d2 > c2. Since d1  c1, tolerance cannot be exhibited
for any (~x0; ~y0) 2 III2d, when (x0; y0) is in Region 2d.
4. For (~x0; ~y0) 2 IV2d, d1 < c1 and d2 > c2. Since both d1 < c1 and d2 > c2, tolerance
will be exhibited for (~x0; ~y0) 2 IV2d, when (x0; y0) is in Region 2d.
Thus, for eigenvector conguration (d), if (~x0; ~y0) is in the rst quadrant above above
both the eigenvectors, then tolerance will be exhibited only if (~x0; ~y0) 2 IV2d, which is
the green region given in the right panel of Figure 40. In the Examples section (4.5.6),
Example 7 shows an example of a trajectory, whose initial condition lies in Region 2d, and
its corresponding (~x0; ~y0)-curve, a portion of which lies in the region marked IV2d.
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4.5.6 Examples
Example 1. Eigenvector conguration (a) with (x0; y0) in Region 1a.
Figure 41: Example 1
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Example 2. Eigenvector conguration (b) with (x0; y0) in Region 2b.
Figure 42: Example 2
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Example 3. Eigenvector conguration (b) with (x0; y0) in Region 3b.
Figure 43: Example 3
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Example 4. Eigenvector conguration (c) with (x0; y0) in Region 2c.
Figure 44: Example 4
163
Example 5. Eigenvector conguration (c) with (x0; y0) in Region 3c.
Figure 45: Example 5
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Example 6. Eigenvector conguration (d) with (x0; y0) in Region 1d.
Figure 46: Example 6
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Example 7. Eigenvector conguration (d) with (x0; y0) in Region 2d.
Figure 47: Example 7
This concludes the results regarding 2D general linear ODE systems. The next section
presents results for the existence of tolerance for 2D general nonlinear ODE systems.
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4.6 TOLERANCE IN 2D GENERAL NONLINEAR ODE SYSTEMS
In Section 4.4, a few results were presented that gave some criteria that implied the existence
of tolerance in system (4.1). These, however, were for very specic cases. For example,
Proposition 8 considers an original trajectory, (t), that does not converge to the xed point
(0; 0), while the competing trajectory,  (t), does converge to (0; 0), providing an obvious case
when tolerance will be exhibited. Not as obvious, but still specic in their statements, are
Propositions 9 and 10. In these propositions, the original trajectory, (t), and competing
trajectory,  (t), both converge to (0; 0), however, they are specically written in the context
of an initial condition of (t) that is an element of the positive x-axis, i.e. (x0; y0) = (x0; 0).
The results, though interesting, are only for a small subset of the initial conditions that can
be considered for (t). It would be nice to eliminate the restriction of only considering
initial conditions that begin on the positive x-axis.
In the present chapter, additional tools are introduced that can be more widely applied to
system (4.1) than the results of Section 4.4. In Section 4.6.1, we introduce the use of isoclines
and the concept of inhibition as a method for determining in a general 2D ODE system if, for
a given (x0; y0), there exists an s  0 such that (~x0; ~y0) = (s) + (x0; 0) produces tolerance.
Recall that for a given (x0; y0), there exists a continuous curve of points (parameterized by
s  0), denoted as the (~x0; ~y0)-curve (see Figure 21) from which a competing trajectory,  (t),
can originate. Thus, for every < (x0; y0); s >, there is a corresponding (~x0; ~y0) point that
might or might not produce tolerance. Using the isocline and inhibition strategy, portions
of the (~x0; ~y0)-curve will be identied as containing points that will not produce tolerance
(i.e.  (t) > (t) for all t  0) and points that might produce tolerance. The inhibition and
isocline strategy is illustrated with several specic ODE examples.
Then, in Section 4.6.2, some numerical tools are presented, including an algorithm for
numerically locating tolerance for a given initial condition, (x0; y0), or a set of initial con-
ditions of the original trajectory, (t). In addition, this subsection also uses isoclines to
acquire a numerical estimate for the time it take for a trajectory to, essentially, get from
Point A to Point B. The idea is to estimate the time it takes for the original trajectory,
(t), to go from (x0; y0) to some nal point (xf ; yf ) and compare it to an estimate of the
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corresponding time for the competing trajectory,  (t), to go from (~x0; ~y0) to (xf ; yf ). The
use of isoclines in the Section 4.6.1, however, proves to be more insightful and functional.
168
4.6.1 Isoclines
Consider the ODE (4.1) and assume both (A1) and (A2) given previously and reproduced
below:
(A1) (0; 0) is a stable xed point of (4.1) the eigenvalues of which are real and negative.
(eliminates spirals and centers)
(A2)  and  are nonnegative for all t  0 and both (x0; y0) and (~x0; ~y0) lie in the basin of
attraction for (0; 0) in the rst quadrant.
Denition 7. The x-isoclines of (4.1) are the family of curves (or level sets) dened by
f(x; y) = C1 2 R.
Along an isocline, f(x; y) = C1, the speed of the vector eld in the x direction is given
by C1. (Similarly, for the y-isocline, g(x; y) = C2, the speed in the y direction is given by
C2.) A nullcline, for instance, is an isocline in which C = 0, meaning that the velocity of
the vector eld along the curve is 0 in the particular direction.
Remark 7. For convenience, we will drop the x- and just use isocline, since we do not
consider the y-isoclines here.
Before illustrating the use of isoclines for determining the existence of tolerance in gen-
eral 2D ODE systems, we rst introduce the concept of inhibition. Inhibition is a widely
used term for describing the suppression of one variable by another. For instance, in the
model used in Chapter 2, the anti-inammatory mediator inhibited the production of pro-
inammatory mediators as well as its own production. However, the use of this term, in this
and similar situations, while intuitive and heuristically understood, is not mathematically
precise.
Hence, we give a precise denition of inhibition below, prove two results relating to inhi-
bition and tolerance, and use these results, in conjunction with isoclines, in several examples
of 2D nonlinear ODE systems, to show for which points of the (~x0; ~y0)-curve tolerance can
and cannot be produced. As a transition into using inhibition and isoclines in these exam-
ples, they are rst illustrated using a linear example, specically the type shown in Figure
32. Now, we precisely dene the concept of inhibition:
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Denition 8. Dene inhibition of x by y in a region, R  R2+, as the property of (4.1)
that satises the following inequality: for (x; y1); (x; y2) 2 R,
f(x; y1) > f(x; y2) whenever y2 > y1.
The next two propositions explore the relationship between inhibition and tolerance.
First, another denition:
Denition 9. The graph of  is said to be bounded below by the graph of  if 2(s1) <
 2(s2), whenever 1(s1) =  1(s2) for some s1; s2 > 0, not necessarily equal. For brevity, we
say  is bounded below by .
Theorem 21. Assume (A1) and (A2) and that (4.1) exhibits tolerance for some
< (x0; y0); s >. If the graph of  is bounded below by the graph of , then there exists a
region of inhibition, R, and s1; s2 2 R+, such that  1(s1) = 1(s2) and  1(s1); 1(s2) 2 R:
Proof. Assume tolerance exists for some < (x0; y0); s >. Now, assume by way of contra-
diction that y does not inhibit x in any region, R, which contains points ( 1(s1);  2(s1))
and (1(s2); 2(s2)), where  1(s1) = 1(s2) and s1; s2 2 R+. Since tolerance exists for <
(x0; y0); s >, by Proposition 1, there exists t such that  1(t
) = 1(t
) and that  1(t^) < 1(t^)
for all t^ 2 (t; t + ) for some  > 0. Since the graph of  is bounded below by the graph
of , we have that at t,  2(t
) > 2(t
). Since  1(t
) = 1(t
), our assumption implies
that y does not inhibit x in any region R, containing the points  (t) and (t). Thus,
f( (t)) > f((t)). However, from Proposition 1, since  1(t
) = 1(t
) and  1(t^) < 1(t^)
for all t^ 2 (t; t+ ), it can be concluded that f( (t))  f((t)), which is a contradiction.
Hence, if the graph of  is bounded below by the graph of , then, in order for (4.1) to
exhibit tolerance for < (x0; y0); s >, it is necessary that there exists a region, R, of inhibition
and s1; s2 2 R+, such that  1(s1) = 1(s2) and  1(s1); 1(s2) 2 R:
Theorem 21 states that a region of inhibition is necessary, although not su¢ cient for
tolerance to occur when the competing trajectory,  (t), is bounded below by the original
trajectory, (t). However, for  bounded above by , inhibition can be a detriment to the
presence of tolerance. In this case, if y inhibits x in a region, R, where (t),  (t) 2 R, for
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all t  0, then, as the next theorem states, tolerance cannot be exhibited. First, we dene
what it means for  to be bounded above by :
Denition 10. The graph of  is said to be bounded above by the graph of  if 2(s1) >
 2(s2), whenever 1(s1) =  1(s2) for some s1; s2 > 0, not necessarily equal. For brevity, we
say  is bounded above by .
Theorem 22. Assume (A1) and (A2). Given < (x0; y0); s >, if the graph of  is bounded
above by the graph of , and y inhibits x in a region, R, such that (t),  (t) 2 R for all
t  0, then (4.1) cannot exhibit tolerance for < (x0; y0); s >.
Proof. Assume by way of contradiction that (4.1) exhibits tolerance for some < (x0; y0); s >.
Then, by Proposition 1, there exists t such that  1(t
) = 1(t
) and that  1(t^) < 1(t^)
for all t^ 2 (t; t + ) for some  > 0. Also, 2(t) >  2(t) since 1(t) =  1(t) and the
graph of  is bounded above by the graph of . Since y inhibits x in a region, R, where
(t),  (t) 2 R, for all t  0, we have that f((t)) < f( (t)). However, from Proposition
1, since  1(t
) = 1(t
) and  1(t^) < 1(t^) for all t^ 2 (t; t + ), it can be concluded that
f((t))  f( (t)), which is a contradiction. Hence, it must be the case that (4.1) cannot
exhibit tolerance for < (x0; y0); s >, if the graph of  is bounded above by the graph of 
and y inhibits x in a region, R, where (t),  (t) 2 R, for all t  0.
Furthermore, the contrapositive of Theorem 22 states that in order for tolerance to be a
possibility for a competing trajectory,  , that is bounded above by the original trajectory, ,
there must exist at least one pair, s1; s2 2 R+, such that  1(s1) = 1(s2) and  1(s1); 1(s2) =2
R, for any region of inhibition, R. An example of a linear system is given below, where it
will be seen that for  bounded above by , the absence of a region of inhibition containing
all of  (t) and (t) makes tolerance possible, although not guaranteed, for  . On the other
hand, for  bounded below by , it will be seen that the absence of a region of inhibition for
any s1; s2 2 R+ such that  1(s1) = 1(s2) eliminates the possibility of tolerance altogether
for such  .
In the examples that are presented here, the isoclines are used to quickly locate any
regions of inhibition. Then, Theorems 21 and 22 are used identify a subset of points from
the (~x0; ~y0)-curve which might produce tolerance. Example 8 will show that this set is larger
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than the actual set of (~x0; ~y0) points that do produce tolerance; however, the previous results
of Section 4.4 can also be employed to hone in closer to the actual set of (~x0; ~y0) points that
do produce tolerance. Now, we give the example of a linear system of the type shown in
Figure 32:
Example 8. Consider the linear system
_x = f(x; y) =  x+ y
_y = g(x; y) = :3x  y
9=; (4.28)
The isoclines for this system are the family of curves given by  x+y = C , C 2 R, which
are simply the lines y = x + C parameterized by C 2 R, having slope 1 and y-intercept,
C. In Figure 48, the isoclines are drawn for various values of C 2 [ 2:4; 0:0], in increments
of 0:1. Of course, since the isoclines are a continuous family of curves, they ll the entire
space; however, viewing it as such is not particularly helpful. Note that as C ranges from
 2:4 up to 0, the speed of the isoclines in the x-direction decreases monotonically going from
right to left, toward the origin. Now we explain the features in Figure 49:
 (t) is the curve shown in solid black for initial condition (0) = (x0; y0) = (1; 0:25).
 The orange curve, denoted as ^, is the curve of points obtained by essentially integrating
(t) in backward time from t = 0 to t   0:9, at which time it intersects the x-axis at
x^  2:19. In other words:
^  f( t)jt 2 (0:0; 0:9) and ( 0:9) = (2:19; 0:0)g :
 The blue dotted curve denotes the (~x0; ~y0)-curve. Formally, dene this set of points as
P  f(~x0; ~y0)j(~x0; ~y0) = (s) + (x0; 0); s  0g.
 Let R1 be the region shown in light green which is bounded inclusively by the black
vertical line, y = x0, the orange curve, ^, and the x-axis. Note that every point (~x0; ~y0)
will lie to the right of the line y = x0, by the denition of ~x0.
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Figure 48: The isoclines for the linear system given in Example 8. The isoclines shown are for values
of C 2 ( 2:4; 0:0) in increments of 0:1. The red isocline is the x-nullcline for C = 0 and the green isocline
is for the C-value of  2:4. Moving from one isocline through another from right to left, the speeds of the
isoclines decrease in the x-direction. (i.e. the speed becomes less negative and closer to zero). Isoclines for
C > 0 are not shown here since they do not need to be considered for this example.
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 Dene the set ST1 6= ; to be the intersection of the (~x0; ~y0)-curve with the complement
of R1 in the rst quadrant :
ST1 
 
R2+nR1
 \ P
 Dene the set ST2 6= ; to be the intersection of the light green region, R1, and the
(~x0; ~y0)-curve:
ST2  R1\P
Remark 8. The slow/weak eigenvector of this system is v = [1:0 :548], which can be viewed
as the line passing through the origin, (0; 0), and the point, (1:0; :548): y = 0:548x. The
nullcline, y = x has a steeper slope than that of the line representing v. Hence, solutions
that originate below v will approach (0; 0) along v and not cross the nullcline (red isocline
in Figure 49). This means that the isoclines for C  0 do not need to be considered in the
example.
Consider the isoclines for C 2 [ 2:4; 0:0). Also, assume 0  x1 < 2:4, which encompasses
the x-intercepts of the isoclines under consideration, since x =  C when y = 0. Thus, given
x1 2 (0:0; 2:4) and any two isoclines dened for C1; C2 2 [ 2:4; 0:0), whenever C1 < C2 < 0
(i.e. whenever C1 is more negative than C2) we have that
y1  x1 + C1
< x1 + C2
 y2.
In other words, for any x1 2 (0:0; 2:4), whenever y1 < y2, then,
f(x1; y1) < f(x1; y2).
Hence, for any subset of the rst quadrant, containing the trajectories of (t) and  (t),
there exist no regions of inhibition. (See Denition 8.) The sets ST1 and ST2 are formed
so that for (~x0; ~y0) 2 ST1,  will be bounded below by , and for (~x0; ~y0) 2 ST2 ,  will
be bounded above by . The the graph of ^, in orange, creates a natural boundary (by
uniqueness of solutions) with which to divide the (~x0; ~y0)-curve.
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Figure 49: Two regions in which the points in the (~x0; ~y0)-curve lie for Example 8. The points on the
(~x0; ~y0)-curve fall into one of two regions dened by (1) the light green area (including its borders) and (2)
the complement of this area with respect to R2+.
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Case 1: Let (~x0; ~y0) 2 ST1. Then,  will be bounded below by . Thus, by Theorem 21,
since there are no regions of inhibition present for  (t) and (t), any (~x0; ~y0) 2 ST1 cannot
produce tolerance.
Case 2: Let (~x0; ~y0) 2 ST2. Then,  will be bounded above by . Thus, by the
contrapositive of Theorem 22, since there are no regions of inhibition present for  (t) and
(t), (~x0; ~y0) might produce tolerance, although tolerance is not guaranteed. Furthermore,
consider the (~x0; ~y0) point that lies on the orange curve, where the (~x0; ~y0)-curve intersects
^. For this (~x0; ~y0),  (t) and (t) are subsets of the same larger solution curve in the vector
eld of 4.28, and, in this particular example, both 1(t) and  1(t)! (0; 0) monotonically as
t!1. By Proposition 7, this particular (~x0; ~y0) will not produce tolerance. In addition, by
continuity, there exists an open ball, B, around (~x0; ~y0), such that (~xb; ~yb) will not produce
tolerance for all (~xb; ~yb) 2 B. Thus, the set of points which might produce tolerance is a
subset of ST2. As a result, the range of (~x0; ~y0) points that will possibly produce tolerance
has been further narrowed.
Since this is an example of a linear system, the methods from Section 4.5 can be used to
precisely pinpoint the set of (~x0; ~y0) points which are guaranteed to produce tolerance. In
Figure 50, the regions I  IV, dening the relationship between the coe¢ cients of the analytic
solution of (t) and  (t), are shown. According to the results of Section 4.5, tolerance
is produced by those (~x0; ~y0) points in region IV, where the only inclusive boundary is the
x-axis. (See the case for Region 2a in Section 4.5.5 for more information.)
In Figure 51, the lines that form the regions I  IV are overlaid on the content shown in
Figure 49. It can be seen in Figure 51 that there is a collection of (~x0; ~y0) points which are
elements of ST2, but which are not elements of Region IV. Hence, this technique of using
inhibition and isoclines to detect tolerance does not sharply dene the subset of points on
the (~x0; ~y0)-curve which do produce tolerance. However, for this example, the estimation is
not grossly far o¤ from the actual set of points (~x0; ~y0) that do produce tolerance.
Now, we look at examples of specic 2D nonlinear ODE systems and apply this approach
to determine when the possibility of tolerance exists.
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Figure 50: Regions I  IV dening the relationship between the coe¢ cients of the analytic solution of
(t) and  (t) for Example 8. According to the results of Section 4.5, tolerance is produced by those (~x0; ~y0)
points in region IV, where the only inclusive boundary is the x-axis.
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Figure 51: The lines that form the regions I  IV are overlaid on the content shown in Figure 49.
Specically, for the (~x0; ~y0) points in region IV (dark green area), tolerance will be produced. In addition
to these points, the inhibition and isocline method also included the (~x0; ~y0) points in the light green region
as possible points that produce tolerance, but which do not.
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Example 9. Consider the nonlinear system:
_x = f(x; y) = (:5x  y)

0:1x
1+y
  1

_y = g(x; y) = 0:4x  y.
9=; . (4.29)
The isoclines for this system are the family of curves given by the equations:
y1 =
3
10
x  1
2
+
1
2
C +
1
10
p
4x2 + 20x+ 30xC + 25 + 50C + 25C2 and (4.30)
y2 =
3
10
x  1
2
+
1
2
C   1
10
p
4x2 + 20x+ 30xC + 25 + 50C + 25C2, (4.31)
where C 2 R. In Figure 52, the isoclines are drawn for various values of C1 2 [ 1:5; 0:0],
in increments of 0:05. For C 2 R, the two curves dened by equations 4.30-4.31 form a
continuous parabola-like curve and the apparent discontinuity is simply due to numerical
issues when graphing. However, it does nicely draw attention to the fact that the portion of
the rst quadrant containing the top curves of the parabolas given by equation 4.30 between
the x-nullcline and the C =  1:5 isocline is not a region of inhibition. However, the portion
of the rst quadrant containing the bottom curves of the parabolas given by equation 4.31
between the x-nullcline and the C =  1:5 isocline is a region of inhibition.
Note that as C ranges from  1:5 up to 0, for the curves dened by equation 4.30, the
speed of the isoclines in the x-direction decreases monotonically going from right to left,
toward the origin. The value of (x0; y0) that we will be considering in this example will
be such that (t) and  (t) will only pass through these isoclines and not the other ones
generated by equation 4.31. Figure 53 shows a specic solution, (t), that will be considered
for this example and also only shows the portions of the isoclines that are of relevance here.
As was done with Example 8, the following features are also a part of Figure 53:
 (t) is the curve shown in solid black for initial condition (0) = (x0; y0) = (2; 0:5).
 The orange curve, denoted as ^, is the curve of points obtained by essentially integrating
(t) in backward time from t = 0 to t   0:85, at which time it intersects the x-axis at
x^  2:5. In other words:
^  f( t)jt 2 (0:0; 0:85) and ( 0:85) = (2:5; 0:0)g :
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Figure 52: Isoclines for Example 9, drawn for various values of C1 2 ( 1:5; 0:0), in increments of 0:05.
 The blue dotted curve denotes the (~x0; ~y0)-curve. Formally, dene this set of points as
P  f(~x0; ~y0)j(~x0; ~y0) = (s) + (x0; 0); s  0g
 Let R1 be the region shown in light green which is bounded inclusively by the black
vertical line y = x0, the orange curve, ^, and the x-axis. Note that every point (~x0; ~y0)
will lie to the right of the line y = x0, by the denition of ~x0.
 Dene the set ST1 6= ; to be the intersection of the (~x0; ~y0)-curve with the complement
of R1 in the rst quadrant:
ST1 
 
R2+nR1
 \ P .
 Dene the set ST2 6= ; to be the intersection of the light green region and the (~x0; ~y0)-
curve:
ST2  R1\P .
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Figure 53: Two regions in which the points in the (~x0; ~y0)-curve lie for Example 9. The points on the
(~x0; ~y0)-curve fall into one of two regions dened by (1) the light green area and (2) the complement of this
area with respect to R2+. The light green area is inclusive of the orange curve, the x-axis, and the line
y = x0.
Remark 9. In this example, because (1) (t),  (t) ! (0; 0) as t ! 1 and (2) _x > 0 in
the region of the rst quadrant bounded by the y-axis and the C = 0 isocline (x-nullcline),
neither (t) nor  (t) cross the x-nullcline. Thus, the isoclines for C  0 do not need to be
considered in the example.
Consider the isoclines for C 2 [ 1:5; 0:0). Also, assume 0  x1 < 3:5, which more than
encompasses the x-intercepts of the isoclines under consideration. The orientation of the
isoclines are very similar to that of the linear Example 8 in that for any subset of the rst
quadrant, containing the trajectories of (t) and  (t), there exist no regions of inhibition.
(See Denition 8.) The sets ST1 and ST2 are formed so that for (~x0; ~y0) 2 ST1 ,  will be
bounded below by  and for (~x0; ~y0) 2 ST2,  will be bounded above by . The the graph of
^, in orange, creates a natural boundary (by uniqueness of solutions) with which to divide
the (~x0; ~y0)-curve.
Case 1: Let (~x0; ~y0) 2 ST1. Then,  will be bounded below by . Thus, by Theorem 21,
since there are no regions of inhibition present for  (t) and (t), any (~x0; ~y0) 2 ST1 cannot
produce tolerance.
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Case 2: Let (~x0; ~y0) 2 ST2. Then,  will be bounded above by . Thus, by the
contrapositive of Theorem 22, since there are no regions of inhibition present for  (t) and
(t), (~x0; ~y0) might produce tolerance, although tolerance is not guaranteed. Furthermore,
consider the (~x0; ~y0) point that lies on orange curve, where the (~x0; ~y0)-curve intersects ^. For
this (~x0; ~y0),  (t) and (t) are subsets of the same larger solution curve of the vector eld 4.28,
and, in this particular example, both 1(t) and  1(t)! (0; 0) monotonically as t!1. By
Proposition 7, this particular (~x0; ~y0) will not produce tolerance. In addition, by continuity,
there exists an open ball, B, around (~x0; ~y0), such that (~xb; ~yb) will not produce tolerance for
all (~xb; ~yb) 2 B. Thus, there exists an S  ST2, the points of which might produce tolerance.
As a result, the range of (~x0; ~y0) points that will possibly produce tolerance has been further
narrowed.
Although the methods from Section 4.5 cannot be applied to this nonlinear system, we
can conrm our results by implementing a numerical approach discussed in the next section.
An algorithm was generated to numerically nd when tolerance occurs for a given (x0; y0).
Figure 54 shows the results of the numerical ndings, with 1(t) denoted by the red curve
and  1(t) for various ~x0 are denoted by the blue curves. The time  at which a blue  1-curve
falls below the red 1-curve indicates that tolerance has occurred:  1() < 1().
Note that all the ~x0-values are all within the range ~x0 2 [2; 2:5) (See panel 3 of Figure
54), which correspond to points (~x0; ~y0) that are members of the set ST2, in which tolerance
was a possibility. The rst panel of Figure 54 shows a denser set of curves of  1(t) for
(~x0; ~y0) points that are closer together. The second panel of this gure shows less curves of
 1(t) for (~x0; ~y0) points spread further apart.
Example 10. Using the system just given by 4.29 in Example 9, consider the initial condition
for (t): (x0; y0) = (2; 0). Figure 55, illustrates this example. There are two cases to
consider:
Case 1: (~x0; ~y0) lies on an isocline dened by equation 4.30, which denes the top
portions of the parabolas, for C 2 [ 1:5; 0]. In this case, both the graphs of  and  
will be completely contained in this region of the rst quadrant where the top portions of
the parabolas lie. As mentioned in the previous example, this is not a region of inhibition.
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Figure 54: Numerical evidence of tolerance in Example 9. The red curve in all the panels is the time
course of 1(t) for (x0; y0) = (2:0; 0:5). First Panel: a dense set of curves (blue) of the time course of  1(t)
for various (~x0; ~y0) points that are close together. Second Panel: a few curves (blue) of the time course
of  1(t) for (~x0; ~y0) points that are spread further apart. Third Panel: A closeup of the ~x0-values for the
various time courses of  1(t) for (~x0; ~y0) points that are spread further apart. It can be seen that these
(blue) time course where tolerance is evident have values of ~x0 2 [2; 2:5), corresponding to (~x0; ~y0) points in
the set of points (ST2) for which tolerance is possible.
Furthermore, in this case  (t) is bounded below by . Thus, by Theorem 21, (~x0; ~y0) cannot
produce tolerance. Now for Case 2:
Case 2: (~x0; ~y0) lies on an isocline dened by equation 4.31, which denes the bottom
portions of the parabolas, for C 2 [ 1:5; 0].
This case is quite subtle for this example, but if (x0; y0) was further to the right on the
x-axis, this becomes more of an issue. Nevertheless, however slight the occurrence, it still
needs to be considered. In this case, (~x0; ~y0) does lie in a region of inhibition and portions
of  also are contained in this region. However, no portion of the region contains , much
less both  and . Thus, from Theorem 21, if these (~x0; ~y0) points produced tolerance than
there would exist a region, R, of inhibition and s1; s2 2 R+, such that  1(s1) = 1(s2) and
 1(s1); 1(s2) 2 R: However, such a region does not exist for this example. Thus, these
(~x0; ~y0) points do not produce tolerance.
The algorithm used in the previous example was used here as well, and numerical calcu-
lations conrmed that tolerance was not exhibited in this system for (x0; y0) = (2; 0).
The previous examples had similar isocline structures, with respect to the direction in
which the speed of the isoclines increased/decreased. This nal example looks at a system
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Figure 55: Important features of Example 10.
with a di¤erent isocline conguration.
Example 11. Consider the system given by
_x = f(x; y) = x
2
1+y
  x
_y = g(x; y) = x2   0:5y
9=; . (4.32)
The isoclines for this system are the family of curves given by the equation:
y =
x2   x  C
x+ C
(4.33)
for C 2 R. Figure 56 shows the isoclines for C 2 [ 6:0; 0] and denotes the change in speed
from the C = 0 isocline (nullcline) to the C =  6:0 isocline. The isoclines for C > 0 are
not drawn or considered here, since, in this region, the ow in the x-direction of the vector
eld is in the positive direction, and inhibition is dened for points at which the ow in the
x-direction is negative. Note that for each C 2 [ 6:0; 0), the C =  x isocline is undened
at x =  C; however the asymptote is not drawn, and the other portion of the isocline which
is on the other side of the asymptote below the positive x-axis is also not drawn. Note that
if a trajectory is passing through a point with an x-value of  C where the C =  x isocline
is approaching innity, it does not mean that the speed of the trajectory at that point is
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Figure 56: Isoclines for Example 11, drawn for various values of C 2 ( 6:0; 0:0).
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innite. Instead, at that particular x-value, the trajectory is simply on a di¤erent isocline
that is dened for x =  C.
Also note, that the sign of the slope of the isoclines in the limit as x!  C is
sign

lim
x! C
d
dx

x2   x  C
x+ C

= sign

2x  1
x+ C
  x
2   x  C
(x+ C)2

=   (sign(C))2
which is negative for all C. Dene RI to be the region bounded by (1) the x-nullcline,
y = x 1, (2) the C =  6:0 isocline, y = x2 x+6
x 6 , (3) the positive x-axis, and (4) the positive
y-axis. Then, for x1 > 0 and y1; y2 2 RI , if y2 > y1, then
f(x1; y2) < f(x1; y1):
Hence, RI is a region of inhibition. Now consider the initial condition (x0; y0) = (4:0; 3:0)
of (t). Figure 57 displays the following features:
 (t) is the curve shown in solid black for initial condition (0) = (x0; y0) = (4:0; 3:0).
 The orange curve, denoted as ^, is the curve of points obtained by essentially integrating
(t) in backward time from t = 0 to t   1:0, at which time it intersects the x-axis at
x^  3:4. In other words:
^  f( t)jt 2 (0:0; 1:0) and ( 1:0) = (3:4; 0:0)g :
 The blue dotted curve denotes the (~x0; ~y0)-curve. Formally, dene this set of points as
P  f(~x0; ~y0)j(~x0; ~y0) = (s) + (x0; 0); s  0g
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Figure 57: Isoclines and (~x0; ~y0) points for Example 11.
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For this example, the curve ^(t) (orange curve in Figure 57) shows that for every (~x0; ~y0) 2
P , the corresponding graph of  will eventually be bounded below by the graph of  since
(1)  will not be allowed to cross the trajectory dened as ^[  and (2) ;  ! (0; 0). Thus,
for all the (~x0; ~y0) 2 P not in region RI ,  (t) must enter this region eventually. To reiterate,
the graph  will be bounded below by the graph of  when  1() = 1(0) = max(1) for
some  > 0.
Now consider the various  trajectories shown in Figure 58 for various values of (~x0; ~y0).
For each  , there exists a  > 0, after which the graph of  is bounded below by the graph
of . All of the  trajectories enter the region RI and   RI . Hence, after  > 0, there
exists a region R  RI and s1; s2 2 R+ (not necessarily equal), such that  1(s1) = 1(s2)
and  1(s1); 1(s2) 2 R: Hence, by Theorem 21, it is possible that tolerance can be exhibited
by any (~x0; ~y0) 2 P , although not guaranteed since the existence of this inhibition region is
only a necessary condition for the existence of tolerance.
Running the numerical tolerance algorithm on this example for initial condition (x0; y0) =
(4:0; 3:0), we see that tolerance does exist. However, the reduction noted is quite small when
it does occur. Figure 59 shows results from the numerical simulations. The left panel gives
the time courses for 1(t) (red curve) and  1(t) for the various (~x0; ~y0) points (blue curves)
which produce tolerance. Note the ~x0-values for these points, given on the "y-" axis of
Figure 59. Then, look at where the corresponding (~x0; ~y0) points are in Figure 58. The
right panel gives a close up of the portion of the left panel, showing that the time courses
for the various blue  1-curves do indeed fall below the red 1-curve, thereby conrming the
existence of tolerance.
The next section discusses two numerical approaches for nding tolerance, one of which
was used above in conrming the existence (or lack thereof) tolerance.
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Figure 58: The isoclines and various examples of trajectories,  (t), originating from the (~x0; ~y0)-curve
of system 4.32 of Example 11 for (x0; y0) = (4:0; 3:0).
Figure 59: Numerical results from the application of the tolerance algorithm to Example 11. Left Panel:
Time courses for 1(t) (red curve) and  1(t) for the various (~x0; ~y0) points which produce tolerance. Right
Panel: A close up of the portion of the left panel, showing that the time courses shown for the various blue
 1-curves do indeed fall below the red 1-curve, thereby implying the existence of tolerance.
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4.6.2 Numerical Approaches for Finding Tolerance
The primary di¢ culty in determining the presence of tolerance in a given ODE system is
that closed form solutions of the system are usually not available and hence, the ability
to determine the amount of time that it takes for a trajectory to traverse from its initial
condition to another point on its path cannot be calculated explicitly. In this section we
discuss the numerical algorithm for nding tolerance in a given system for a specied initial
condition or a set of initial conditions. Also discussed is a method that uses isoclines to
determine tolerance. This method directly deals with estimating the time it takes for a
trajectory to reach a certain point, starting from a given initial condition.
4.6.2.1 Tolerance Algorithm A purely numerical approach to identifying the existence
of tolerance in a given dynamical system has been to create an algorithm that tests the
system for tolerance, given several input parameters. The algorithm is not restricted to two
dimensional systems, so for now this is the only method for nding tolerance in systems of
dimension greater than two. This algorithm was written as an m-le in MatLab. [72] First,
the input that the algorithm requires is explained.
INPUT
 ODEfile: MatLab m-le giving the ODE system (2-d, 3-d, . . . , n-d) with equations
ordered so that the tolerance variable is rst
 X0: Matrix whose rows contain the various initial condition vectors, x0, for an original
trajectory
 HitIndex: Column index (for all the x0) in the X0matrix to which the hit is administered
(note: could be di¤erent from the Tolerance Variable.)
 HitSize: size of hit; default value is the value of the variable found in the HitIndexth
entry of the row currently being considered in the X0 matrix.
 TolVarIndex: Column index (for all the x0) in the X0 matrix for which tolerance is being
checked. This is the "Tolerance Variable."
 MinTolPercent: minimum amount of reduction accepted (in percentage form)
 tstop: Duration of integration
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 s: vector of time points at which the hit is given; This also serves as the sequence of
times at which solutions are compared.
 JStepSize: step size used to divide up the interval [0 tstop] to create the vector, s
There are a number of practical issues to consider with respect to the presence of tol-
erance. Since the curve of (~x0; ~y0) points is a continuous curve parameterized by s > 0,
numerically, it is impossible to test every (~x0; ~y0) to see if tolerance is produced. However, it
is important to try a sampling of s-values that range from s = 0 to a later time point corre-
sponding to (s)  (0; 0) . Thus, a step size, JStepSize, is specied to divide this interval
of times, denoted [0 tstop], into a discrete set of points, where tolerance can be checked.
This is su¢ cient to ensure that the entire (~x0; ~y0)-curve is represented well enough.
Another practical issue has to do with the degree of tolerance that is exhibited. Recall
in Chapter 2, when we noted that in some of the endotoxin tolerance simulations, there
was a percentage decrease in the pro-inammatory mediator, sometimes 40% or 70% of the
original amount at a particular time point. Again, because of continuity, the amount of
tolerance that is exhibited can be arbitrarily small. Hence, in order to numerically address
this, the minimum percentage amount of reduction accepted must be specied. This is done
by specifying a value for the variable, MinTolPercent. For Example 11 in the last section,
the MinTolPercent was set to 1% and for each of the blue curves shown, all had a maximum
reduction of less than 2%. Hence, if the MinTolPercent was given, for example, a value of
2, then the algorithm would have returned:
"There was no reduction with a percentage greater than the minimum tolerance percent."
The algorithm is set up to consider a number of options beyond what was presented in
this chapter. For example, recall that (~x0; ~y0) is a shifting of the point (s), s > 0, by
the amount x0. This was assumed to be the case throughout every section. However, it
might be the case that the hit sizes are di¤erent as they were in the endotoxin tolerance
experiments of Chapter 2. Thus, the algorithm allows for the separate specication of the
variable in which tolerance is being checked and the variable to which the extra "hit" amount
is given.
A host of data can be returned by the algorithm. Note that the equation for the
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variable in which tolerance is being checked is always the rst equation in the ODE le.
This simplies the discussion and makes the code simpler. As it stands now, the following
information is returned in a table format, if and when the algorithm nds tolerance:
 Row number for the initial condition in X0 for which tolerance occured. Since X0
is a matrix, the rows of which contain various initial condition vectors (e.g. (x0; y0))
from which to check for tolerance, it is important to know to which initial condition the
presence of tolerance refers.
 Jump Time. Recall that s was dened to be the "jump time" the time for which an
(~x0; ~y0) is dened.
 Time when maximum degree of tolerance occurred. i.e. the time  at which  1() 
1() was greatest.
 First time when tolerance occurred. Again, because numerically it is virtually impossible
to nd the "rst" time,  , for which  1(t) < 1(t), this is an estimate.
 Value of 1(t) at the time when the maximum degree of tolerance occurred.
 Value of  1(t) at the time when the maximum degree of tolerance occurred.
 The amount (as a percentage) of the maximum degree of tolerance between 1(t) and
 1(t).
 Graph of time courses of 1(t) and corresponding  1(t), for every initial condition given
in X0 matrix (This is all put in one gure, which can get cumbersome, but the graphing
feature was intended for displaying the results from running the algorithm on one initial
condition. The table format displaying output is better suited for a multiple initial
condition run.)
In order to make sure that the presence of tolerance is not being missed, it is important
to carefully consider the amount of integration time, since this essentially determines which
(~x0; ~y0) points are checked. As s!1, (s)! (0; 0) and (~x0; ~y0)! (0). However, if the
integration time is too short, then, for the last specied s value, (s) many not yet be close
enough to (0; 0) and (~x0; ~y0)  (0) may not be included in the points under consideration.
In addition, a reasonable array of s values should be considered, i.e. JStepSize should not
be too big. However, if tolerance is produced by many (~x0; ~y0) points, then JStepSize
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can be reduced so that more of the individual time courses  1(t) can be seen on the graph
that is generated. As a good example to compare results, Figure 60 shows the results of
running the algorithm on the linear system 4.28 given in Example 8 for the initial condition
(x0; y0) = (1; 0:25).
4.6.2.2 Isoclines Another approach deals with using isoclines to estimate the time it
takes for a trajectory to get from point A to point B. We pose this problem for the 2D
system (4.1). The main idea of this approach is to use isoclines to estimate the speed of
a trajectory in a certain direction (or variable) and then use the estimate to determine the
amount of time it takes for the trajectory to reach a certain value in the variable. Since the
speed of a trajectory is time dependent we will look for upper bounds and/or lower bounds
on speed in a particular direction. For simplicity, assume the direction we are interested in
is the rst component of the system and call it the tolerance variable.
We compare the speed estimates for two trajectories, one which we call the original
trajectory since all other trajectories will be compared to it, and the other trajectory we call
the competing trajectory, which comes from a family of trajectories dened from the original
trajectory. We include this approach under numerical approaches since many times isoclines
are too di¢ cult to analyze analytically and one must numerically graph the isoclines and
trajectories to estimate the supremum and inmum that are needed below. In addition, we
restrict this to a two dimensional case, since isoclines become isoplanes in dimensions greater
than two, and beyond the third dimension, this approach breaks down completely.
As done in previous work, consider two trajectories: (t)  (x0; y0)  t for some (x0; y0)
and for t  0, which we label as the original trajectory, and  (t)  (~x0; ~y0)  t, where
(~x0; ~y0)  (s0)+(x0; 0), for some s0  0 and where t  0, which is the competing trajectory.
Note that by taking di¤erent values of s0, we form a family of competing trajectories. Let
xf be a given x-value. Also, we will assume that  and  remain in the rst quadrant for
all time and that as t!1, both approach (0; 0). We wish to estimate the time it takes for
1(t) and  1(t) to travel from x0 and ~x0, respectively, to xf and then determine conditions
under which  1(t) will arrive at xf before 1(t). Assume that xf < x0 < ~x0.
Consider the family of isoclines f(x; y) = C, where C 2 R. Each C-value represents the
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Figure 60: Numerical results showing the presence of tolerance for a host of di¤erent (~x0; ~y0) points for
the system 4.28 given in Example 8 compared to the other methods for pinpointing tolerance. The initial
condition for (t) is (x0; y0) = (1; 0:25). Left Panel: The red curve is the time course for 1(t). The various
blue time courses of  1(t) for di¤erent (~x0; ~y0) points. The ~x0-value associated with each of the (~x0; ~y0)
points can be clearly seen. Right Panel: This gure is reproduced from Example 8, showing both the
results from the linear methods from section 4.5.5 and the isocline method from Section 4.6.1. Compare the
~x0-values for the  1(t) curves on the left to the ~x0-values of the (~x0; ~y0) points that fall in the dark green
region shown on the right panel.
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speed of _x along each isocline f(x; y) = C. Let c = inft2[0;t)f _x(1(t); 2(t))g, where [0; t)
is such that 1(0) = x0 and 1(t) = xf , so that t is dened to be the time it takes for
1(t) to go from x0 to xf . Also, let c = supt2[0;t )f _x( 1(t);  2(t))g, where [0; t ) is such
that  1(0) = ~x0 and  1(t ) = xf , so that t is the time it takes for  1(t) to go from ~x0 to
xf . Assume c < 0 and c < 0 which makes c the smallest or most negative isocline that
the trajectory (t) passes through. Likewise, c is the largest or least negative isocline that
the trajectory  (t) passes through. Let
d  1(0)  1(t)
and
d   1(0)   1(t )
If C and C are the actual speeds (both dependent on time) of (t) and  (t), respec-
tively, then we know that
d = jC(t)jt
and
d = jC (t)jt 
since distance is the product of speed and time. Using this along with jcj and jc j, we
have the following inequalities:
d  jcjt
and
d  jc jt 
Thus, if
(t ) djvj
>
d 
jc j( t ) then t < t
and this implies tolerance. Although this condition is su¢ cient for tolerance, it is also quite
restrictive because it underestimates t and overestimates t. In addition, the method is
tedious in practice since a separate estimate for each competing trajectory would have to be
calculated. Also, since we assumed that c < 0 and c < 0 then _x < 0 at x0 and ~x0 and all
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along the respective trajectories. The case where _x > 0 at x0 can be approached in a similar
way by estimating the speed of the original trajectory after it intersects the _x nullcline and
_x < 0 ensues. This again will overestimate t, even more so than the other case.
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5.0 USING NONLINEAR MODEL PREDICTIVE CONTROL TO FIND
OPTIMAL THERAPY STRATEGIES TO MODULATE INFLAMMATION
5.1 INTRODUCTION
Controlling inammation has become a key focal point in the treatment of critically ill
patients. Much of the theoretical work regarding this has been with the objective to unravel
the inner workings of systemic inammation and understand how the mediators interact with
one another with respect to their di¤erent time scales. [20, 112, 65] Signicant insight has
been acquired from these approaches and implications have been made regarding types of
treatment that may be e¤ective against persistent inammation. A main result coming from
this research conrms that the timing of events, such as the production and decay of both
pro- and anti-inammatory mediators, is critical to nding and implementing appropriate
therapies [28, 98].
When the issue of controlling inammation was initially pursued, the approach was to
target a sole inammatory mediator. It is now known, however, that there is no one mediator
which stands as the source for persistent inammation [13, 71, 15]. Instead, a cascade of
inammation occurs, which is, perhaps, started by a few key mediators but persists as a
result of a complicated feedback process involving mediators that are produced later than
the initial inammatory instigator. In addition, anti-inammatory mediators may be present
in elevated levels during prolonged inammation, but their e¤ect on the pro-inammatory
mediators may be small or negligible due to the relative amounts of inammation present in
the system.
There is still much to be done in the area of identifying proper biological targets in order
to develop therapies to combat excessive and pervasive inammation. However, equally
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necessary is determining a strategy for delivering therapies, in the correct amount, at the right
time. One of the tools that can help determine this complex dose regimen is Nonlinear Model
Predictive Control (NMPC). This area of research has mainly been applied to industrial
operations involving industrial systems that can be well described with a mathematical
model, usually a system of ordinary di¤erential equations.
The advantage of this procedure over other control algorithms is its ability to (1) pre-
dict the real system state at a future time, using a mathematical model, (2) receive actual
feedback from the system and (3) use both the prediction of the model and the feedback
from the system to suggest a control move that will help to optimize the desired outcome
for a specic plant variable (e.g. minimize temperature). In section 5.2, a more detailed
description of this approach is given. More recently, MPC has been used in biological appli-
cations involving the regulation of glucose supply in diabetic patients and in the exploration
of optimal dosing of Tamoxon for treating breast cancer [38, 89].
The application of NMPC discussed here, in the context of the inammatory response,
stretches the capability of this tool further than previous applications. The model that
we consider is a highly nonlinear system, which cannot be approximated well by any linear
system1, nor can the various rate coe¢ cients be identied as easily from existing data. It
is also a model that is not as robust as those available for predicting the e¤ect of insulin on
glucose levels or the dynamics of tumor growth. In other words, because the inammatory
response is a very complex process involving positive and negative feedback, it is extremely
di¢ cult to predict the response of the various mediators to perturbations (i.e. to therapy)
made to one or more of the variables.
In this current exploration of NMPC, we chose to use a small (four equation) ordinary
di¤erential equations (ODE) model, the dynamics of which have been thoroughly explored in
[98]. There are two essential entities in an NMPC scheme: the process to be predicted and
the model predicting the process. The current exposition is completely simulation based,
meaning that it is necessary for the actual process, i.e. a patients immune response, to be
emulated by a model. Thus, the ODE model that we use will serve the dual purpose of not
1Many NMPC applications transform the nonlinear model describing a process into a linear model that
approximates the dynamics, symplifying the model complexity to optimize controller performance.
198
only predicting patient data but generating the patient data as well. Hence, there are two
copies of the model equations.
Initially, it is assumed that the predictive model and the patient (model) are identical
with respect to equations, parameter values, and initial conditions. This is referred to as
the absence of patient-model mismatch. Later patient-model mismatch will be introduced in
some of the parameter values and initial conditions. The model we use is not sophisticated
enough to predict quantitative data in actual patients; however, there is currently much
work being done in this area, regarding the generation of models that predict quantitative
measurements of specic inammatory mediators, such as Tumor Necrosis Factor (TNF)
and Interleukin-6 (IL-6), or anti-inammatory cytokines, like Interleukin-10 (IL-10) and
Transforming Growth Factor- (TGF-), among others. The extension of NMPC to such a
model holds promise for suggesting optimal therapies and dosing proles in actual patients.
The process of getting from the initial results to the current results was a rather involved
one, including many di¤erent paths which cannot all be explained here. However, it is
instructive to see a portion of the di¤erent strategies that were implemented along the way
and the corresponding results and explanations for the modications that were made from
one change to the next. Indeed, the process will still continue as the method is rened and
becomes better understood in the context of this problem. While this chapter is only based
on in silico simulation studies, it is an ambitious and enthusiastic e¤ort toward bringing
model-based immunomodulation strategies closer to the bedside of the critically ill.
5.2 METHODS
Nonlinear Model Predictive Control is a methodology for creating a class of control algo-
rithms which encompasses several principles. These principles include the use of a model
that describes a certain process to make predictions about future process behavior, in order
for recommendations to be made regarding a corrective action to direct the predicted per-
formance closer toward a preferred outcome [86]. As such, schemes of this nature are ideal
for industrial processes that can typically be well described by a set of equations. In fact,
NMPC has been used on industrial applications since the 1970s.
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Recently, NMPC has also been used in the somewhat less concrete area of medicine, where
it is more di¢ cult to develop accurate models that describe biological processes. The use of
an underlying model for prediction is the key feature that makes the use of this class of control
schemes so appealing. In addition, because the algorithm takes into account the di¤erences
that are expected to exist between the model and the actual process, the underlying model
may not need to make perfect predictions. However, the question How accurate does the
core model need to be? remains open. In this chapter, we explore this question in the
setting of therapy administration in a reduced model of the acute inammatory response to
pathogen. It will be shown that when mismatch between the model and the patient exist,
mechanisms need to be put into place in order to maintain the predictive accuracy of the
underlying model.
In every NMPC algorithm, there are essential elements that must exist [86]. Below,
we outline and describe them, using examples from our NMPC setup and the ordinary
di¤erential equation model [98] given below by equations 5.1-5.4.
dP
dt
= kpgP (1  P
p1
)  kpmsmP
m + kmpP
  kpnf(NA)P; (5.1)
dN
dt
=
snrR
knr +R
  nN; (5.2)
dD
dt
= kdn
f(N)6
x6dn + f(N
)6
  dD; (5.3)
dCA
dt
= sc + kcn
f(N + kcndD)
1 + f(N + kcndD)
  cCA (5.4)
where
R =
(knpP + kndD + knnN
)
1 + (CA=c1)2
;
f(x) =
x
1 + (CA=c1)2
;
I. The Specication of a Reference Trajectory
The reference trajectory denes the target level that we would like our process output
variables to eventually achieve. For instance, in our model, we would like damage to
eventually decrease back down to zero, if it is currently at an elevated state. So, our
reference trajectory for damage might be the constant function, RD(t) = 0, or it might be
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a function gradually decreasing to the target value, perhaps even in a step-wise fashion.
The reference trajectory can be thought of as the outcome goal that is desired. It is used
in the objective function to dene what is to be optimized, or more specically, in our
case, what is to be minimized.
II. The Prediction of Process Output
Prediction of process behavior (i.e. patient data) is accomplished via the underlying
model. In our case, this is a reduced ordinary di¤erential equation model, given by
5.1-5.4, describing the process of the acute inammatory response to pathogen.
III. The Denition of an Objective Function
The objective function denes the goals to be achieved by an optimizer routine, which is
an algorithm for locating the values at which the objective function reaches a minimum
(or maximum) given constraints on the function variables. (See IV below.) The objective
function(s) used in this chapter have the typical two norm squared form, kk22 [78]. In
addition, the objective function penalizes the change in doses, u, as well as the actual
dose amount, u. Ultimately, the minimization of the objective function is achieved by
selecting only u, since u is uniquely specied by the sequence of dose changes.
IV. The Computation of a Sequence of Control Actions
Using the model to predict future values of the systems response to changes in input,
an optimal sequence of control moves (i.e. input changes) are sought that will bring the
specied output variables as close as possible to the reference trajectory. The control is
simply an input into the ODE system, calculated in such a way as to achieve the desired
goal. For example, in our model, there is a positive control term in the anti-inammatory
equation which represents an anti-inammatory therapy. Thus, the goal might be to nd
the right amount of anti-inammatory therapy which will minimize the distance between
the predicted levels of damage and the reference trajectory for damage, over a specied
prediction window, h, given constraints on the dosing.
Practically, this is accomplished via the use of the fmincon algorithm made available by
MatLab [72]. This algorithm nds a minimum of a constrained nonlinear multivariable
function. In other words, it solves what is commonly known as a nonlinear programming
problem. In particular, fmincon uses a sequential quadratic programming method. For
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more information, see [73]. The number of control moves, m, that are allowed during
the prediction horizon, h, can also be specied. If the algorithm is set so that the model
predicts out to h = 24 hours and therapy is administered on an hourly basis, m is number
of control actions (doses) to be computed in order to minimize the objective function over
24 hours. Ifm < h, which is typically the case, then themth control move is held constant
for the remainder of the prediction window, in determining the systems response to the
input given over this time frame. See the MPC schematic given on page 997 of [86].
Thus, in our simulations, the objective function is minimized over all possible values of
u for m control moves over a prediction window, h. Only the rst control move is
then implemented as the dose for the current hour, after which the algorithm moves on
to nd the dose for the next hour.
V. Error Prediction Update
A very important element of the algorithm is in this error prediction step. Error predic-
tion is implemented to correct the imbalance that may exist between patient data and
the current state of the model (i.e. when there is patient-model mismatch). After the
current control action is implemented in both the process and the model, a current mea-
surement, M(k), of the process is taken and compared to the current model state, p(k),
where k is the current time step in the algorithm. This error quantity, M(k)  p(k), is
then used to update upcoming predictions used to calculate the dose for the next hour.
It is minimized as a part of the objective function terms pertaining to the output vari-
ables being measured. (Note that while it is technically feasible to have all the model
variables designated as output variables that can be measured, in reality this is typically
not the case.)
In our NMPC scheme, when a mismatch exists, updating is done di¤erently. This is
due to the fact that in these particular instances, the variables which can be realistically
measured are not those that appear in the objective function. For instance, we may wish
to minimize damage (D) and pathogen (P ), while only having access to measurements
of the levels of activated phagocytes (N) and the anti-inammatory mediator (CA).
Hence, the di¤erence in the measurements between the patient data for N and CA
and the current model values for these two mediators cannot be worked into an objective
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function that contains only terms for the damage and pathogen variables. The strategies
we explore for this situation are discussed later in the context of specic conguration
types where it applies.
On page 997 of [86], a schematic is given that aptly illustrates some of the elements of an
MPC algorithm. For equations 5.1-5.4, there are three states (outcomes) that are possible
given certain parameter values and initial pathogen levels [98]:
1. Healthy: Healthy is dened as the state in which pathogen has been eliminated and the
mediators have returned to their baseline levels at the end of the simulation time.
2. Aseptic: Aseptic is dened as the state in which pathogen has been eliminated, yet both
the pro-inammatory and anti-inammatory mediators are at elevated levels at the end
of the simulation time.
3. Septic: Septic is dened as the state in which all mediator levels, as well as pathogen
levels, are elevated at the end of the simulation time.
Through the use of the NMPC control algorithm, proper therapy dosing proles are
identied in order to correct inammatory responses that would result in either the aseptic
or septic scenarios in the absence of any controller based therapy. The resulting therapy
found by the control algorithm is referred to as targeted therapy. In addition, the aim also
includes not harming those patients whose inammatory response resolves to the healthy
state in the absence of targeted therapy. It is also assumed that basic therapy, including
the administration of antibiotics, resuscitation of uids, and so forth, are implicitly modeled
in system (5.1)-(5.4). This means that the various outcomes mentioned above can occur
despite administration of basic treatment. This assumption is made due to the small size
of the model.
The algorithm we use is a modied version of that used by Florian et al. in [38], acquired
through [37]. The initial algorithm underwent many customized modications throughout
the di¤erent stages of this NMPC exploration for inammation, which are discussed through-
out this chapter. Much thanks are owed to Je¤Florian and Robert Parker of the University
of Pittsburghs Chemical Engineering Department for the suggestion to apply NMPC, specif-
ically, to the problem at hand, for making an algorithm available, and for their very helpful
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assistance in the beginning stages of becoming familiar with the NMPC methodology and
the specic algorithm. In all of the simulations that we discuss, the total simulation time is
168 hours (1 week). In addition, k is an hourly step, so doses are given on an hourly basis
and administered as instantaneous injections.
5.3 RESEARCH AND DEVELOPMENT PHASE
Having established the general components of the NMPC scheme and the basic behaviors
present in the model, we now discuss the metamorphosis of the algorithm through the various
exploratory stages of nding therapeutic strategies to correct the septic and aseptic scenarios
previously discussed. In the initial investigations, it is assumed that the process, i.e. the
patient, and the model describing the process/patient are one and the same. Later, a mis-
match between the two is introduced, since such an incongruity is more realistic. There are
other di¤erences between the various congurations and each will be explained separately in
detail.
5.3.1 Conguration 1: No Mismatch; 1 Therapy
In this setup, there is no patient-model mismatch. Hence, we will generically refer to
the system instead of the model and the patient, separately, until a later setup when
we introduce di¤erences between the two. The model equations (5.1)-(5.4) are numerically
integrated from a given initial condition for 6 hours. After this time, therapeutic intervention
is initiated by way of the NMPC algorithm. We assume that at this time point the system
is not yet in a state of mortalityand that therapeutic intervention is a feasible option.
For this setup, anti-inammatory therapy is explored. It is modeled in the equation of
the anti-inammatory mediator, CA, as a positive source term, AIDose:
dCA
dt
= sc + kcn
f(N + kcndD)
1 + f(N + kcndD)
  cCA + AIDose.
Furthermore, there are constraints which prevent dosing from going negative, meaning that
therapy can be infused into the system but not extracted. Later, we explore the possibility
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of "extraction therapy." The maximum dose amount of therapy allowed at a given step is
calculated as the di¤erence between the current level of CA and CAMax = 0:6264. The value
for CAMax was chosen based on the analysis done in [98] on the subsystems of equations
(5.1)-(5.4), namely the Damage-Pathogen subsystem. Values of CA higher than 0:6264 cause
the system to exhibit nonbiological behavior. Thus, this maximum level of CA is imposed
to ensure that the NMPC results remain plausible.
The objective function in this setup contains terms to penalize the following: damage
levels (D), pathogen levels (P ), changes in dosing (u), and total amount of drug delivered
(u). As mentioned, the objective function uses the standard two norm squared:
k DDk22 + k pPk22 + k uuk22 + k uuk22 (5.5)
The  -parameters are weighting constants, which can be used to emphasize the importance
of one term over another.
The variables D and P are also the output variables that are measured from the patient.
However, because there is no patient-model mismatch in this case, there is no di¤erence
between the current measurement, M(k), of the damage and pathogen levels in the patient
and the current model state for damage and pathogen. Thus, the predicted error is zero.
For this case, we experimented with a range of values for m and h, deciding on m = 2 and
h = 24. In general, there is no systematic way to choose the various controller "tuning
parameters" which include m, h, and the weighting parameters present in the objective
function.
Summary for Conguration 1:
 No patient-model mismatch
 One Therapy: Anti-inammatory therapy (no extraction) given on an hourly basis
 Measured patient output variables: D and P
 Objective function: k DDk22 + k pPk22 + k uuk22 + k uuk22
 m = 2 and h = 24
   weighting constants: various values explored
 CAMax = 0:6264
 Pathogen growth rate values: Aseptic scenario: kpg = 0:514; Septic scenario: kpg = 0:52
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 Initial conditions for simulations: (P0; N; D;CA) = (0:5; 0; 0; 0:125)
To arrive at the specic conguration given in Setup 1, there were a number of prior
congurations that led us to this one. For instance, for a time, we only considered one
output variable (measurable), namely D, which was also the only model variable appearing
in the objective function. However, it became apparent that if minimizing pathogen was
not also a part of the objective, then the algorithm would do its best to minimize damage
by administering the anti-inammatory therapy; however, this would only prevent the in-
ammation from trying to eradicate pathogen on its own. Instead, pathogen would grow
uncontrolled because inammation was being suppressed by treatment. This, obviously,
was not ideal, so there needed to be a modication to let the algorithm know that it was
important to minimize both damage and pathogen.
This, however, introduces a di¢ cult challenge: maintaining a balance between these two
objectives. An emphasis on minimizing damage, as mentioned, might lead to unrestricted
pathogen growth. On the other hand, an emphasis on minimizing pathogen might lead to
an overzealous immune response bent on eliminating pathogen as soon as possible whatever
the costs, after which it might be too late to bring the inammation back down. The
latter di¢ culty becomes more apparent in Conguration 3 on page 209 where both pro- and
anti-inammatory therapies are considered.
The term in the objective function, k uuk22, responsible for penalizing total therapy
administered, was also something not initially included. In preliminary experiments, the
control was essentially overdosing the system with therapy. In other words, the therapy
would continue to be given even after it was clear that the model dynamics were responding
favorably to treatment (i.e. the reference trajectory was being reached) and would only need
time, not more therapy, to resolve to the healthy state. This problem occurred because of
the third term, k uuk22, in the objective function 5.5 that penalizes the change in dose,
u, from one step to the next. Once the reference trajectory was reached, the controllers
strategy to minimize the objective function focussed on not making any more dose changes,
(i.e. u = 0 ) and so the current dose would stay at its current level for the remainder of
the simulation. Hence, it became necessary to add a fourth term, k uuk22, in 5.5, which
penalizes the amount of drug delivered. This way, once the reference is reached, there will
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be competing objective function penalties: one hindering alterations in dose level and one
attempting to reduce how much drug is delivered. This allows the system to taper o¤ to
zero administered drug [37].
In addition, the maximum level on CA was not implemented until some of the results
we were getting did not appear to be in line with normal model behaviors. Our early
experiments led to the specication of an upper bound on the amount of therapy allowed at
the current dosing step. This maximum allowable dose is calculated based on the current
level of the anti-inammatory mediator. For the model parameter values established in [98],
the amount of CA in the system can reach a maximum level, specically, CAMax = 0:6264,
before a break down occurs in the model dynamics established in the subsystems used to
build the model. See [98] for more details.
The manner in which therapeutic intervention was initiated was another aspect that
evolved in the process of settling on Conguration 1. In prior simulations, the starting
point for initiating therapy was quite di¤erent. The initial pathogen level and pathogen
growth rate were chosen so that in the absence of any therapy, the system would end up
aseptic. A second pathogen load was introduced as the system approached the aseptic state 
simulating a secondary infection. It was assumed that at the onset of the secondary infection,
the system was not yet in a state of mortalityand hence therapeutic intervention was a
feasible option. Immunomodulation was then initiated after the onset of the secondary
infection instead of simply after a specied amount of time (6 hours), as is the case for
Conguration 1.
Initiating immunomodulation in the previous manner was
1. more complicated than what we wanted an initial exploratory simulation to be, and
2. would not apply in the future, when patient-model mismatch is introduced.
For reason (2), there would be a need for treatment to be initialized, other than at the
onset of an infection, either initial or secondary. Hence, it was determined that for the setup
in Conguration 1, 6 hours was enough time for the system to evolve "naturally" from its
initial state so that treatment is not started at time zero, an unlikely scenario. However, 6
hours is soon enough after the onset of infection for treatment to still be a possibility and
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not a time when the patient is in a physiologic state beyond the point of intervention. Since
there are outward signs such as fever, elevated heart rate, etc, that can alert physicians to the
presence of an infection, we equated semi-elevated levels of N at 6 hours with being "sick
enough" to warrant the initiation of targeted therapy. Again, we reiterate our assumption
that model dynamics incorporate basic care, such as antibiotics, uid resuscitation, etc, and
that the patients condition at 6 hours is in spite of (or, perhaps, even because of) this earlier
basic treatment.
5.3.2 Conguration 2: No Mismatch; 2 Therapies
In Conguration 2, there is again no patient-model mismatch. Thus, again, we refer to the
systeminstead of the model and the patient, separately. Like Cong. 1, after 6 hours of
running (numerically integrating) the system, therapeutic intervention is initiated by way of
the NMPC algorithm.
Although the original NMPC algorithm was written to handle more than one control
input, it had only been used and tested for one control input. Thus, there were some
errors that needed to be worked through in order for the code to work properly in the case
of two inputs, which this setup considers. The therapy for this setup includes both an
anti-inammatory therapy, present as a source term (+AIDose) in the equation of the anti-
inammatory mediator, CA, as well as a pro-inammatory therapy, present as a source term
(+PIDose) in the equation for activated phagocytes, N:
dN
dt
=
snrR
knr +R
  nN + PIDose
dCA
dt
= sc + kcn
f(N + kcndD)
1 + f(N + kcndD)
  cCA + AIDose
As was the case for Cong. 1, constraints are dened which prevent dosing from going
negative, meaning that therapy can be infused into the system but not extracted. Our
objective function contains terms to minimize the following: damage levels, D, pathogen
levels, P , changes in dosing (u1 and u2) and total therapy given (u1 and u2) for both CA
and N, respectively:
k DDk22 + k pPk22 + k u1u1k22 + k u2u2k22 + k u1u1k22 + k u2u2k22 (5.6)
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Again, the  -parameters are the weighting constants. The maximum dose amount of anti-
inammatory therapy allowed at a given step is calculated as the di¤erence between the
current level of CA and CAMax = 0:6264. The maximum dose amount of proinammatory
therapy allowed at a given step is calculated as the di¤erence between the current level of
N and NMax = 2:0. The maximum was chosen based on average levels of N; however,
in later simulations we will see that this maximum level is too high.
The variables D and P are also the output variables that are measured from the patient.
However, because there is no patient-model mismatch, there is no di¤erence between the
current measurement, M(k), of the damage and pathogen levels in the patient and the
current model state for damage and pathogen. Thus, the predicted error is zero. For this
case, we experimented with a range of values for m and h, deciding on m = 2 and h = 24
for the results shown.
Summary for Conguration 2:
 No patient-model mismatch
 Two Therapies: Anti-inammatory and proinammatory therapy (no extractions)
 Measured patient output variables: D and P
 Objective function: k DDk22+k pPk22+k u1u1k22+k u2u2k22+k u1u1k22+k u2u2k22
 m = 2 and h = 24
   weighting constants: various values explored
 CAMax = 0:6264
 NMax = 2:0
 Pathogen growth rate values: Aseptic scenario: kpg = 0:514; Septic scenario: kpg = 0:52
 Initial conditions for simulations: (P0; N; D;CA) = (0:5; 0; 0; 0:125)
5.3.3 Conguration 3: Patient-Model Mismatch; 2 Therapies
Unlike that of Congurations 1 and 2, here, in Conguration 3, patient-model mismatch is
introduced, with respect to several model parameters and two initial conditions. Patients are
"generated" with varying proles, meaning that some of the parameters used in the model
representing Patient X are di¤erent from those of the underlying predictive model and are
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di¤erent from proles of other generated patients. Several parameters in the equations 5.1-
5.4 are identied as reasonable parameters for which variability may exist from patient to
patient. These parameters include those given in Table 9. Note that initial conditions P0
and CA0 are treated as parameters here.
The values in [98] used for the parameters shown here in Table 9 (except for the values
of P0 and kpg) are considered here as the "mean" values. Furthermore, variability for the
ranges was chosen to be +=  25% of the mean, for those parameters that had "estimated"
values in [98]. For these parameters, the range of variability is calculated so that += 25% of
the mean value is two standard deviations on either side of the mean. Then, when a patient
prole is generated, values from this range are chosen randomly with a normal distribution.
For the parameter kpg, where a range is available (see [98]), values from this range are chosen
randomly with a normal distribution, where the lower and upper bounds on kpg are assumed
to be two standard deviations from the mean.
Any randomly generated values that fall outside of the range of variability are discarded
and another value is generated, until a value is found that falls in the range of variability.
Hence, the parameter values are chosen with a "normal-like" distribution because of the
upper and lower bounds of the variability ranges. In addition, some parameters are chosen
to co-vary. This means that if paramters p1 and p2 co-vary and the value chosen for p1
is +n% of its mean value, then the generated value for p2 should also be +n% of its mean
value. For example, the variability in kcnd, the production of the anti-inammatory mediator
(CA) by damaged tissue (D), is to vary by the same percentage as kcn, the production of
CA by activated phagocytes (CA), so that one is not relatively producing more or less (CA)
than the other.
The simulation results for this conguration are not viewed in graph format as those
done for Congurations 1 and 2 above. Instead, the individual outcomes (healthy, aseptic,
septic) from each simulation are tallied and reported as percentages of the total number of
patients treated with targeted therapy. The rst step in this process is generating the patient
population, which is accomplished by selecting parameters in the way described above. This
creates a "prole" for an individual patient. This is repeated for the total number of patients
to be considered. In this case, there will be 1000 patients.
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Table 9: Model parameters in which variability was assumed in the patient-model mismatch case given by
Conguration 3. Patient parameters are generated by choosing a normally (normal-like) distributed random
value from the given ranges.
Name Patient Parameter
Ranges
Mean Description
P0 0.0-1.0 0.5 Initial condition of pathogen (P )
CA0 0.0938-0.1563 0.125 Initial condition of the anti-inammatory me-
diator (CA)
kpg 0.021-1.0 0.5105 Growth rate of pathogen (P )
kcn 0.03-0.05 0.04 Maximum production of anti-inammatory
mediator (CA)
knd 0.015-0.025 0.02 Activation of phagocytes by tissue damage
(D)
knp 0.075-0.125 (Co-varies
w/ knd)
0.1 Activation of phagocytes (N) by pathogen
(P )
kcnd 36.0-60.0 (Co-varies
w/ kcn)
48.0 Controls relative e¤ectiveness of activated
phagocytes (N) versus damage (D) in the
production of the anti-inammatory mediator
(CA)
knn 0.0075-0.0125 (Co-
varies w/ knd)
0.01 Activation of phagocytes (N) by already ac-
tivated phagocytes (N) (or the cytokines
that they produce)
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As discussed in Conguration 2 on page 208, the time at which intervention is initiated
becomes an issue for consideration when there is patient-model mismatch. This is because
in the case of mismatch, many patients are considered, and it no longer seems realistic to
initiate therapy at the exact same time in each patient. In fact, for some patients, 6 hours
into the infection might not be long enough for signs of the infection to show, whereas in
others, 6 hours might be too late. Therefore, the intervention time in Conguration 3 is
based on the level of N. If a patients N level rises above a certain threshold, then the
patient is deemed "sick enough" to receive targeted therapy. This implies a biomarker
driven approach to initiating therapeutic intervention. This implementation, however, is
not without its caveats. For instance, how should the threshold be chosen? This question
is likely to be answered di¤erently depending on the physician one talks to. In the current
exploration, an N threshold of 0.1 was selected, since this amount was a considerable
elevation for this variable in a simulation having a septic or aseptic endpoint.
Like Conguration 2, the therapy for Conguration 3 includes both an anti-inammatory
therapy, present as a source term (+AIDose) in the equation of the anti-inammatory
mediator, CA, as well as a pro-inammatory therapy, present as a source term (+PIDose)
in the equation for activated phagocytes, N:
dN
dt
=
snrR
knr +R
  nN + PIDose
dCA
dt
= sc + kcn
f(N + kcndD)
1 + f(N + kcndD)
  cCA + AIDose
As was the case for Cong. 1, constraints are dened which prevent dosing from going
negative, meaning that therapy can be infused into the system but not extracted. As
before, the objective function, given by (5.6), contains terms to minimize the following:
damage levels, D, pathogen levels, P , changes in dosing (u1 and u2) and total therapy
given (u1 and u2) for both CA and N, respectively.
The maximum dose amount of anti-inammatory therapy allowed at a given step is
calculated as the di¤erence between the current level of CA and CAMax = 0:6264. The
maximum dose amount of proinammatory therapy allowed at a given step is calculated as
the di¤erence between the current level of N and NMax = 1:0. The maximum was chosen
based on average levels of N during a moderate to severe infection and the fact that the
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value used in Cong. 1 (NMax = 2:0) was too high. However, in later simulations, we
will see that even this reduced maximum level is probably too high.
For this conguration, it is N and CA that are designated as the output variables to be
measured, instead of the variables D and P . This change was incorporated because damage
is a di¢ cult, if not impossible, variable to quantify and measure in clinical settings, and it
is unlikely that a measurement of the pathogen population could be made at all, much less
made every hour. However, we still want the algorithm to focus on minimizing damage and
pathogen levels. Because of this, typical error prediction and updating procedures cannot
be employed here, as was briey discussed in point V: Error Prediction Update on page 202.
The di¤erence in the measurements, between the patient data for N and CA and the current
model values for these two mediators, cannot be worked into an objective function that only
contains mediator prediction terms for the damage and pathogen variables. This becomes
very important, now that we have introduced patient-model mismatch, and the underlying
model is now di¤erent from the patient model, with respect to parameter values and starting
conditions.
Thus, to address this, the model state for N and CA is synchronized with the current
patient data measurements forN and CA, right after the prescribed dose for the current hour
has been implemented in the model and in the patient and before the next measurements
are taken. Thus, in essence, hourly measurements are taken of the patients levels of N
and CA and the model is updated with these values.
The underlying model drives the design of the therapy that is chosen to be implemented in
the patient, with measurements taken from the patient to correct for mismatch. Therefore,
the accuracy of the underlying model is important. Note, however, the updating scheme
described in the last paragraph does not address any possible discrepancies between the
model and patient with respect to levels of damage and pathogen, both of which are the
cause for pushing the system toward an unhealthy endpoint.
Thus, in the initial exploration of this conguration, it was determined that the model
parameters for those given in Table 9 on page 211, specically P0 and kpg, were not chosen
well enough to accurately represent those patients who were on the path to a septic or
aseptic outcome. In other words, the therapy regimens that the controller was nding were
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being based on an underlying model that normally would resolve to healthy, being able to
eliminate pathogen and damage even in the absence of therapy. So, in many cases, the
levels of pathogen were still elevated in the patient, but not in the model. Such a mismatch,
between model and patient, was not adequately being taken care of with the synchronization
of the N and CA values in the model with the patient measurements.
As a rst attempt at addressing this issue, the model was conditioned to be more rep-
resentative of a sicker patient, by increasing the models pathogen growth rate, kpg. This
makes the pathogen more powerful in the model, and thus, the resulting therapy would be
more applicable to patients which experienced a stronger, more persistent infection. How-
ever, this change only indirectly addresses the problem when pathogen levels in the patient
and model are vastly di¤erent. It became apparent from the results of this conguration that
some kind of updating involving pathogen would need to be included, without directly syn-
chronizing the model pathogen levels with a measurement of pathogen levels in the patient.
This is addressed in the next conguration. Finally, for this conguration, we experimented
with a range of values for m and h, deciding on m = 2 and h = 24 for the results shown.
Summary for Conguration 3:
 Patient-model mismatch
 1000 patients considered, with di¤ering proles (i.e. di¤ering values for the parameters
shown in Table 9 on page 211
 Patient proles are generated by choosing a normally (normal-like) distributed random
value from a specied range for six selected parameters and two initial conditions.
 Therapy is initiated in the patient when N levels reach a threshold of 0:1.
 Two Therapies: Anti-inammatory and proinammatory therapy (no extractions), given
on an hourly basis
 Objective function: k DDk22+k pPk22+k u1u1k22+k u2u2k22+k u1u1k22+k u2u2k22
  -weighting constants: various values explored
 CAMax = 0:6264
 NMax = 1:0
 Measured patient output variables: N and CA
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 Model kpg = 0:8
 Model initial conditions: (P0; N; D;CA) = (0:5; 0; 0; 0:125)
 Patient initial conditions: (P0; N; D;CA) = (P0-random; 0; 0; CA0-random)
 m = 2 and h = 24
5.3.4 Extraction Therapy Considered
Before explaining the various changes made for the next conguration, we take a brief mo-
ment to discuss a side path that was explored between Conguration 3 and Conguration
4. This involved the consideration of "extraction therapy" with respect to both the pro-
and anti-inammatory therapies. Each could be administered not only in a positive way
(addition to the system), but also negatively (extraction from the system). Technically, this
means that the algorithm was allowed to nd changes in the doses (u1 and u2) that
caused the doses (u1 and u2) to be a negative quantity, implying that CA and/or N were
being removed from the patient. Hence, because each therapy can be given and taken out,
there are essentially four therapies that can be employed.
However, the consideration of four therapies is more unrealistic than the previous con-
gurations. In the initial experimentation with the use of four therapies, it quickly became
apparent that the extra "knobs" available for turning the levels of CA andN up and/or down
were too powerful for the size of model being used. The usual strategy the controller would
exercise would be to promote inammation by giving pro-inammatory therapy and extract-
ing some of the anti-inammatory mediator to ensure pathogen was eliminated. Then, when
pathogen was under control, the controller would extract the pro-inammatory mediator and
give anti-inammatory therapy in order to bring down the inammation previously created,
thereby helping the patient resolve to healthy.
This is illustrated in the Figure 61, showing a patient treated with this "4-knob" therapy
(targeted therapy shown in blue). The patient would have otherwise ended up in a septic
state (placebo shown in red). The therapy dosing strategy described above can be seen
in the last row of Figure 61. The left panel of the last row is the pro-inammatory doses
and the right panel is the anti-inammatory doses. The therapy is hugely successful in
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preventing the patient from ending up in the septic case.
Figure 61: A sample simulation from a simulation incorporating four therapies. These include the
addition as well as the extraction of pro- and anti-inammatory therapy, PI and AI, respectively. A di¢ cult
scenario, that would otherwise end up septic (red curves) is managed very well by the algorithm (blue curves,
rst 4 panels) with the use of the four therapies. The PI doses are shown in the left panel of the last row.
The AI doses are shown in the right panel of the last row. Both are shown over a 24 hour period, after
which no more doses are given.
Although it was interesting to explore this conguration and encouraging to know that
the therapy regimen generated by the algorithm made sense, a four therapy strategy like
this one is not one that can realistically be discussed at this time. Methods for extracting
cytokines and other molecules from a patients bloodstream are still in the very early stages
of development. Furthermore, in a model the size of the one we are using, although the
dynamics are complex, there is only so much that can happen in response to input. In
a larger model, input to one variable might not imply a global-like a¤ect on the system
dynamics. However, in a small model, inputs tend to a¤ect the entire dynamics, so it is
somewhat articial to allow the consideration of too many therapies. Thus, we return to the
two therapy conguration, but make additional changes, specically to address the mismatch
regarding pathogen and also to add some realism with respect to the length of time that the
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anti-inammatory mediator can stay elevated from the addition of therapy.
5.3.5 Conguration 4: Patient-Model Mismatch; 2 Therapies; Pathogen Up-
date; CA therapy cap
In Conguration 4, the patient parameters are generated slightly di¤erently than in Cong-
uration 3. During the many simulations conducted with Conguration 3, it became clear
that the patient placebo outcomes were primarily being driven by the patientsvalues of
the pathogen growth rate, kpg, and the initial pathogen load, P0. To address this problem,
we rst modied the patient generator scheme so that the selected parameters are chosen
randomly with a uniform distribution rather than a normal distribution from the specied
variability ranges.
This allows more variability in parameter selection, since, with a uniform distribution, all
the values in a range are equally likely to be chosen. In addition, the range for the pathogen
growth rate, kpg, was modied so that the placebo outcomes in the patient population are not
driven primarily by kpg and P0, but by the parameter prole as a whole. Also modied was
the N threshold for intervention: from 0:1 down to 0:05. The scatterplot shown in Figure
62 depicts patient placebo outcomes with respect to corresponding kpg and P0 levels. The
scatterplot shows that the new range for kpg, along with the reduced N threshold, allows
a signicant degree of overlap between outcome possibilities in the kpg-P0- plane, meaning
that parameters other than P0 and kpg are driving the outcome in a signicant number of
individuals. Table 10 on page 219 shows the patient parameter ranges again with an updated
range for kpg.
Another signicant change made for Conguration 4 is with respect to the issue men-
tioned in Conguration 3, regarding the case when pathogen levels in the patient and
model are vastly di¤erent. An updating strategy is necessary; however, directly measuring
pathogen levels in the patient and synchronizing the model with this value is unrealistic and
articial. Hence, we added an update that notes the level of pathogen
1. in the patient when it increases above a specied threshold, and
2. in the model when it is under a certain small threshold.
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Figure 62: The scatterplot showing the distribution of patient outcomes with respect to kpg and P0. For
the given ranges of kpg and P0 the various outcomes (healthy, aseptic, and septic) of the patient proles in
the placebo case are well mixed in the P0-kpg plane. Thus, P0 and kpg are not the primary driving force of
patient outcome.
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Table 10: Model parameters in which variability was assumed in the patient-model mismatch case given
by Conguration 4. Patient parameters are generated by choosing a uniformly (uniform-like) distributed
random value from the given ranges.
Name Patient Parameter Ranges Description
P0 0.0-1.0 Initial condition of pathogen (P )
CA0 0.0938-0.1563 Initial condition of the anti-inammatory me-
diator (CA)
kpg 0.3-0.6 Growth rate of pathogen (P )
kcn 0.03-0.05 Maximum production of anti-inammatory
mediator (CA)
knd 0.015-0.025 Activation of phagocytes by tissue damage
(D)
knp 0.075-0.125 (Co-varies w/ knd) Activation of phagocytes (N) by pathogen
(P )
kcnd 36.0-60.0 (Co-varies w/ kcn) Controls relative e¤ectiveness of activated
phagocytes (N) versus damage (D) in the
production of the anti-inammatory mediator
(CA)
knn 0.0075-0.0125 (Co-varies w/ knd) Activation of phagocytes (N) by already ac-
tivated phagocytes (N) (or the cytokines
that they produce)
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If 1: and 2. above occur at the same time, then the pathogen level of the model state
is reset to a higher level compared to the pathogen state at which it is currently. This can
be looked at as a type of re-initialization of the pathogen value in the model. Although
this strategy does use a measurement of the patients pathogen values, we note that this
is the only way that the current simulation setup can detect the presence of a persistent
infection. In a clinical setting, a physician can see outward signs that an infection is still
raging, i.e. fever, elevated heart rate, etc. Thus, because we are not directly setting the
models pathogen state to the value "measured" in the patient, the updating strategy is a
reasonable way to alert the algorithm of the case when pathogen levels in the patient are
high and those in the model are not. Practically, the levels of pathogen are checked every
four hours and if the criteria are met, the model state for pathogen is reset to its initial value
of 0:5.
As we worked through the process of developing one conguration to the next, making
the algorithm more realistic was one of the main goals. Therefore, when it was noticed
that the amount of anti-inammatory therapy given to patients would sometimes cause the
levels of the anti-inammatory mediator to stay elevated for very long periods of time, a
mechanism to prevent this needed to be put in place. This problem usually happens in
scenarios when inammation is high after the eradication of pathogen, and the production
of anti-inammation by inammatory mediators causes the levels of CA to be elevated as
well. Then, when the anti-inammatory therapy is given, pushing the level of CA up to the
maximum allowable level, it does not have an immediate e¤ect on bringing inammation
down. Thus, the therapy would have to be continually given in an attempt to essentially
saturate the system with as much CA as possible for as long as possible.
This, however, is not a realistic treatment regimen, since clinicians are careful not to
purposely induce a state of immunosuppression in patients, which would make them suscep-
tible to secondary infections. In order to address this issue, a mechanism was put into place
so that if the level of CA remains constant for more than 48 hours, the maximum allowable
amount of CA is reduced by half. In some cases, this means that patients who fall into this
category might end up aseptic instead of healthy since the amount of inammation in their
system is decreasing, and the amount of inammation, that may have been decreasing with
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the elevated CA levels, will once again rise. However, as mentioned, the alternative is not a
realistic one.
The last change made from the previous congurations is the reduced value of the predic-
tion horizon, h, from 24 to 8 hours. It was determined that an 8 hour prediction window was
long enough to capture essential model dynamics and it also decreased the computational
time for running the algorithm on 1000 patients. The value of h (as well as m) may have
to be reconsidered in future congurations, especially since computational time has become
less of an issue, due to the resources now available.
This conguration, while the most sophisticated of those presented, is not without its
di¢ culties, as will be shown in the Results section. Hence, also included in the Results sec-
tion after the outcomes for Cong. 1-4 are presented, are several ideas and a few preliminary
results for future congurations that address some of the issues brought up by Conguration
4.
Summary for Conguration 4:
 Patient-model mismatch
 1000 patients considered, with di¤ering proles (i.e. di¤ering parameter values)
 Patient proles generated from choosing a uniformly distributed random value from a
specied range (ranges shown in Table 10 on page 219)
 N threshold = 0:05 (for determining when to initiate therapeutic intervention)
 Two Therapies: Anti-inammatory and proinammatory therapy (no extractions), given
on an hourly basis
 Objective function: k DDk22+k pPk22+k u1u1k22+k u2u2k22+k u1u1k22+k u2u2k22,
where the following are being minimized: damage levels, D, pathogen levels, P , changes
in dosing (u1 and u2) and total therapy given (u1 and u2) for both CA and N,
respectively.
  -weighting constants: various values explored
 CAMax = 0:6264
 NMax = 1:0
 Measured patient output variables: N and CA
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 Model kpg = 0:8
 Pathogen update mechanism
 48 hour CA cap
 Model initial conditions: (P0; N; D;CA) = (0:5; 0; 0; 0:125)
 Patient initial conditions: (P0; N; D;CA) = (P0-random; 0; 0; CA0-random)
 m = 2 and h = 8
5.4 RESULTS
The congurations of the last section detailed the setup of each individual simulation or set
of simulations. In this section, specic results for each conguration will be shown, keeping
in mind the discussions and points made in the previous sections for the corresponding con-
guration types. For the congurations in which the simulation sets included 1000 patients,
not only are the results from one conguration compared to another, the results within an
individual conguration are compared to alternative therapies that we now describe.
5.4.1 Alternative Therapies for Multi-Patient Simulations
The therapy strategies found by the NMPC algorithm are referred to as "targeted" therapy.
In the simulation sets that include 1000 patients, all with di¤ering proles, the algorithm
generates a therapy specic to that patients particular dynamics. Many times, the dosing
regimens are similar among patients, but nonetheless, the therapy specically targets an
individual patient. In order to get an idea of how well the targeted therapy does, it is
compared to the results from the administration of alternative therapies.
These alternate therapies include, of course, the Placebo Therapy, where no control-
based treatment is given. In addition, two other alternative therapies are explored. The
rst of these is known as Standard Therapy. Standard therapy is calculated in the follow-
ing way: using the underlying model (and corresponding parameters) as both the patient
and the model and starting from the usual model initial conditions of (P0; N; D; CA) =
(0:5; 0; 0; 0:125) , with the setup given in one of the congurations, the control algorithm is
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run on this "patient" and a dosing prole is generated, as usual. For example, in Cong. 3,
standard therapy is calculated by implementing all the di¤erent specications of that con-
guration in the algorithm and running the algorithm on a patient with exactly the same
parameter values as the model. In other words, the model becomes one of the patients and
a targeted therapy is found for the model patient. This one dosing prole then becomes a
standard therapy to administer to all the patients. An example of a standard therapy dosing
prole is given in Figure 63:
Figure 63: An example of a standard therapy dose prole. This standard dose regimen is administered to
all patients within a simulation set, for the purpose of comparing the resulting outcomes with the outcomes
from targeted therapy generated specically for each patient.
The third and nal alternate therapy is referred to as Uber Standard Therapy, meaning
that it is very standard, since it does not employ any control-based methods to generate. In
fact, this therapy is designed to represent the therapy regimen currently given to critically ill
patients with severe inammatory disorders in the intensive care unit: a consistent dosing
regimen of an anti-inammatory therapy known as Activated Protein C. Practically, a dosing
prole is created that gives a small dose of the anti-inammatory therapy (via instantaneous
injections, as usual) each hour over a period of 72 hours.
Once an entire therapy dosing prole has been administered to a patient, it is necessary
to have some methodology for determining the outcome of an individual simulation. This
proved to be another rather technical issue. At the end of the simulation time, how are
the outcomes of 1000 di¤erent simulations systematically determined and tallied? Initially,
these results were based on the values of the variables at the end of 168 hours; however,
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sometimes this was ambiguous. For example, damage which might be elevated beyond the
threshold that we designate as a "healthy" level might also be decreasing toward equilibrium.
In such a case, the system might evolve to the healthy steady state, given some more time
(in the absence of any more therapeutic intervention).
Thus, it was decided to create a post processing algorithm that takes the ending values
of the variables in the patient at 168 hours and integrates the system for another 300 hours,
when it would be highly likely that the solution has, by then, settled to a state, whether
healthy, aseptic, or septic. A patient outcome is labeled "septic" if the pathogen levels
are above a threshold of 1.0, and damage and activated phagocytes are also above their
designated thresholds, 1.0 and 0.05, respectively. If pathogen levels are not above threshold,
yet damage and activated phagocyte levels are, then the patient outcome is labeled "aseptic,"
in accordance with the denitions of these physiologic states mentioned earlier. Otherwise,
a patient is labeled "healthy." (Note, we do have a check for inconclusive results, however,
there have never been any outcomes that fall into this category.)
Hence, in the upcoming results presented for multiple patient simulations, the outcomes
are not given graphically, but rather in table format showing percentages of the total treated
patient population that fell into the di¤erent outcome types. The multiple patient sim-
ulations are run on a network of computers known as PittGrid, which is a University of
Pittsburgh project networking computers from all around campus. Account users submit
jobs into a queue, which then sends copies of the les for a specic job to any unused nodes in
the network. A special thanks to Senthil Natarajan for making it possible for these NMPC
simulations to be run on PittGrid. Next, we present the specic results from Congurations
1-4, beginning with Cong. 1, in which there is no patient-model mismatch and where only
one therapy is considered.
5.4.2 Results: Conguration 1
Recall that in Conguration 1 the following specications are made:
 No patient-model mismatch
 One Therapy: Anti-inammatory therapy (no extraction) given on an hourly basis
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 Measured patient output variables: D and P
 Objective function: k DDk22 + k pPk22 + k uuk22 + k uuk22
 m = 2 and h = 24
   weighting constants: various values explored
 CAMax = 0:6264
 Pathogen growth rate values: Aseptic scenario: kpg = 0:514; Septic scenario: kpg = 0:52
 Initial conditions for simulations: (P0; N; D;CA) = (0:5; 0; 0; 0:125)
Figure 64 shows the placebo outcome for an aseptic scenario, where kpg = 0:514 and
P0 = 0:5. Then, in Figure 65 the NMPC results are shown for weighting constants shown as
follows:  D = 1:0;  p = 1:0;  u = 1:0;  u = 1:0. The control-based therapy that the NMPC
algorithm generates for this case is able to turn the aseptic scenario, shown in Figure 64,
into a healthy outcome. However, notice that when the damage weight,  D, is signicantly
increased with respect to the other weights, the result, shown in Figure 66, is not favorable.
In this case, the therapy that the algorithm generates, while successful in suppressing damage
at least in the beginning stages, turns the aseptic scenario, shown in Figure 64, into septic.
Thus, it is important to be aware of the a¤ect that the weights can have on outcome.
Next consider the case when the placebo outcome is a septic scenario (Figure 67) gen-
erated with kpg = 0:52 and P0 = 0:5. Looking at both Figure 68 and Figure 69, the
anti-inammatory therapy is irrelevant for this scenario, since the system cannot overcome
the pathogen. In the rst case (Figure 68), the objective function is weighted so that
minimizing damage over pathogen is not stressed. Here, the algorithm tries to eliminate
pathogen by letting inammation grow unsuppressed by any additional anti-inammatory
therapy (note the at line at zero on the CA dose prole). However, if minimizing damage is
a priority (second case: Figure 69), then the algorithm attempts to minimize damage; how-
ever, pathogen is then allowed to grow without restriction, and eventually, the inammation
must respond to this, causing the system to arrive (albeit in a slightly delayed fashion) at
the septic state.
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Figure 64: An example of a simulation under Conguration 1 with an aseptic outcome for the placebo
case (i.e. without any therapeutic intervention from the NMPC algorithm).
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Figure 65: An example of a simulation under Conguration 1, where the aseptic response presented
in Figure 64 has been modulated with therapy from the NMPC algorithm. The therapy regimen found
is successful to change an otherwise aseptic case into a healthy outcome. The time at which therapy is
initiated by the NMPC algorithm was set at 6 hours after the onset of the infection.
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Figure 66: The simulation shown in Figure 65 for the aseptic Placebo case of Figure 64 is rerun with a
heavy weight on Damage. The therapy regimen found is unsuccessful to change an otherwise aseptic case
into a healthy outcome. Instead the simulation results in a septic outcome, showing that the weighting
parameters can be inuential in the outcome of a simulation. The heavy weight on damage causes the
algorithm to prescribe the anti-inammatory therapy to supress damage; however, this only postpones the
onset of inammation and the situation is made worse. The time at which therapy is initiated by the NMPC
algorithm was set at 6 hours after the onset of the infection.
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Figure 67: An example of a simulation under Congurations 1 and 2 with a septic outcome for the
placebo case (i.e. without any therapeutic intervention from the NMPC algorithm).
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Figure 68: For the septic scenario under Conguration 1 shown in Figure 67, therapeutic intervention
was intiated 6 hours after the onset of infection. However, since Conguration 1 only includes the ability
to administer anti-inammatory therapy, the algorithm is unable to nd a suitable treatment to resolve the
septic scenario to healthy. Essentially, in this case the anti-inammatory therapy become irrelevant because
it does nothing to help the eradication of the pathogen and can only hurt it more if administered, as Figure
69 shows.
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Figure 69: Similar to the simulation run in Figure 68 for the septic scenario under Conguration 1 shown
in Figure 67, therapeutic intervention was intiated 6 hours after the onset of infection. However, in this
simulation the weight on damage is increased signicanlty. This causes the NMPC algorithm to attempt
to minimize damage with the anti-inammatory therapy available. While successful for a while, eventually
inammation grows out of control in response to the unrestricted pathogen growth. This shows the need for
another therapy besides the anti-inammatory therapy.
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5.4.3 Results: Conguration 2
Recall that in Conguration 2 the following specications are made:
 No patient-model mismatch
 Two Therapies: Anti-inammatory and proinammatory therapy (no extractions), given
on an hourly basis
 Measured patient output variables: D and P
 Objective function: k DDk22+k pPk22+k u1u1k22+k u2u2k22+k u1u1k22+k u2u2k22
 m = 2 and h = 24
   weighting constants: various values explored
 CAMax = 0:6264
 NMax = 2:0
 Pathogen growth rate values: Aseptic scenario: kpg = 0:514; Septic scenario: kpg = 0:52
 Initial conditions for simulations: (P0; N; D;CA) = (0:5; 0; 0; 0:125)
Conguration 2 applies two therapies instead of one, but otherwise the conguration is
the same as Conguration 1. Thus, the results from the previous section for Conguration
1 can be compared to the results that are now presented for Conguration 2. Only the
septic scenario is considered, since the anti-inammatory therapy alone could not help rectify
this case in Conguration 1 above. Figure 67, shows the placebo outcome that results in
Conguration 2 in a septic scenario with kpg = 0:52 and P0 = 0:5. Figure 70 shows that a
two therapy strategy is able to successfully curb the potentially septic scenario and allows
the system to resolve to healthy. Since this conguration can restore both septic and aseptic
scenarios, it is likely that this setup would restore to health most, if not all, patients who have
di¤ering proles like those generated in subsequent congurations. However, the fact that
there is no patient-model mismatch in this conguration makes these potentially nice results
less impressive, considering that the presence of mismatch is to be expected in a more real
world setting. Hence, in simulations involving a larger patient population, a patient-model
mismatch is necessary to better emulate reality.
All the simulations so far initiated therapy 6 hours after the onset of infection. We also
take a quick look at what might happen if therapeutic intervention is initiated much later,
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Figure 70: An example of a simulation under Conguration 2, where the septic response presented in
Figure 67 has been modulated with therapy fromt the NMPC algorithm. The therapy regimen found is
successful to change an otherwise septic case into a healthy outcome. The time at which therapy is initiated
by the NMPC algorithm was set at 6 hours after the onset of the infection.
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say 40 hours. Figure 71 shows that intervention initiated at this much later time point is
able to eradicate pathogen, but inammation becomes too great by this time for the system
to resolve, even with the maximum amount of CA therapy given over a very lengthy amount
of time. Therefore, the success of the algorithm to nd appropriate therapies also depends
on when intervention is initiated.
5.4.4 Results: Conguration 3
Remark 10. As a shorthand for referring to therapies and particular details of the di¤erent
schemes, the following abbreviations will be used for simulation sets of 1000 patients:
 NE: Both pro- and anti-inammatory therapies are applied but with No Extraction
 WE: Bot pro- and anti-inammatory therapies With Extraction
 W  1: All the weighting parameters of the objective function have a weight equal to 1.
 ST: Standard Therapy
 UST: Uber Standard Therapy
 [; ; ; ;   , "] : Species the weighting parameters when they are are not all equal
to 1. The order matches the way in which they appear in the objective function used in
the particular conguration.
Recall that in Conguration 3 a multi-patient simulation is carried out and the other
following specications are made:
 Patient-model mismatch
 1000 patients considered, with di¤ering proles (i.e. di¤ering values for the parameters
shown in Table 9 on page 211)
 Patient proles are generated from choosing a normally (normal-like) distributed random
value from a specied range
 Therapy is initiated in the patient when N levels reach a threshold of 0:1
 Two Therapies: Anti-inammatory and proinammatory therapy (no extractions), given
on an hourly basis
 Objective function: k DDk22+k pPk22+k u1u1k22+k u2u2k22+k u1u1k22+k u2u2k22
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Figure 71: The same simulation that was run for Figure 70, under Conguration 2 in the Placebo septic
case, is shown for a di¤erent intervention time. Instead of the NMPC algorithm initiating therapy at 6
hours after the onset of infection, the algorithm is congured to wait till 40 hours after the onset of infection.
The result is unfavorable, with the patient now ending up with an aseptic condition as opposed to septic.
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  -weighting constants: various values explored
 CAMax = 0:6264
 NMax = 1:0
 Measured patient output variables: N and CA
 Model kpg = 0:8
 Model initial conditions: (P0; N; D;CA) = (0:5; 0; 0; 0:125)
 Patient initial conditions: (P0; N; D;CA) = (P0-random; 0; 0; CA0-random)
 m = 2 and h = 24
The results shown for this conguration include three comparison data sets, in addition
to the targeted therapy results. The rst two alternative data sets, shown on the same table
as the targeted therapy results, are for standard therapy and "4 knob" therapy (i.e. therapy
that includes extraction capability). The third alternative therapy data set, shown later and
separately, is that of the uber standard therapy. At this stage, we were experimenting with
nding proper doses to be administered for the 72 hour period in such a way as to not violate
the CAMax constraint. Hence these results are presented in a separate table, but can still
be compared to the other results.
Out of the 1000 patients in the population considered for this conguration, 525 of them
reached the N threshold of 0.1, after which therapeutic intervention was initiated. The
remaining 425 did not receive any treatment; however, percentages are out of the total 1000
patients. Table 11 compares the results of di¤erent treatment strategies: 4 therapies (WE),
2 therapies with damage weight emphasized (NE), and 2 therapies with all weights equal to
one (NE; W 1). Also shown with respect to the underlying models values for kpg and P0
is the number of patients not rescued with a therapy that
1. had both a higher kpg and P0 value,
2. had a higher kpg but a lower P0 value,
3. had a higher P0 but a lower kpg value, or
4. had both a lower kpg and P0 value.
Data such as this drew our attention to the fact that perhaps these two parameters were
driving the outcomes too much, and that it would be better if the patient proles were
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Table 11: Comparison of Treatment Schemes for Conguration 3
Conguration 3:
Comparison of Treatment Schemes and kpg and P0 values
No Pathogen Update
575/1000 patients receive treatment; Percentages are out of 1000
WE WE/ST NE NE/ST NE NE/ST
Placebo W  1 [1;100 ;1 ;1] [1;100 ;1 ;1] W  1 W  1
Percentage
Rescued
7.3% 57.3% 57.5% 9.8% 20.9% 15.0% 21.3%
Percentage
Not Rescued
50.2% 0.2% 0.0% 47.7% 36.6% 42.5% 36.2%
Both Higher
kpg and P0
n/a 0 0 35 31 39 39
Higher kpg n/a 2 0 36 28 40 38
Higher P0 n/a 0 0 308 235 264 215
Both Lower n/a 0 0 98 72 82 70
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such that all of the parameters that varied from patient to patient had more signicance in
determining outcome. Hence, changes are made to the way patient proles are generated
in the next conguration. Also note that, surprisingly, standard therapy does better than
the targeted therapy in all of the di¤erent simulation types. At the time, it was not yet
clear as to why this was the case, since targeted therapy was supposed to be designed for
the individual patient; however, in light of recent work, this could have been the result
of patient-model mismatch not being dealt with very well. Also, at this stage, the post
processing technique was not employed here, and outcomes were only sorted as "rescued" or
"not rescued", instead of by the three possible outcomes: septic, aseptic, and healthy. Thus,
it may be the case that some of the patient outcomes were mislabeled due to the inaccuracy
of the sorting method used at the time.
Nevertheless, these results for Conguration 3 show that the extraction therapy works
unrealistically well and that once again the weighting parameters can have a (perhaps un-
expected) negative e¤ect. Increasing the pathogen weight was done with the intention that
this might help more patients. However, the e¤ect was actually detrimental, with more
patients ending up in the "not rescued" category.
In addition to the standard therapy and "4 knob" therapy results, we also administered
several uber standard therapies to the patient population. In Table 12, an array of di¤ering
doses given every hour over 72 hours is shown. Only one of these did not violate the CAMax
constraint for any of the patients. It is interesting to note that the dose regimen of 0.0008
CA-therapy/hr for 72 hours was able to rescue all patients, although it was not safe for all
patients (in fact, it was only unsafe for 1 patient). So, the dose regimen of 0.0006 CA-
therapy/hr for 72 hours was taken as the safe therapy to administer and, surprisingly, this
therapy does just as well as the "4 knob" therapy. However, the fact that this uber standard
therapy does better than either of the "2 knob" therapy scenarios and just as well as the "4
knob" therapy gives reason for pause. By this juncture, the need to modify the proles of
the patient population was apparent, as well as the need for a pathogen update and a cap
on CA levels. Thus, we essentially moved into Conguration 4, without troubleshooting the
ill-equipped Conguration 3 setup.
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Table 12: Uber Standard Therapy Exploration for Conguration 3
Conguration 3:
Uber Standard Therapy (U.S.T.) Exploration
575/1000 patients receive treatment; Percentages are out of 1000
U.S.T. dose per hour 0.0006 0.0008 0.001 0.002 0.0025 0.005 0.2
for 72 hours Safe Too Too Too Too Too Too
for all High High High High High High
Percentage Rescued 57.3% 57.5% 7.6% 7.6% 7.6% 8.5% 8.6%
Percentage Not Rescued 2% 0% 49.9% 49.9% 49.9% 49.0% 48.9%
However, before doing so, a direct pathogen update was tested on the patient population
from Conguration 3. "Direct" means that the model is synchronized with the patients
pathogen levels at the time it is checked (i.e. measured). We explored a range of time
intervals at which to check pathogen levels: every 1, 5, 10 or 20 hours. Table 13 shows
the results for these di¤erent cases, compared against Standard Therapy results in the rst
column and Targeted therapy results without a pathogen update in the second column.
The larger the time interval (i.e. every 20 hours compared to every hour), the less the
direct pathogen update helps, which makes sense. As nice as the direct pathogen update
is, it is not realistic and so, as was discussed previously, Conguration 4 includes an indirect
pathogen update.
5.4.5 Results: Conguration 4
Recall that in Conguration 4 a multi-patient simulation is carried out, patient proles are
generated di¤erently, a pathogen update is included, a 48 hour cap on elevated CA levels is
enforced, and the following other specications are made:
 Patient-model mismatch
 1000 patients considered, with di¤ering proles (i.e. di¤ering parameter values)
 Patient proles generated from choosing a uniformly distributed random value from a
specied range (ranges shown in Table 10 on page 219)
 N threshold = 0:05 (for determining when to initiate therapeutic intervention)
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Table 13: Direct Pathogen Update Exploration for Conguration 3
Conguration 3:
Direct Pathogen Update: every 1, 5, 10, or 20 hours
575/1000 patients receive treatment; Percentages are out of 1000
Therapy Type: Placebo NE/ST NE NE NE NE NE
Pathogen Update?: n/a no no yes yes yes yes
PU Check Time every x hrs: n/a n/a n/a 1 5 hrs 10hrs 20hrs
Percentage Rescued 7.3% 52.5% 45.4% 57.5% 52.8% 46.5% 45.4%
Percentage Not Rescued 50.2% 5.9% 12.1% 0.0% 4.7% 11.0% 12.1%
 Two Therapies: Anti-inammatory and proinammatory therapy (no extractions), given
on an hourly basis
 Objective function: k DDk22+k pPk22+k u1u1k22+k u2u2k22+k u1u1k22+k u2u2k22,
where the following are being minimized: damage levels, D, pathogen levels, P , changes
in dosing (u1 and u2) and total therapy given (u1 and u2) for both CA and N,
respectively.
  -weighting constants: various values explored
 CAMax = 0:6264
 NMax = 1:0
 Measured patient output variables: N and CA
 Model kpg = 0:8
 Pathogen update mechanism
 48 hour CA cap
 Model initial conditions: (P0; N; D;CA) = (0:5; 0; 0; 0:125)
 Patient initial conditions: (P0; N; D;CA) = (P0-random; 0; 0; CA0-random)
 m = 2 and h = 8
It would be nice to say that all the new features implemented in this conguration solved
the previous problems encountered, and that the results acquired were superb. However,
this case is really just another stepping stone in the development and custom-tailoring of
the NMPC algorithm. What can be said, is that at this point in the process the algorithm
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Table 14: Indirect Pathogen Update and 48 hours CA Cap Results for Conguration 4
Conguration 4:
INDIRECT Pathogen Update; 48 Hour CA maximum Cap
620/1000 patients receive treatment; Percentages are out of 620
Number of patients out of 620 given in parenthesis.
Therapy Type: Placebo NE NE/ST UST:
Indirect Pathogen Update?: no yes n/a 0.001/hr
PU Check Time every x hrs: n/a 4 hrs n/a for 72 hrs
Percentage Septic: 22.7% 0.0% 0.0% 23.7%
(141) (0) (0) (147)
Percentage Aseptic: 36.8% 81.1% 56.6% 35.0%
(228) (503) (351) (217)
Percentage Healthy: 40.5% 18.9% 43.4% 41.3%
(251) (117) (269) (256)
and subprograms have been rened from previous steps and many of them streamlined to
make running and compiling the results more e¢ cient than in the past. Also, many of the
technical issues that were a part of the previous congurations, especially #3, have been
ironed out. For instance, a post processing routine is implemented so that the outcomes
can be clearly classied and divided into categories (healthy, aseptic, septic) that give more
information about the results than just "rescued" or "not rescued." Though several of the
things mentioned seem minor, altogether they are important for producing and presenting
solid results that can be explained well and, if need be, reproduced.
The results for Conguration 4 are perhaps the most disappointing out of all the results,
simply because the expectations for this conguration were high. However, it once again
shows areas of the algorithm that need attention. Recall that these results are for a new
patient population whose parameters are generated di¤erently than before. Table 14 shows
the results for this conguration, as well as the placebo outcomes in the rst column, the
standard therapy results in the third column, and uber standard therapy results in the fourth
column.
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Targeted therapy does really poorly, compared to all the other treatments, especially
placebo. Apparently, the therapy is converting all the septic patients, and a number of
the otherwise healthy patients, into aseptic cases. Looking graphically at several patients
and the dosing prole generated from them, it was seen that the algorithm was prescribing
rather large amounts of the pro-inammatory therapy at the beginning, in order to eliminate
pathogen rapidly; however, inammation was being profusely generated and the level of the
anti-inammatory mediator even with the addition of anti-inammatory therapy could not
adequately suppress the inammation. In addition, the 48 hour CA cap that is enforced
in this conguration further prevents the system from controlling the inammation. Thus,
even those patients, who would otherwise be healthy, are harmed by this aggressive pathogen
elimination strategy. There are several reason why the algorithm is choosing to do this and
these are addressed in the next section where current and future conguration modications
are discussed.
Standard therapy does not do too much better than placebo or uber standard therapy,
but once again, it does better than targeted therapy. Still, in this case, it is likely that all the
septic cases turned into aseptic cases and some of the aseptic cases were converted to healthy.
In fact, consider the sum of the number of septic and aseptic patients in the Placebo column:
141 + 228 = 369. Also, consider the di¤erence between the number of healthy patients in
the Standard Therapy column and the number of healthy patients in the Placebo column:
269  251 = 18. Then the di¤erence between these two quantities is 369  18 = 351, which
is the number of aseptic patients in the Standard Therapy column. Thus, it appears that
18 of the aseptic patients became healthy with standard therapy, and all 141 of the septic
patients became aseptic with standard therapy. Hence, standard therapy is not a really
good therapy, since no septic patients are helped.
The results of Uber Standard Therapy are pretty close to the placebo results. It might
be the case that the uber standard therapy that was implemented was not strong enough to
exact any major di¤erences from the placebo results. This is another aspect that is in need
of modication and renement.
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5.4.6 Preliminary Results: Current/Future Congurations
The results for Conguration 4 brought up still other issues that were of concern. The
rst modication to be considered after Conguration 4 deals with the pathogen update
mechanism and NMax. In the strategy described in Conguration 3, an update only
occurs if the pathogen levels are high in the patient and low in the model. However, just as
important is the opposite case: when pathogen levels are high in the model and low in the
patient. Thus, as a new feature in the this current conguration, the models pathogen levels
are set to zero when pathogen levels are elevated in the model and low in the patient. Also,
the algorithm previously seemed to be applying the maximum amount of pro-inammatory
therapy, in order to quickly eradicate pathogen. This occurs even in cases where the patient
might be able to naturally take care of pathogen or when only a little therapy is needed
to boost inammation enough to eliminate pathogen. An initial step taken simply reduced
NMax.
These two changes did meet with some success; however, even with this success, if the
number of patients who are septic in the placebo scenario are considered, not many of these
patients are rescued. Table 15 shows the results in the same format as was presented for
Conguration 4. It is mainly the aseptic patients who are helped. In addition, the level at
which NMax should be set is something that needs further exploration. Here, results for
an NMax value of 0.1 is shown. Preliminary results suggest that a value of 0.5 would be
better, however, this has not been tested on the entire patient population. This was tested
on 6 patients that had a variety of placebo outcomes: 1 septic patient, 3 aseptic patients,
and 2 healthy patients. (Note that all of these patients did reach the specied N threshold
of intervention.) With an NMax of 0.5, 5 out of the 6 patients resolved to healthy cases.
Another possible angle, with which we slightly experimented, deals with changing the
objective function weights on dosing for N. While adjusting the weights on dosing for
N seems like a reasonable course of action to follow, it did not produced the desired ef-
fect. First of all, penalizing the changes made to N doses,  u2, only means that drastic
changes to dosing are avoided. While this might help the initial N dose from being too
large, it usually means that the dosing occurs gradually. This, however, turns out to be a
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Table 15: Work in Progress Conguration featuring results from the implementation of an indirect 2-way
pathogen update
Work in Progress Conguration:
INDIRECT 2-way Pathogen Update; 48 Hour CA maximum Cap
Reduced NMax (0.1)
620/1000 patients receive treatment; Percentages are out of 620
Number of patients out of 620 given in parenthesis.
Therapy Type: Placebo NE NE/ST UST:
2-Way Pathogen Update?: no yes n/a 0.005/hr
PU Check Time every x hrs: n/a 4 hrs n/a for 72 hrs
Percentage Septic: 22.7% 21.9% 21.1% 23.1%
(141) (136) (131) (143)
Percentage Aseptic: 36.8% 17.7% 46.1% 31.5%
(228) (110) (286) (195)
Percentage Healthy: 40.5% 60.3% 32.7% 45.5%
(251) (374) (203) (282)
worse therapeutic strategy, since in some patients, the pathogen might be strongly driving
inammation, but the response is not strong enough in the beginning stages to be able to
overcome it. Instead, the gradual addition of an immune booster only adds to the already
accumulated inammation at a time when the anti-inammatory levels are also elevated.
Preliminary results show that a heavy  u2 weight cause all 6 of the test patients to end up
septic or aseptic, for NMax = 0:5, for which there was previously success for this group of
patients.
The heavy weight not only restricts the treatment from being given too sharply, but also
from being sharply cut o¤. By this time, even though pathogen might be eliminated, both
the inammatory and anti-inammatory levels are very high, so the addition of an anti-
inammatory therapy puts the patient in the situation described above in Conguration 4
with respect to the 48 hour CA cap: patients end up aseptic instead of healthy since the
amount of inammation in their system is decreasing due to the CA cap and the amount of
inammation, which may have been decreasing with the elevated CA levels, is on the rise
once again.
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Lastly, the underlying model under the current conguration is such that the algorithm
is actually unable to nd a successful therapy for it, meaning that the standard therapy
generated from the model does not even help the model itself to resolve to healthy, but
instead to an aseptic case. However, because of this, the treatment is really aggressive
toward eliminating pathogen rst and giving much anti-inammatory therapy afterward,
in an attempt to curb the inammation, at which it is actually unsuccessful. This is the
reason why in Table 15 the standard therapy converts septic patients into aseptic patients.
Additionally, for those patients who would be aseptic otherwise, the copious amounts of anti-
inammatory therapy prescribed by the standard therapy actually help some aseptic patients
to transfer to the healthy camp. Therefore, it is probably the case that the underlying model
should at least generate a therapy from which the model itself actually benets. In order
for this to happen under the current conguration, the models kpg and P0 values will have
to be modied. In fact, the current kpg value of 0.8 in the model is outside of the range
chosen for the individual patientskpg values, which was an oversight in this process.
Overall, the di¤erences in the results between the cases where patient-model mismatch
does not exist and the cases where it does exist are strikingly apparent. There are an
entirely di¤erent set of issues and di¢ culties that arise because of mismatch. Hence, there
are still other congurations to be found that are more e¤ective at dealing with the balance
between minimizing damage and pathogen levels and making the algorithm more sensitive
to patient-model mismatch.
5.5 DISCUSSION
The various congurations that have been explored thus far show that there are many facets
to the application of NMPC for nding proper therapies and dosing regimens for correcting
immune dysfunction. It remains to be seen whether the changes mentioned above in the
current/future conguration section will bring about more favorable results when applied to
a large patient population. There are also other things that need to be reexamined, such as
the size of the move horizon, m, and prediction horizon, h, as well as the objective function
weights ( ) in order to make sure that these tuning parameters are chosen thoughtfully in
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light of the many changes that the algorithm has undergone.
It was seen that only the four therapy module (briey discussed in Conguration 4) was
really able to help signicantly in converting both potentially aseptic and septic patients into
healthy ones. On the other hand, it appears that the two therapy cases are limited in their
ability to balance the objectives between minimizing damage and pathogen, objectives that
are at odds with one another. It might be the case that the options given to the algorithm
with respect to therapy types are either too many (e.g. the four therapy case) or are too
limited for the current model, meaning that the system, in some sense, might be too simple
either way for the application of NMPC. More success might be found if it is applied to a
larger model where there is a one-to-one correspondence between variables in the model and
mediators of the inammatory response. For example, in such models, there is more than
one anti-inammatory mediator and so changes to one may not have such drastic e¤ects on
the entire system as is seen in this smaller model. On the other hand, it might be much
more di¢ cult to troubleshoot any issues of the algorithm for such a large model.
There are many sub programs in addition to the main NMPC algorithm that were de-
veloped to take care of the various tasks along the way. These include programs to generate
patient prole data, process and compile patient outcomes after the NMPC data is cal-
culated, and to administer alternate therapies, along with other routines for visualization
and troubleshooting. The development phase and corresponding results discussed in the
previous sections were the culmination of a year long process which brought the idea of a
controller based therapy from a conceptual phase into an experimental design phase. The
results presented here are not as successful as what is desired and many challenges of this
approach have been exposed. Nonetheless, the idea of using a control-based algorithm to
generate appropriate therapy regimens only makes more sense in light of the fact that nd-
ing appropriate, successful therapies under precarious conditions is a nontrivial and di¢ cult
venture.
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6.0 CONCLUSION
The research presented in this manuscript covers a wide array of topics pertaining to the
process of understanding and controlling the acute inammatory response. Even the work
presented in Chapters 3 and 4, which can be considered apart from the context of inam-
mation, was motivated by this area of research. The chapters are strung together with
this common thread, and many interesting results as well as challenging problems have been
reached.
The work in Chapter 2 gives a strong argument supporting the viewpoint that endotoxin
tolerance and potentiation are characteristics of the dynamics of the acute inammatory
response. It highlights the importance of the timing of the di¤erent mediators involved
in the response and how preconditioning can shift the system into a very di¤erent state
compared to the state of the non-preconditioned system.
The desire to graphically illustrate these di¤ering states, with respect to the threshold
that exists between the healthy and unhealthy states, led to the stable manifold code im-
plementation in Chapter 3. Although the method to generate the manifold mesh is due to
Krauskopf and Osinga [63], many parts of the implementation of it are not explicitly a part
of their paper. Hence, the task of creating the computer code is quite a formidable one,
with many challenges.
Although the manifold program presented has some shortcomings, as far as we know,
there is not yet a program that exists for use in the academic community. Therefore, this
MatLab implementation might be the rst published code of a program for generating 2D
(un)stable manifolds of 3D ODE systems. The topic of numerically generating a manifold
is interesting enough to, in the future, continue renement of the current program or to
implement other methods that have been published in the literature, which do not have a
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workable code available.
In addition to Chapter 2 inspiring the work on manifolds, it also brought to light the
transient nature of tolerance. The magnitude of the tolerance reduction is very much
dependent on the levels of the various mediators and the timing of the precondition dose(s).
Figure 13 nicely shows this transient behavior. This aspect of the endotoxin tolerance
research led to the work in Chapter 4, where tolerance-like behavior is studied from a purely
dynamical systems point of view.
Chapter 4, which contains perhaps the most interesting results (at least mathematically
speaking), presents a novel research topic, regarding when the tolerance behavior can and
cannot occur in a given di¤erential equations system. A plethora of original results are
presented and in the case of 2D linear systems, in particular, the results give a completely
systematic way to identify exactly where tolerance will occur. In the case of 2D nonlinear
systems, the methods for identifying tolerance are not as exact as the linear case. However,
the methods for 2D nonlinear systems are a creative use of the combination of isoclines and
the concept of inhibition and can narrow down the possibilities of where tolerance can occur
in a system.
Most of the results are restricted to the two-dimensional case, so this area of research
has room for expansion and further generalization. For example, knowing for which initial
conditions tolerance will exist does not imply that the time at which tolerance is exhibited
is known. For instance, in the linear case, it can be determined for a given < (x0; y0); s >
whether or not there exists a  > 0, such that  1() < 1(), but the value of  remains
unknown. Also, results are based on shifting the graph of (t) by the amount x0 in the
x-direction and not shifting the graph at all in the y-direction. A more generic "hit" size in
both directions could be considered. In particular, the linear results rely on the assumption
that the shift was only in the x-direction and only by the amount x0. Hence, there are
several di¤erent angles from which to further explore this area of research in the future.
Lastly, Chapter 5 presents a preliminary, but thorough, exposition on the use of nonlinear
model predictive control (NMPC) as a tool for generating and implementing immunomod-
ulation strategies and therapies. A majority of the work regarding modeling the acute
inammatory response has focussed on understanding the dynamics of the interactions be-
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tween mediators and how they relate to the di¤erent outcomes. Here, the application of
NMPC is explored for the purpose of controlling the inammatory response. NMPC has not
before been applied for the purpose of controlling systemic inammation via immunomodu-
lation strategies. As was discussed in Chapter 5, there are many challenges that exist, and
this research area is still very much an ongoing one.
As a whole, this dissertation contains a breadth of results that are both interesting
and insightful for the mathematical community, as well as for those in systems biology.
Bridging the gap between the creation and use of mathematical/engineering tools and their
application in the clinical realm is an immense challenge. The work presented here and
that to be conducted in the future is focussed on continuing this bridging process, keeping
in mind that todays ideas are tomorrows realities.
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APPENDIX
GLOSSARY OF ABBREVIATIONS
 ABM: Agent Based Model
 AIDose: Anti-inammatory Dose
 CA: Anti-inammatory mediator (Cytokine - Anti-inammatory)
 D: Damage
 EVC: Eigenvector Conguration
 HIV: Human Immunodeciency Virus
 HMG-1:
 IL-10: Interleukin-10
 IL-12: Interleukin-12
 IL-6: Interleukin-6
 LPS: Lipopolysaccharide
 MPC: Model Predictive Control
 N: Activated Phagocytes (i.e. Neutrophils)
 NE: No Extraction
 NMPC: Nonlinear Model Predictive Control
 ODE: Ordinary Di¤erential Equations
 P: Pathogen
 PE: Pathogen Endotoxin
 PIDose: Proinammatory Dose
 PU: Pathogen Update
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 R+: The set of positive real numbers
 RHS: Right Hand Side
 ST: Standard Therapy
 TGF-1: Transforming Growth Factor-1
 TNF: Tumor Necrosis Factor
 UST: Uber Standard Therapy
 WE: With Extraction
 W 1: All Weighting parameters of the objective function are identically equal to 1
 WLOG: Without Loss Of Generality
 Ws(x0): Global stable manifold of the xed point, x0
 Wsloc(x0): Local stable manifold of the xed point, x0
 Wu(x0): Global unstable manifold of the xed point, x0
 Wuloc(x0): Local unstable manifold of the xed point, x0
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